[As of March 2019]
The following table shows a list of patent term extension applications filed with Japanese Patent Office from 2016 to 2019.
The list includes patent term extension application numbers, patent numbers, Drug names. The drug names were translated from Japanese to English by machine translation.
○: Application
■: Granted
| Application No. | Patent No. | Drugs |
|---|---|---|
| 2018-700408 (○) | JP6034327 | Name of sale: Linzess Tablet 0.25 mg General name: linaclotide |
| 2018-700407 (○) | JP5770629 | Name of sale: Linzess Tablet 0.25 mg General name: linaclotide |
| 2018-700406 (○) | JP5748791 | Name of sale: Linzess Tablet 0.25 mg General name: linaclotide |
| 2018-700405 (○) | JP5563384 | Name of sale: Linzess Tablet 0.25 mg General name: linaclotide |
| 2018-700404 (○) | JP5553132 | Name of sale: Linzess Tablet 0.25 mg General name: linaclotide |
| 2018-700403 (○) | JP4584911 | Name of sale: Linzess Tablet 0.25 mg General name: linaclotide |
| 2018-700402 (○) | JP5537704 | (I) Name: Tagrisso Tablet 80 mg (ii) Active ingredient: Osimertinib mesylate |
| 2018-700401 (○) | JP5537704 | (I) Name: Tagrisso Tablet 40 mg (ii) Active Ingredient: Osimartinib Mesylate |
| 2018-700400 (○) | JP5427321 | (I) Name: Tagrisso Tablet 80 mg (ii) Active ingredient: Osimertinib mesylate |
| 2018-700399 (○) | JP5427321 | (I) Name: Tagrisso Tablet 40 mg (ii) Active Ingredient: Osimartinib Mesylate |
| 2018-700398 (○) | JP5820045 | Name of sale: ODEFSEY combination tablet active ingredient: rilpivirin hydrochloride, tenofovir alafenamide fumarate, emtricitabine |
| 2018-700397 (○) | JP4912309 | Name of sale: ODEFSEY combination tablet active ingredient: rilpivirin hydrochloride, tenofovir alafenamide fumarate, emtricitabine |
| 2018-700396 (○) | JP4822707 | Name of sale: ODEFSEY combination tablet active ingredient: rilpivirin hydrochloride, tenofovir alafenamide fumarate, emtricitabine |
| 2018-700395 (○) | JP4838396 | Name of sale: ODEFSEY combination tablet active ingredient: rilpivirin hydrochloride, tenofovir alafenamide fumarate, emtricitabine |
| 2018-700394 (○) | JP4150379 | CYCLANILIPROLE |
| 2018-700393 (○) | JP6117252 | Name of sale: Taltz subcutaneous injection 80 mg auto injector General name: Ixekizumab (genetically modified) |
| 2018-700392 (○) | JP6117252 | Name of sale: Taltz subcutaneous injection 80 mg syringe Common name: Ixekizumab (genetically modified) |
| 2018-700391 (○) | JP5063612 | Name of sale: Taltz subcutaneous injection 80 mg auto injector General name: Ixekizumab (genetically modified) |
| 2018-700390 (○) | JP5063612 | Name of sale: Taltz subcutaneous injection 80 mg syringe Common name: Ixekizumab (genetically modified) |
| 2018-700389 (○) | JP5330347 | Metacam 2% Injection (active ingredient: meloxicam) |
| 2018-700388 (○) | JP5729564 | Types of pesticides: Fentrazamide, benzobicyclon, metazosulfuron wettable powder Name of pesticides: Sky flowable Types of active ingredients: 1- {3-chloro-1-methyl-4-[(5RS) -5 , 6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2018-700386 (○) | JP5488778 | Types of pesticides: Dimethamethrin, Dimron, tefuryl trione, metazosulfuron granules Name of pesticides: Lebras 1 kg granules Types of active ingredients: 1- {3-Chloro-1-methyl-4-[( 5RS) -5,6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2018-700385 (○) | JP5488778 | Types of pesticides: Fentrazamide, benzobicyclon, metazosulfuron granules Name of pesticides: Sky 1 kg granules Types of active ingredients: 1- {3-Chloro-1-methyl-4-[(5RS) -5,6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2018-700384 (○) | JP5488778 | Types of pesticides: Dimron, pyraclonyl, benzobicyclon, metazosulfuron granules Name of pesticides: Geppard 1 kg granules Types of active ingredients: 1- {3-chloro-1-methyl-4-[( 5RS) -5,6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2018-700383 (○) | JP3982542 | Types of pesticides: Fentrazamide, benzobicyclon, metazosulfuron granules Name of pesticides: Heavenly jumbo Types of active ingredients: 1- {3-chloro-1-methyl-4-[(5RS) -5, 6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2018-700382 (○) | JP5599158 | Name of sale: YERVOY Intravenous Drip Solution 50mg Active Ingredient: Ipilimumab (genetically modified) |
| 2018-700379 (○) | JP6313777 | Musiotil |
| 2018-700378 (○) | JP5090351 | Pesticide name: Decide flowable Active ingredient: (common name) pyraziflumid (chemical name) N- (3 ', 4'-difluorobiphenyl-2-yl) -3- (trifluoromethyl) pyrazine -2-carboxamide (IUPAC name) |
| 2018-700377 (○) | JP5246709 | General name: Leucine-rich α2 glycoprotein kit (84097000) Product name: Nanopier LRG Components involved in the reaction system Anti-human LRG mouse monoclonal antibody sensitized latex |
| 2018-700376 (○) | JP6325627 | Name: EFIENT OD Tablet 20 mg Active Ingredient: Prasugrel hydrochloride |
| 2018-700375 (○) | JP5363307 | Name: EFIENT OD Tablet 20 mg Active Ingredient: Prasugrel hydrochloride |
| 2018-700374 (○) | JP5289975 | Name: EFIENT OD Tablet 20 mg Active Ingredient: Prasugrel hydrochloride |
| 2018-700373 (○) | JP4874482 | Name: EFIENT OD Tablet 20 mg Active Ingredient: Prasugrel hydrochloride |
| 2018-700372 (○) | JP4029974 | Name: EFIENT OD Tablet 20 mg Active Ingredient: Prasugrel hydrochloride |
| 2018-700371 (○) | JP4001199 | Name: EFIENT OD Tablet 20 mg Active Ingredient: Prasugrel hydrochloride |
| 2018-700370 (○) | JP6275644 | Name of sale: Metanaa combination tablet HD Active ingredient: anagliptin and metformin hydrochloride |
| 2018-700369 (○) | JP6275644 | Name of sale: Metanaa combination tablet LD Active ingredient: anagliptin and metformin hydrochloride |
| 2018-700368 (○) | JP5922310 | Name of sale: Metanaa combination tablet HD Active ingredient: anagliptin and metformin hydrochloride |
| 2018-700367 (○) | JP5922310 | Name of sale: Metanaa combination tablet LD Active ingredient: anagliptin and metformin hydrochloride |
| 2018-700366 (○) | JP4643760 | Name of sale: Metanaa combination tablet HD Active ingredient: anagliptin and metformin hydrochloride |
| 2018-700365 (○) | JP4643760 | Name of sale: Metanaa combination tablet LD Active ingredient: anagliptin and metformin hydrochloride |
| 2018-700364 (○) | JP4184378 | Name of sale: Metanaa combination tablet HD Active ingredient: anagliptin and metformin hydrochloride |
| 2018-700363 (○) | JP4184378 | Name of sale: Metanaa combination tablet LD Active ingredient: anagliptin and metformin hydrochloride |
| 2018-700362 (○) | JP4557131 | Types of Pesticides: Amisulbrom · Shimoxanil Hydrating Agent Name of Pesticide: Dynamo Water Hydrating Agent Type of Active Ingredients: 3- (3-Bromo-6-fluoro-2-methylindol-1-ylsulfonyl ) -N, N-Dimethyl-1,2,4-triazole-1-sulfonamide |
| 2018-700361 (○) | JP5524220 | Lynparza Tablet 150 mg |
| 2018-700360 (○) | JP5524220 | Lynparza Tablet 100 mg |
| 2018-700359 (○) | JP5519097 | Name of Sale: Lynparza Tablet 150 mg Active Ingredient: Olaparib |
| 2018-700358 (○) | JP5519097 | Name of Sale: Lynparza Tablet 100mg Active Ingredient: Olaparib |
| 2018-700357 (○) | JP5719471 | Name of Sale: Lynparza Tablet 150 mg Active Ingredient: Olaparib |
| 2018-700356 (○) | JP5719471 | Name of Sale: Lynparza Tablet 100mg Active Ingredient: Olaparib |
| 2018-700355 (○) | JP4268651 | Name of Sale: Lynparza Tablet 150 mg Active Ingredient: Olaparib |
| 2018-700354 (○) | JP4268651 | Name of Sale: Lynparza Tablet 100mg Active Ingredient: Olaparib |
| 2018-700353 (○) | JP4027406 | Name of Sale: Lynparza Tablet 150 mg Active Ingredient: Olaparib |
| 2018-700352 (○) | JP4027406 | Name of Sale: Lynparza Tablet 100mg Active Ingredient: Olaparib |
| 2018-700351 (○) | JP6236071 | Name: IMBRUVICA Capsule 140mg Active Ingredient: Ibrutinib |
| 2018-700350 (○) | JP6057309 | Name: IMBRUVICA Capsule 140mg Active Ingredient: Ibrutinib |
| 2018-700349 (○) | JP4934197 | Name: IMBRUVICA Capsule 140mg Active Ingredient: Ibrutinib |
| 2018-700348 (○) | JP5837504 | Name of Sale: IMIFINDI Intravenous Drip Injection 500mg Active Ingredient: Durbarumab (genetically modified) |
| 2018-700347 (○) | JP5837504 | Name of Sale: IMIFINDI Intravenous Drip 120mg Active Ingredients: Durbarumab (genetically modified) |
| 2018-700346 (○) | JP5004390 | Name of sale: Imifindi IV 500 mg General name: Durbarumab (genetically modified) |
| 2018-700345 (○) | JP5004390 | Name of sale: imifindi intravenous infusion 120 mg Common name: Durbarumab (genetically modified) |
| 2018-700344 (○) | JP4896327 | Name of sale: Imifindi IV 500 mg General name: Durbarumab (genetically modified) |
| 2018-700343 (○) | JP4896327 | Name of sale: imifindi intravenous infusion 120 mg Common name: Durbarumab (genetically modified) |
| 2018-700342 (○) | JP5421974 | Name of sale: Mekinist tablet 2 mg Active ingredient: (Common name) Trametinib dimethyl sulfoxide adduct |
| 2018-700341 (○) | JP5421974 | Name of sale: Mekinist tablet 0.5 mg Active ingredient: (Common name) Trametinib dimethyl sulfoxide adduct |
| 2018-700340 (○) | JP4913768 | Name of sale: Mekinist tablet 2 mg Active ingredient: (Common name) Trametinib dimethyl sulfoxide adduct |
| 2018-700339 (○) | JP4913768 | Name of sale: Mekinist tablet 0.5 mg Active ingredient: (Common name) Trametinib dimethyl sulfoxide adduct |
| 2018-700338 (○) | JP4163738 | Name of sale: Mekinist tablet 2 mg Active ingredient: (Common name) Trametinib dimethyl sulfoxide adduct |
| 2018-700337 (○) | JP4163738 | Name of sale: Mekinist tablet 0.5 mg Active ingredient: (Common name) Trametinib dimethyl sulfoxide adduct |
| 2018-700336 (○) | JP5963013 | (I) Name of sale: Gazaiba Drip IV 1000 mg (ii) Active ingredient: Obinutuzumab |
| 2018-700335 (○) | JP5646626 | (I) Name of sale: Gazaiba Drip IV 1000 mg (ii) Active ingredient: Obinutuzumab |
| 2018-700334 (○) | JP5881950 | Name of Sale: Gazaiba Intravenous Drip Injection 1000 mg Active Ingredient: Obinutuzumab (genetically modified) |
| 2018-700333 (○) | JP5232352 | Name of sale: Refexia for intravenous injection 2000 Active ingredient: Nonacog beta pegol (genetically modified) |
| 2018-700332 (○) | JP5232352 | Name of sales: 1000 for intravenous injection of |
| 2018-700331 (○) | JP5232352 | Name of sale: Lexixia for intravenous injection 500 Active ingredient: Nonacog beta pegol (genetically modified) |
| 2018-700330 (○) | JP5457185 | Name of sale: Refexia for intravenous injection 2000 Active ingredient: Nonacog beta pegol (genetically modified) |
| 2018-700329 (○) | JP5457185 | Name of sales: 1000 for intravenous injection of |
| 2018-700328 (○) | JP5457185 | Name of sale: Lexixia for intravenous injection 500 Active ingredient: Nonacog beta pegol (genetically modified) |
| 2018-700327 (○) | JP5258809 | Name of sale: Refexia for intravenous injection 2000 Active ingredient: Nonacog beta pegol (genetically modified) |
| 2018-700326 (○) | JP5258809 | Name of sales: 1000 for intravenous injection of |
| 2018-700325 (○) | JP5258809 | Name of sale: Lexixia for intravenous injection 500 Active ingredient: Nonacog beta pegol (genetically modified) |
| 2018-700324 (○) | JP6316784 | Name of sale: Refexia for intravenous injection 2000 Active ingredient: Nonacog beta pegol (genetically modified) |
| 2018-700323 (○) | JP6316784 | Name of sales: 1000 for intravenous injection of |
| 2018-700322 (○) | JP6316784 | Name of sale: Lexixia for intravenous injection 500 Active ingredient: Nonacog beta pegol (genetically modified) |
| 2018-700321 (○) | JP6235521 | Name of Sale: Gazaiba Intravenous Drip Injection 1000mg Active Ingredient: Obinutuzumab (genetically modified) |
| 2018-700320 (○) | JP4653109 | Name of Sale: Gazaiba Intravenous Drip Injection 1000mg Active Ingredient: Obinutuzumab (genetically modified) |
| 2018-700319 (○) | JP6154039 | Name of Sale: Gazaiba Intravenous Drip Injection 1000mg Active Ingredient: Obinutuzumab (genetically modified) |
| 2018-700318 (○) | JP5547709 | Name of Sale: Gazaiba Intravenous Drip Injection 1000mg Active Ingredient: Obinutuzumab (genetically modified) |
| 2018-700317 (○) | JP6126014 | Name of sale: Mekinist tablet 2 mg Common name: Trametinib dimethyl sulfoxide adduct |
| 2018-700316 (○) | JP6126014 | Name of sale: Mekinist tablet 0.5 mg Common name: Trametinib dimethyl sulfoxide adduct |
| 2018-700315 (○) | JP5718929 | Name of sale: Mekinist tablet 2 mg Common name: Trametinib dimethyl sulfoxide adduct |
| 2018-700314 (○) | JP5718929 | Name of sale: Mekinist tablet 0.5 mg Common name: Trametinib dimethyl sulfoxide adduct |
| 2018-700313 (○) | JP5718929 | Name: Taffiner Capsule 75mg Common Name: Dabrafenib Mesilate |
| 2018-700312 (○) | JP5718929 | Name of sale: Taffiner capsule 50 mg Common name: Dabrafenib mesylate |
| 2018-700311 (○) | JP5426664 | Name: Taffiner Capsule 75mg Common Name: Dabrafenib Mesilate |
| 2018-700310 (○) | JP5426664 | Name of sale: Taffiner capsule 50 mg Common name: Dabrafenib mesylate |
| 2018-700309 (○) | JP6190360 | Name of Sale: Entaibio Intravenous Drip Injection 300mg Active Ingredient: Vedolizumab (genetically modified) |
| 2018-700308 (○) | JP6021959 | Name of Sale: Entaibio Intravenous Drip Injection 300mg Active Ingredient: Vedolizumab (genetically modified) |
| 2018-700307 (○) | JP5764524 | Name of Sale: Entaibio Intravenous Drip Injection 300mg Active Ingredient: Vedolizumab (genetically modified) |
| 2018-700306 (○) | JP6143416 | Name of sale: Ilaris subcutaneous injection solution 150 mg Active ingredient: canakinumab (genetically modified) |
| 2018-700305 (○) | JP6061747 | Name of sale: Ilaris subcutaneous injection solution 150 mg Active ingredient: canakinumab (genetically modified) |
| 2018-700304 (○) | JP6061747 | Name of sale: Ilaris for subcutaneous injection 150 mg Active ingredient: canakinumab (genetically modified) |
| 2018-700303 (○) | JP4271936 | Name of sale: Ilaris subcutaneous injection solution 150 mg Active ingredient: canakinumab (genetically modified) |
| 2018-700302 (○) | JP4271936 | Name of sale: Ilaris for subcutaneous injection 150 mg Active ingredient: canakinumab (genetically modified) |
| 2018-700301 (○) | JP6101010 | Common Name: Fidaxomycin Tablet Name: Duff Clear Tablet 200 mg Active Ingredient: Fidaxomycin |
| 2018-700300 (○) | JP5734545 | Common Name: Fidaxomycin Tablet Name: Duff Clear Tablet 200 mg Active Ingredient: Fidaxomycin |
| 2018-700299 (○) | JP5468388 | Common Name: Fidaxomycin Tablet Name: Duff Clear Tablet 200 mg Active Ingredient: Fidaxomycin |
| 2018-700298 (○) | JP5291624 | Types of pesticides: triaphamone, phenquinotrione, fentrazamide wettable powder pesticide name: Avanti flowable active ingredients · common name: triafamone, phenquinotrione, fentrazamide chemical name: 2 '-[ (4,6-Dimethoxy-1,3,5-triazin-2-yl) carbonyl] -1,1,6'-trifluoro-N-methylmethanesulfonanilide, 2- [8-chloro-3 , 4-Dihydro-4- (4-methoxyphenyl) -3-oxoquinoxalin-2-ylcarbonyl] cyclohexane-1,3-dione, 4- (2-chlorophenyl) -N-cyclohexyl-N-ethyl -4,5-Dihydro-5-oxo-1H-tetrazole-1-carboxamide |
| 2018-700297 (○) | JP5680898 | Name: TRERIEF OD Tablet 25mg Active Ingredient: Zonisamide |
| 2018-700296 (○) | JP3364481 | Name: TRERIEF OD Tablet 25mg Active Ingredient: Zonisamide |
| 2018-700295 (○) | JP3364481 | Name of sale: TRERIEF Tablet 25mg Active Ingredient: Zonisamide |
| 2018-700294 (○) | JP4361545 | Name of sale: Opdivo IV 100 mg Active ingredient name: Nivolumab (genetically modified) |
| 2018-700293 (○) | JP4361545 | Name of Sale: Opdivo Intravenous Drip Injection 20mg Active Ingredient Name: Nivolumab (genetically modified) |
| 2018-700292 (○) | JP5872377 | Name of sale: Opdivo IV 100 mg Active ingredient name: Nivolumab (genetically modified) |
| 2018-700291 (○) | JP5872377 | Name of Sale: Opdivo Intravenous Drip Injection 20mg Active Ingredient Name: Nivolumab (genetically modified) |
| 2018-700290 (○) | JP4409430 | Name of sale: Opdivo IV 100mg Active Ingredient: Nivolumab (genetically modified) |
| 2018-700289 (○) | JP4409430 | Name of Sale: Opdivo Intravenous Drip Injection 20mg Active Ingredient: Nivolumab (genetically modified) |
| 2018-700288 (○) | JP4093757 | Name of sale: YERVOY Intravenous Drip Solution 50mg Active Ingredient: Ipilimumab (genetically modified) |
| 2018-700287 (○) | JP5599158 | Name of sale: YERVOY Intravenous Drip Solution 50mg Active Ingredient: Ipilimumab (genetically modified) |
| 2018-700286 (○) | JP5819192 | Name of sale: Livecell TSAb "Otsuka" Components involved in the reaction system: Human-derived TSH receptor, cAMP-dependent calcium ion channel and aequorin-expressing Chinese hamster ovary-derived cells coelenterazine derivative calcium chloride |
| 2018-700285 (○) | JP5535640 | Fentostape 0.5 mg Ingredients and dose: 1 dose of fentanyl citrate per formulation unit (1 sheet) |
| 2018-700284 (○) | JP4987187 | Name of sale: Zactran injection for pig Active ingredient: Gamithromycin |
| 2018-700283 (○) | JP5564425 | Name of Sale: Bravect Spot for Cats Active Ingredient: Full Laranel |
| 2018-700282 (○) | JP4479917 | Name of Sale: Bravect Spot for Cats Active Ingredient: Full Laranel |
| 2018-700281 (○) | JP6246864 | Item (sale name): Bravect for spot cat Active ingredient: full laranel |
| 2018-700280 (○) | JP6014006 | Item (sale name): Bravect for spot cat Active ingredient: full laranel |
| 2018-700279 (○) | JP6002148 | Item (sale name): Bravect for spot cat Active ingredient: full laranel |
| 2018-700278 (○) | JP5411135 | Item (sale name): Bravect for spot cat Active ingredient: full laranel |
| 2018-700277 (○) | JP6122639 | Common Name: Ralte Gravir Potassium Tablet Name: Isentores Tablet 600 mg Active Ingredients: Raltegravir Potassium |
| 2018-700276 (○) | JP4705956 | Common Name: Ralte Gravir Potassium Tablet Name: Isentores Tablet 600 mg Active Ingredients: Raltegravir Potassium |
| 2018-700275 (○) | JP3927175 | Common Name: Ralte Gravir Potassium Tablet Name: Isentores Tablet 600 mg Active Ingredients: Raltegravir Potassium |
| 2018-700274 (○) | JP6200436 | Pesticide name: Fine save flowable (Meiji fine save flowable) Active ingredient name: Phlomethokine Active ingredient chemical name: 2-ethyl-3,7-dimethyl-6- [4- (trifluoromethoxy) phenoxy] -4 -Quinolyl methyl carbonate |
| 2018-700273 (○) | JP5697655 | Pesticide name: Fine save flowable (Meiji fine save flowable) Active ingredient name: Phlomethokine Active ingredient chemical name: 2-ethyl-3,7-dimethyl-6- [4- (trifluoromethoxy) phenoxy] -4 -Quinolyl methyl carbonate |
| 2018-700272 (○) | JP5558352 | Pesticide name: Fine save flowable (Meiji fine save flowable) Active ingredient name: Phlomethokine Active ingredient chemical name: 2-ethyl-3,7-dimethyl-6- [4- (trifluoromethoxy) phenoxy] -4 -Quinolyl methyl carbonate |
| 2018-700271 (○) | JP5128536 | Pesticide name: Fine save flowable (Meiji fine save flowable) Active ingredient name: Phlomethokine Active ingredient chemical name: 2-ethyl-3,7-dimethyl-6- [4- (trifluoromethoxy) phenoxy] -4 -Quinolyl methyl carbonate |
| 2018-700270 (○) | JP4319223 | Pesticide name: Fine save flowable (Meiji fine save flowable) Active ingredient name: Phlomethokine Active ingredient chemical name: 2-ethyl-3,7-dimethyl-6- [4- (trifluoromethoxy) phenoxy] -4 -Quinolyl methyl carbonate |
| 2018-700269 (○) | JP5844045 | (I) Name of sale: gelatin capsule 123 mg (ii) Common name: Migarastat hydrochloride |
| 2018-700268 (○) | JP6026268 | (I) Name of sale: gelatin capsule 123 mg (ii) Common name: Migarastat hydrochloride |
| 2018-700267 (○) | JP5107350 | (I) Name of sale: gelatin capsule 123 mg (ii) Common name: Migarastat hydrochloride |
| 2018-700266 (○) | JP6062582 | Name written in approval letter: Humira subcutaneously injected 80 mg pen 0.8 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2018-700265 (○) | JP6062582 | Name written in the written approval: Humira subcutaneous injection 40 mg pen 0.4 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2018-700264 (○) | JP6062582 | Name written on approval letter: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2018-700263 (○) | JP6062582 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2018-700262 (○) | JP5919606 | Name written in approval letter: Humira subcutaneously injected 80 mg pen 0.8 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2018-700261 (○) | JP5919606 | Name written in the written approval: Humira subcutaneous injection 40 mg pen 0.4 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2018-700260 (○) | JP5919606 | Name written on approval letter: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2018-700259 (○) | JP5919606 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2018-700258 (○) | JP5840364 | Name written in approval letter: Humira subcutaneously injected 80 mg pen 0.8 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2018-700257 (○) | JP5840364 | Name written in the written approval: Humira subcutaneous injection 40 mg pen 0.4 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2018-700256 (○) | JP5840364 | Name written on approval letter: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2018-700255 (○) | JP5840364 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2018-700254 (○) | JP4925582 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: Adalimumab (genetically modified) |
| 2018-700253 (○) | JP4759102 | Sujanu formulated tablet (as an active ingredient, sitagliptin phosphate hydrate and ipragliflozin L-proline) |
| 2018-700252 (○) | JP5210154 | Sujanu formulated tablet (as an active ingredient, sitagliptin phosphate hydrate and ipragliflozin L-proline) |
| 2018-700251 (○) | JP4913104 | Sujanu formulated tablet (as an active ingredient, sitagliptin phosphate hydrate and ipragliflozin L-proline) |
| 2018-700250 (○) | JP4222450 | Sujanu formulated tablet (as an active ingredient, sitagliptin phosphate hydrate and ipragliflozin L-proline) |
| 2018-700249 (○) | JP6168673 | Name of Sale: Orkedia Tablets 2 mg General Name of Active Ingredient: Evocalcet |
| 2018-700248 (○) | JP6168673 | Name of sale: Orkedia Tablets 1 mg General name of active ingredient: Evocarset |
| 2018-700247 (○) | JP5421974 | Name of sale: Mekinist tablet 2 mg Active ingredient: (Common name) Trametinib dimethyl sulfoxide adduct |
| 2018-700246 (○) | JP5421974 | Name of sale: Mekinist tablet 0.5 mg Active ingredient: (Common name) Trametinib dimethyl sulfoxide adduct |
| 2018-700245 (○) | JP4913768 | Name of sale: Mekinist tablet 2 mg Active ingredient: (Common name) Trametinib dimethyl sulfoxide adduct |
| 2018-700244 (○) | JP4913768 | Name of sale: Mekinist tablet 0.5 mg Active ingredient: (Common name) Trametinib dimethyl sulfoxide adduct |
| 2018-700243 (○) | JP4163738 | Name of sale: Mekinist tablet 2 mg Active ingredient: (Common name) Trametinib dimethyl sulfoxide adduct |
| 2018-700242 (○) | JP4163738 | Name of sale: Mekinist tablet 0.5 mg Active ingredient: (Common name) Trametinib dimethyl sulfoxide adduct |
| 2018-700241 (○) | JP5291624 | Types of pesticides: pyraclonyl-pyriminobac-methyl-phenquinotrione agent Pesticide name: emperor jumbo active ingredient / general name: pyraclonyl, pyriminoc methyl, phenquinotrione chemical name: 1- (3-Chloro-4,5,6,7-tetrahydropyrazolo [1,5-a] pyridin-2-yl) -5- [methyl (prop-2-ynyl) amino] pyrazole-4-carbo Nitrile methyl 2- (4,6-dimethoxypyrimidin-2-yloxy) -6- (1-methoxyiminoethyl) benzoate (IUPAC name: methyl 2- (4,6-dimethoxy-2) -Pyrimidinyloxy) -6- (1-methoxyiminoethyl) benzoate,) 2- [8-chloro-3,4-dihydro-4- (4-methoxyphenyl) -3-oxo] Nokisarin 2-ylcarbonyl] cyclohexane-1,3-dione |
| 2018-700240 (○) | JP5291624 | Types of pesticides: pyraclonyl-pyriminobac-methyl-phenquinotrione agent Pesticide name: emperor bean crush 250 active ingredient / general name: pyraclonyl, pyriminobac methyl, phenquinotrione chemistry Name: 1- (3-Chloro-4,5,6,7-tetrahydropyrazolo [1,5-a] pyridin-2-yl) -5- [methyl (prop-2-ynyl) amino] pyrazole-4 -Carbonitrile methyl 2- (4,6-dimethoxypyrimidin-2-yloxy) -6- (1-methoxyiminoethyl) benzoate (IUPAC name: methyl 2- (4,6-dimethoxy) -2-Pyrimidinyloxy) -6- (1-methoxyiminoethyl) benzoate), 2- [8-chloro-3,4-dihydro-4- (4-methoxyphenyl) -3-o Sokinokisarin 2-ylcarbonyl] cyclohexane-1,3-dione |
| 2018-700239 (○) | JP5291624 | Types of pesticides: pyraclonyl-pyriminobac-methyl-phenquinotrione granules Pesticide name: emperor 1 kg granules active ingredient / general name: pyraclonyl, pyriminocarb methyl, phenquinotrione Chemical name: 1- (3-chloro-4,5,6,7-tetrahydropyrazolo [1,5-a] pyridin-2-yl) -5- [methyl (prop-2-ynyl) amino] pyrazole -4-carbonitrile methyl 2- (4,6-dimethoxypyrimidin-2-yloxy) -6- (1-methoxyiminoethyl) benzoate (IUPAC name methyl 2- (4,6 -Dimethoxy-2-pyrimidinyloxy) -6- (1-methoxyiminoethyl) benzoate), 2- [8-chloro-3,4-dihydro-4- (4-methoxyphenyl) -3-o Sokinokisarin 2-ylcarbonyl] cyclohexane-1,3-dione |
| 2018-700238 (○) | JP5291624 | Types of pesticides: pyriminobac-methyl-fenquinotrione granules names of pesticides: 1 kg of beluga granules active ingredients / general names: pyriminobac-methyl, phenquinotrione chemical name: Methyl 2- (4,6-dimethoxypyrimidin-2-yloxy) -6- (1-methoxyiminoethyl) benzoate (IUPAC name: methyl 2- (4,6-dimethoxy-2-pyrimidinyloxy) -6- (1-Methoxyiminoethyl) benzoate), 2- [8-chloro-3,4-dihydro-4- (4-methoxyphenyl) -3-oxoquinoxalin-2-ylcarbonyl] cyclohexane- 1,3-dione |
| 2018-700237 (○) | JP5291624 | Types of pesticides: triaphamone, phenquinotrione, fentrazamide granules pesticide names: avanti 1 kg granules active ingredients · common names: triaphamone, phenquinotrione, fentrazamide chemical name: 2 ' -[(4,6-Dimethoxy-1,3,5-triazin-2-yl) carbonyl] -1,1,6'-trifluoro-N-methylmethanesulfonanilide, 2- [8-chloro -3,4-Dihydro-4- (4-methoxyphenyl) -3-oxoquinoxalin-2-ylcarbonyl] cyclohexane-1,3-dione, 4- (2-chlorophenyl) -N-cyclohexyl-N -Ethyl-4,5-dihydro-5-oxo-1H-tetrazole-1-carboxamide |
| 2018-700236 (○) | JP5291624 | Types of pesticides: triaphamone, fenquintrione, fentrazamide granules pesticide name: avanti jumbo active ingredients · common names: triafammon, fenquinorion, fentrazamide chemical name: 2 '-[( 4,6-Dimethoxy-1,3,5-triazin-2-yl) carbonyl] -1,1,6'-trifluoro-N-methylmethanesulfonanilide, 2- [8-chloro-3, 4-Dihydro-4- (4-methoxyphenyl) -3-oxoquinoxalin-2-ylcarbonyl] cyclohexane-1,3-dione, 4- (2-chlorophenyl) -N-cyclohexyl-N-ethyl- 4,5-Dihydro-5-oxo-1H-tetrazole-1-carboxamide |
| 2018-700235 (○) | JP6126014 | Name of sale: Mekinist tablet 2 mg Common name: Trametinib dimethyl sulfoxide adduct |
| 2018-700234 (○) | JP6126014 | Name of sale: Mekinist tablet 0.5 mg Common name: Trametinib dimethyl sulfoxide adduct |
| 2018-700233 (○) | JP5718929 | Name of sale: Mekinist tablet 2 mg Common name: Trametinib dimethyl sulfoxide adduct |
| 2018-700232 (○) | JP5718929 | Name of sale: Mekinist tablet 0.5 mg Common name: Trametinib dimethyl sulfoxide adduct |
| 2018-700231 (○) | JP5718929 | Name: Taffiner Capsule 75mg Common Name: Dabrafenib Mesilate |
| 2018-700230 (○) | JP5718929 | Name of sale: Taffiner capsule 50 mg Common name: Dabrafenib mesylate |
| 2018-700229 (○) | JP5426664 | Name: Taffiner Capsule 75mg Common Name: Dabrafenib Mesilate |
| 2018-700228 (○) | JP5426664 | Name of sale: Taffiner capsule 50 mg Common name: Dabrafenib mesylate |
| 2018-700227 (○) | JP5738509 | Brand name: Azilect Tablet 0.5 mg (active ingredient: rasagiline mesilate 0.78 mg) |
| 2018-700226 (○) | JP5738509 | Brand name: Azilekto Tablet 1 mg (active ingredient: rasagiline mesilate 1.56 mg) |
| 2018-700225 (○) | JP6046161 | (I) Name of sale: Ozenpick subcutaneous injection 2 mg (ii) Active ingredient: semaglutide (genetically modified) |
| 2018-700224 (○) | JP5726532 | (I) Name of sale: Ozenpick subcutaneous injection 2 mg (ii) Active ingredient: semaglutide (genetically modified) |
| 2018-700223 (○) | JP4585037 | (I) Name of sale: Ozenpick subcutaneous injection 2 mg (ii) Active ingredient: semaglutide (genetically modified) |
| 2018-700222 (○) | JP5209463 | (I) Name of sale: Ozenpick subcutaneous injection 2 mg (ii) Active ingredient: semaglutide (genetically modified) |
| 2018-700221 (○) | JP4949838 | (I) Name of sale: Ozenpick subcutaneous injection 2 mg (ii) Active ingredient: semaglutide (genetically modified) |
| 2018-700220 (○) | JP5558655 | (I) Name of sale: Ozenpick subcutaneous injection 2 mg (ii) Active ingredient: semaglutide (genetically modified) |
| 2018-700219 (○) | JP5681841 | Name of Sale: Orkedia Tablets 2mg Active Ingredient: Evocalcet |
| 2018-700218 (○) | JP5681841 | Name of Sale: Orkedia Tablets 1mg Active Ingredient: Evocalcet |
| 2018-700217 (○) | JP5829741 | Name of Sale: Orkedia Tablets 2mg Active Ingredient: Evocalcet |
| 2018-700216 (○) | JP5829741 | Name of Sale: Orkedia Tablets 1mg Active Ingredient: Evocalcet |
| 2018-700215 (○) | JP6013915 | Name of sale: HEMLIBRA subcutaneous injection 150 mg Active ingredient: Emicizumab (genetically modified) |
| 2018-700214 (○) | JP6013915 | Name of sale: HEMLIBRA subcutaneous injection 105 mg Active ingredient: Emicizumab (genetically modified) |
| 2018-700213 (○) | JP6013915 | Name of sale: HEMLIBRA subcutaneous injection 90 mg Active ingredient: Emicizumab (genetically modified) |
| 2018-700212 (○) | JP6013915 | Name of sale: HEMLIBRA subcutaneous injection 60 mg Active ingredient: Emicizumab (genetically modified) |
| 2018-700211 (○) | JP6013915 | Name of sale: HEMLIBRA subcutaneous injection 30 mg Active ingredient: Emicizumab (genetically modified) |
| 2018-700210 (○) | JP5438880 | Name of sale: HEMLIBRA subcutaneous injection 150 mg Active ingredient: Emicizumab (genetically modified) |
| 2018-700209 (○) | JP5438880 | Name of sale: HEMLIBRA subcutaneous injection 105 mg Active ingredient: Emicizumab (genetically modified) |
| 2018-700208 (○) | JP5438880 | Name of sale: HEMLIBRA subcutaneous injection 90 mg Active ingredient: Emicizumab (genetically modified) |
| 2018-700207 (○) | JP5438880 | Name of sale: HEMLIBRA subcutaneous injection 60 mg Active ingredient: Emicizumab (genetically modified) |
| 2018-700206 (○) | JP5438880 | Name of sale: HEMLIBRA subcutaneous injection 30 mg Active ingredient: Emicizumab (genetically modified) |
| 2018-700205 (○) | JP5246905 | Name of sale: HEMLIBRA subcutaneous injection 150 mg Active ingredient: Emicizumab (genetically modified) |
| 2018-700204 (○) | JP5246905 | Name of sale: HEMLIBRA subcutaneous injection 105 mg Active ingredient: Emicizumab (genetically modified) |
| 2018-700203 (○) | JP5246905 | Name of sale: HEMLIBRA subcutaneous injection 90 mg Active ingredient: Emicizumab (genetically modified) |
| 2018-700202 (○) | JP5246905 | Name of sale: HEMLIBRA subcutaneous injection 60 mg Active ingredient: Emicizumab (genetically modified) |
| 2018-700201 (○) | JP5246905 | Name of sale: HEMLIBRA subcutaneous injection 30 mg Active ingredient: Emicizumab (genetically modified) |
| 2018-700200 (○) | JP4917024 | Name of sale: HEMLIBRA subcutaneous injection 150 mg Active ingredient: Emicizumab (genetically modified) |
| 2018-700199 (○) | JP4917024 | Name of sale: HEMLIBRA subcutaneous injection 105 mg Active ingredient: Emicizumab (genetically modified) |
| 2018-700198 (○) | JP4917024 | Name of sale: HEMLIBRA subcutaneous injection 90 mg Active ingredient: Emicizumab (genetically modified) |
| 2018-700197 (○) | JP4917024 | Name of sale: HEMLIBRA subcutaneous injection 60 mg Active ingredient: Emicizumab (genetically modified) |
| 2018-700196 (○) | JP4917024 | Name of sale: HEMLIBRA subcutaneous injection 30 mg Active ingredient: Emicizumab (genetically modified) |
| 2018-700195 (○) | JP4580928 | Name of sale: SIGNIFOR LAR intramuscular injection kit 40 mg Active ingredient: Pasireotide pamoate |
| 2018-700195 (■) | JP4580928 | Name of sale: SIGNIFOR LAR intramuscular injection kit 40 mg Active ingredient: Pasireotide pamoate |
| 2018-700194 (○) | JP4580928 | Name of sale: SIGNIFOR LAR intramuscular injection kit 30 mg Active ingredient: Pasireotide pamoate |
| 2018-700194 (■) | JP4580928 | Name of sale: SIGNIFOR LAR intramuscular injection kit 30 mg Active ingredient: Pasireotide pamoate |
| 2018-700193 (○) | JP4580928 | Name of sale: SIGNIFOR LAR intramuscular injection kit 20 mg Active ingredient: Pasireotide pamoate |
| 2018-700193 (■) | JP4580928 | Name of sale: SIGNIFOR LAR intramuscular injection kit 20 mg Active ingredient: Pasireotide pamoate |
| 2018-700192 (○) | JP4580928 | Name of sale: SIGNIFOR LAR intramuscular injection kit 10 mg Active ingredient: Pasireotide pamoate |
| 2018-700192 (■) | JP4580928 | Name of sale: SIGNIFOR LAR intramuscular injection kit 10 mg Active ingredient: Pasireotide pamoate |
| 2018-700191 (○) | JP5507447 | Name of sale: SIGNIFOR LAR intramuscular injection kit 40 mg Active ingredient: Pasireotide pamoate |
| 2018-700191 (■) | JP5507447 | Name of sale: SIGNIFOR LAR intramuscular injection kit 40 mg Active ingredient: Pasireotide pamoate |
| 2018-700190 (○) | JP5507447 | Name of sale: SIGNIFOR LAR intramuscular injection kit 30 mg Active ingredient: Pasireotide pamoate |
| 2018-700190 (■) | JP5507447 | Name of sale: SIGNIFOR LAR intramuscular injection kit 30 mg Active ingredient: Pasireotide pamoate |
| 2018-700189 (○) | JP5507447 | Name of sale: SIGNIFOR LAR intramuscular injection kit 20 mg Active ingredient: Pasireotide pamoate |
| 2018-700189 (■) | JP5507447 | Name of sale: SIGNIFOR LAR intramuscular injection kit 20 mg Active ingredient: Pasireotide pamoate |
| 2018-700188 (○) | JP5507447 | Name of sale: SIGNIFOR LAR intramuscular injection kit 10 mg Active ingredient: Pasireotide pamoate |
| 2018-700188 (■) | JP5507447 | Name of sale: SIGNIFOR LAR intramuscular injection kit 10 mg Active ingredient: Pasireotide pamoate |
| 2018-700187 (○) | JP4682145 | Name of sale: SIGNIFOR LAR intramuscular injection kit 40 mg Active ingredient: Pasireotide pamoate |
| 2018-700187 (■) | JP4682145 | Name of sale: SIGNIFOR LAR intramuscular injection kit 40 mg Active ingredient: Pasireotide pamoate |
| 2018-700186 (○) | JP4682145 | Name of sale: SIGNIFOR LAR intramuscular injection kit 30 mg Active ingredient: Pasireotide pamoate |
| 2018-700186 (■) | JP4682145 | Name of sale: SIGNIFOR LAR intramuscular injection kit 30 mg Active ingredient: Pasireotide pamoate |
| 2018-700185 (○) | JP4682145 | Name of sale: SIGNIFOR LAR intramuscular injection kit 20 mg Active ingredient: Pasireotide pamoate |
| 2018-700185 (■) | JP4682145 | Name of sale: SIGNIFOR LAR intramuscular injection kit 20 mg Active ingredient: Pasireotide pamoate |
| 2018-700184 (○) | JP4682145 | Name of sale: SIGNIFOR LAR intramuscular injection kit 10 mg Active ingredient: Pasireotide pamoate |
| 2018-700184 (■) | JP4682145 | Name of sale: SIGNIFOR LAR intramuscular injection kit 10 mg Active ingredient: Pasireotide pamoate |
| 2018-700183 (○) | JP3829118 | Name of sale: SIGNIFOR LAR intramuscular injection kit 40 mg Active ingredient: Pasireotide pamoate |
| 2018-700183 (■) | JP3829118 | Name of sale: SIGNIFOR LAR intramuscular injection kit 40 mg Active ingredient: Pasireotide pamoate |
| 2018-700182 (○) | JP3829118 | Name of sale: SIGNIFOR LAR intramuscular injection kit 30 mg Active ingredient: Pasireotide pamoate |
| 2018-700182 (■) | JP3829118 | Name of sale: SIGNIFOR LAR intramuscular injection kit 30 mg Active ingredient: Pasireotide pamoate |
| 2018-700181 (○) | JP3829118 | Name of sale: SIGNIFOR LAR intramuscular injection kit 20 mg Active ingredient: Pasireotide pamoate |
| 2018-700181 (■) | JP3829118 | Name of sale: SIGNIFOR LAR intramuscular injection kit 20 mg Active ingredient: Pasireotide pamoate |
| 2018-700180 (○) | JP3829118 | Name of sale: SIGNIFOR LAR intramuscular injection kit 10 mg Active ingredient: Pasireotide pamoate |
| 2018-700180 (■) | JP3829118 | Name of sale: SIGNIFOR LAR intramuscular injection kit 10 mg Active ingredient: Pasireotide pamoate |
| 2018-700179 (○) | JP4381137 | Name of sale: Zellyanz Tablets 5mg Active Ingredient: Tofacitinib Citrate |
| 2018-700178 (○) | JP4201135 | Name of sale: Zellyanz Tablets 5mg Active Ingredient: Tofacitinib Citrate |
| 2018-700177 (○) | JP4078074 | Name of sale: Zellyanz Tablets 5mg Active Ingredient: Tofacitinib Citrate |
| 2018-700176 (○) | JP5773875 | Common Name: Tedizolide Phosphate for Injection Name of Sales: Cibektro Intravenous Drip Injection 200 mg Active Ingredient: Tedizolide |
| 2018-700175 (○) | JP5773875 | Common Name: Tedizolide Phosphate Tablet Name: Shibektro Tablet 200 mg Active Ingredient: Tedizolide Phosphate |
| 2018-700174 (○) | JP5584705 | Common Name: Tedizolide Phosphate for Injection Name of Sales: Cibektro Intravenous Drip Injection 200 mg Active Ingredient: Tedizolide |
| 2018-700173 (○) | JP5584705 | Common Name: Tedizolide Phosphate Tablet Name: Shibektro Tablet 200 mg Active Ingredient: Tedizolide Phosphate |
| 2018-700172 (○) | JP4739229 | Common Name: Tedizolide Phosphate for Injection Name of Sales: Cibektro Intravenous Drip Injection 200 mg Active Ingredient: Tedizolide |
| 2018-700171 (○) | JP4739229 | Common Name: Tedizolide Phosphate Tablet Name: Shibektro Tablet 200 mg Active Ingredient: Tedizolide Phosphate |
| 2018-700170 (○) | JP4629036 | Name: Orquedia Tablets 2mg Active Ingredient: Evocalcet |
| 2018-700169 (○) | JP4629036 | Name of Sale: Orkedia Tablets 1mg Active Ingredient: Evocalcet |
| 2018-700168 (○) | JP5193881 | Name of sale: Tremfir subcutaneous injection 100 mg syringe Active ingredient: Gusercumab FB (as Gusercumab (genetically modified)) |
| 2018-700167 (○) | JP4733631 | General name: Retelmobil Injection Name: Previvin Intravenous Drip 240 mg Active Ingredient: Retelmobil |
| 2018-700166 (○) | JP4733631 | Name: Previvis Tablets 240mg Active Ingredients: Rethemobil |
| 2018-700165 (○) | JP5090351 | Name of Pesticide: Parade 15 Floorable Active Ingredient: (General Name) pyraziflumid (Chemical Name) N- (3 ', 4'-Difluorobiphenyl-2-yl) -3- (trifluoromethyl) pyrazine -2-carboxamide (IUPAC name) |
| 2018-700164 (○) | JP5090351 | Pesticide name: Parade 20 flowable Active ingredient: (general name) pyraziflumid (chemical name) N- (3 ', 4'-difluorobiphenyl-2-yl) -3- (trifluoromethyl) pyrazine-2- Carboxamide (IUPAC name) |
| 2018-700163 (○) | JP4463768 | Common Name: Sitagliptin Phosphate Hydrate / Ipragliflozin L-Proline |
| 2018-700162 (○) | JP3762407 | Common Name: Sitagliptin Phosphate Hydrate / Ipragliflozin L-Proline |
| 2018-700161 (○) | JP3727009 | Name of sale: Mircera injection syringe 12.5 micro g Active ingredient: Epoetin beta pegol (genetically modified) content of active ingredient: 1 epoetin beta pegol (genetically modified) in a syringe (0.3 mL) Contains 12.5 microg |
| 2018-700160 (○) | JP5840167 | Name of sale: Cingrix for injection Active ingredient: Varicella zoster virus gE antigen |
| 2018-700159 (○) | JP5420842 | Name of sale: Cingrix for injection Active ingredient: Varicella zoster virus gE antigen |
| 2018-700158 (○) | JP3967594 | Name of sale: Mircera injection syringe 12.5 microg Active ingredient: Epoetin beta pegol (genetically modified) |
| 2018-700157 (○) | JP5048871 | Lembima Capsule 4mg (active ingredient: lenvatinib mesylate) |
| 2018-700157 (■) | JP5048871 | Lembima Capsule 4mg (active ingredient: lenvatinib mesylate) |
| 2018-700156 (○) | JP4834553 | Lembima Capsule 4mg (active ingredient: lenvatinib mesylate) |
| 2018-700156 (■) | JP4834553 | Lembima Capsule 4mg (active ingredient: lenvatinib mesylate) |
| 2018-700155 (○) | JP4648835 | Lembima Capsule 4mg (active ingredient: lenvatinib mesylate) |
| 2018-700155 (■) | JP4648835 | Lembima Capsule 4mg (active ingredient: lenvatinib mesylate) |
| 2018-700154 (○) | JP3712393 | Lembima Capsule 4mg (active ingredient: lenvatinib mesylate) |
| 2018-700154 (■) | JP3712393 | Lembima Capsule 4mg (active ingredient: lenvatinib mesylate) |
| 2018-700153 (○) | JP4330313 | Pesticide type: Picalbutrazox water-dispersible powder Pesticide name: Picilox flowable Active ingredient: tert-butyl = (6-{[(Z)-(1-methyl-1H-5-tetrazolyl) ) (Phenyl) methylene] aminooxymethyl} -2-pyridyl) carbamate |
| 2018-700152 (○) | JP4330313 | Pesticide type: Picalbutrazox water-dispersible powder Pesticide name: Picilox flowable Active ingredient: tert-butyl = (6-{[(Z)-(1-methyl-1H-5-tetrazolyl) ) (Phenyl) methylene] aminooxymethyl} -2-pyridyl) carbamate |
| 2018-700151 (○) | JP4330313 | Types of pesticides: picalbutrazox water dispersible powder Name of pesticides: naefine flowable active ingredient: tert-butyl = (6-{[(Z)-(1-methyl-1H-5-tetrazolyl) ) (Phenyl) methylene] aminooxymethyl} -2-pyridyl) carbamate |
| 2018-700150 (○) | JP4330313 | Types of Pesticides: Picalbutrazox Powder Name of Pesticides: Nae Fine Powder Active Ingredients: tert-Butyl = (6-{[(Z)-(1-Methyl-1H-5-tetrazolyl) (phenyl) ) Methylene] aminooxymethyl} -2- pyridyl) carbamate |
| 2018-700149 (○) | JP5285070 | Types of pesticides: picalbutrazox water dispersible powder Name of pesticides: naefine flowable active ingredient: tert-butyl = (6-{[(Z)-(1-methyl-1H-5-tetrazolyl) ) (Phenyl) methylene] aminooxymethyl} -2-pyridyl) carbamate |
| 2018-700148 (○) | JP5285070 | Types of Pesticides: Picalbutrazox Powder Name of Pesticides: Nae Fine Powder Active Ingredients: tert-Butyl = (6-{[(Z)-(1-Methyl-1H-5-tetrazolyl) (phenyl) ) Methylene] aminooxymethyl} -2- pyridyl) carbamate |
| 2018-700147 (○) | JP5173126 | Isofetamide |
| 2018-700146 (○) | JP5702933 | Trifafamon, fenquinotrione, fentrazamide granules Council energy jumbo 2 '-[(4,6-dimethoxy-1,3,5-triazine-2-yl) carbonyl] -1,1,6' -Trifluoro-N-methylmethanesulfonanilide (general name: triaphamone), 2- [8-chloro-3,4-dihydro-4- (4-methoxyphenyl) -3-oxoquinoxalin-2-ylcarbonyl] cyclohexane 1,3-1,3-dione (general name: phenquinotrione), and 4- (2-chlorophenyl) -N-cyclohexyl-N-ethyl-4,5-dihydro-5-oxo-1H-tetrazole-1-carboxamide Common name: Fentrazamide) |
| 2018-700146 (■) | JP5702933 | (4) Names of pesticides subject to disposal Council energy jumbo (5) Active ingredient compounds subject to disposal 2 '-[(4,6-dimethoxy-1,3 , 5-Triazin-2-yl) carbonyl] -1,1,6'-trifluoro-N-methylmethanesulfonanilide (General name: triafamone), 2- [8-chloro-3,4-dihydro-4- (4-Methoxyphenyl) -3-oxoquinoxalin-2-ylcarbonyl] cyclohexane-1,3-dione (General name: phenquinotrione), and 4- (2-chlorophenyl) -N-cyclohexyl-N-ethyl- 4,5-Dihydro-5-oxo-1H-tetrazole-1-carboxamide (General name: fentrazamide) |
| 2018-700145 (○) | JP5702933 | Trifafamon, phenquinotrione, fentrazamide granules Council energy 1 kg granules 2 '-[(4,6-dimethoxy-1,3,5-triazine-2-yl) carbonyl] -1,1 , 6'-Trifluoro-N-methylmethanesulfonanilide (General name: triaphamone), 2- [8-chloro-3,4-dihydro-4- (4-methoxyphenyl) -3-oxoquinoxalin-2-yl [Carbonyl] cyclohexane-1,3-dione (General name: phenquinotrione), and 4- (2-chlorophenyl) -N-cyclohexyl-N-ethyl-4,5-dihydro-5-oxo-1H-tetrazole-1 -Carboxamide (General name: fentrazamide) |
| 2018-700145 (■) | JP5702933 | Triafammon fenquinotrione fentrazamide granules |
| 2018-700144 (○) | JP5097116 | Trifafamon, fenquinotrione, fentrazamide granules Council energy jumbo 2 '-[(4,6-dimethoxy-1,3,5-triazine-2-yl) carbonyl] -1,1,6' -Trifluoro-N-methylmethanesulfonanilide (general name: triaphamone), 2- [8-chloro-3,4-dihydro-4- (4-methoxyphenyl) -3-oxoquinoxalin-2-ylcarbonyl] cyclohexane 1,3-1,3-dione (general name: phenquinotrione), and 4- (2-chlorophenyl) -N-cyclohexyl-N-ethyl-4,5-dihydro-5-oxo-1H-tetrazole-1-carboxamide Common name: Fentrazamide) |
| 2018-700144 (■) | JP5097116 | Triafammon fenquinotrione fentrazamide granules |
| 2018-700143 (○) | JP5097116 | Trifafamon, phenquinotrione, fentrazamide granules Council energy 1 kg granules 2 '-[(4,6-dimethoxy-1,3,5-triazine-2-yl) carbonyl] -1,1 , 6'-Trifluoro-N-methylmethanesulfonanilide (General name: triaphamone), 2- [8-chloro-3,4-dihydro-4- (4-methoxyphenyl) -3-oxoquinoxalin-2-yl [Carbonyl] cyclohexane-1,3-dione (General name: phenquinotrione), and 4- (2-chlorophenyl) -N-cyclohexyl-N-ethyl-4,5-dihydro-5-oxo-1H-tetrazole-1 -Carboxamide (General name: fentrazamide) |
| 2018-700143 (■) | JP5097116 | Triafammon fenquinotrione fentrazamide granules |
| 2018-700142 (○) | JP5069107 | Trifafamon, fenquinotrione, fentrazamide granules Council energy jumbo 2 '-[(4,6-dimethoxy-1,3,5-triazine-2-yl) carbonyl] -1,1,6' -Trifluoro-N-methylmethanesulfonanilide (general name: triaphamone), 2- [8-chloro-3,4-dihydro-4- (4-methoxyphenyl) -3-oxoquinoxalin-2-ylcarbonyl] cyclohexane 1,3-1,3-dione (general name: phenquinotrione), and 4- (2-chlorophenyl) -N-cyclohexyl-N-ethyl-4,5-dihydro-5-oxo-1H-tetrazole-1-carboxamide Common name: Fentrazamide) |
| 2018-700142 (■) | JP5069107 | Triafammon fenquinotrione fentrazamide granules |
| 2018-700141 (○) | JP5069107 | Trifafamon, phenquinotrione, fentrazamide granules Council energy 1 kg granules 2 '-[(4,6-dimethoxy-1,3,5-triazine-2-yl) carbonyl] -1,1 , 6'-Trifluoro-N-methylmethanesulfonanilide (General name: triaphamone), 2- [8-chloro-3,4-dihydro-4- (4-methoxyphenyl) -3-oxoquinoxalin-2-yl [Carbonyl] cyclohexane-1,3-dione (General name: phenquinotrione), and 4- (2-chlorophenyl) -N-cyclohexyl-N-ethyl-4,5-dihydro-5-oxo-1H-tetrazole-1 -Carboxamide (General name: fentrazamide) |
| 2018-700141 (■) | JP5069107 | Triafammon fenquinotrione fentrazamide granules |
| 2018-700140 (○) | JP5291624 | Types of pesticides: fenquinotrione granules Name of pesticides: 1 kg granules Zeta active ingredients / general names: fenquinotriones chemical name: 2- [8-chloro-3, 4 -Dihydro-4- (4-methoxyphenyl) -3-oxoquinoxalin-2-ylcarbonyl] cyclohexane-1,3-dione |
| 2018-700139 (○) | JP5097194 | Name of Sale: Orensia Intravenous Drip Injection 250mg Active Ingredient · Common Name: Abatacept |
| 2018-700138 (○) | JP5096369 | Name of Sale: Orensia Intravenous Drip Injection 250mg Active Ingredient · Common Name: Abatacept |
| 2018-700137 (○) | JP4496086 | Name of Sale: Orensia Intravenous Drip Injection 250mg Active Ingredient · Common Name: Abatacept |
| 2018-700136 (○) | JP5718372 | Name: Ikstanji Tablets 80mg Active Ingredient: Enzalutamide |
| 2018-700136 (■) | JP5718372 | Name: Ikstanji Tablets 80mg Active Ingredient: Enzalutamide |
| 2018-700135 (○) | JP5718372 | Name of sale: Ikstanji Tablets 40 mg Active ingredient: Enzalutamide |
| 2018-700135 (■) | JP5718372 | Name of sale: Ikstanji Tablets 40 mg Active ingredient: Enzalutamide |
| 2018-700134 (○) | JP5138753 | Name: Ikstanji Tablets 80mg Active Ingredient: Enzalutamide |
| 2018-700134 (■) | JP5138753 | Name: Ikstanji Tablets 80mg Active Ingredient: Enzalutamide |
| 2018-700133 (○) | JP5138753 | Name of sale: Ikstanji Tablets 40 mg Active ingredient: Enzalutamide |
| 2018-700133 (■) | JP5138753 | Name of sale: Ikstanji Tablets 40 mg Active ingredient: Enzalutamide |
| 2018-700132 (○) | JP4644737 | Name: Ikstanji Tablets 80mg Active Ingredient: Enzalutamide |
| 2018-700132 (■) | JP4644737 | Name: Ikstanji Tablets 80mg Active Ingredient: Enzalutamide |
| 2018-700131 (○) | JP4644737 | Name of sale: Ikstanji Tablets 40 mg Active ingredient: Enzalutamide |
| 2018-700131 (■) | JP4644737 | Name of sale: Ikstanji Tablets 40 mg Active ingredient: Enzalutamide |
| 2018-700130 (○) | JP5069561 | Zytiga Tablet 250 mg (Active Ingredient: "Abiraterone Acetate") |
| 2018-700129 (○) | JP5199667 | Zytiga Tablet 250 mg (Active Ingredient: "Abiraterone Acetate") |
| 2018-700128 (○) | JP5582662 | Name of sale: HARVONI combination tablet Common name: Recipesvir sohosbuvir combination drug Active ingredient: Ledipasvir and Sohosbuville |
| 2018-700128 (■) | JP5582662 | Name of sale: HARVONI combination tablet Common name: Recipesvir sohosbuvir combination drug Active ingredient: Ledipasvir and Sohosbuville |
| 2018-700127 (○) | JP5318085 | Name of sale: HARVONI combination tablet Common name: Recipesvir sohosbuvir combination drug Active ingredient: Ledipasvir and Sohosbuville |
| 2018-700127 (■) | JP5318085 | Name of sale: HARVONI combination tablet Common name: Recipesvir sohosbuvir combination drug Active ingredient: Ledipasvir and Sohosbuville |
| 2018-700126 (○) | JP6212678 | Name of sale: XOFLUZA Tablets 20 mg General name: Baloxavir Marboxil Chemical name: Carbonic acid ({(12aR) -12-[(11S) -7,8-difluoro-6,11-dihydrodibenzo [ b, e] thiepin-11-yl] -6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H- [1,4] oxazino [3,4-c] pyrido [2, 1-f] [1,2,4] triazin-7-yl} oxy) methylmethyl |
| 2018-700125 (○) | JP6212678 | Name of sale: XOFLUZA Tablet 10 mg Common name: Baloxavir Marboxil Chemical name: Carbonic acid ({(12aR) -12-[(11S) -7,8-difluoro-6,11-dihydrodibenzo [ b, e] thiepin-11-yl] -6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H- [1,4] oxazino [3,4-c] pyrido [2, 1-f] [1,2,4] triazin-7-yl} oxy) methylmethyl |
| 2018-700124 (○) | JP5988406 | Name of Sales: Hirudoid Form 0.3% Common Name: Heparin-like substance |
| 2018-700123 (○) | JP6267397 | Name of sale: XOFLUZA Tablet 20 mg Common name: Baloxavir Marboxil Chemical name: Carbonic acid ({(12aR) -12-[(11S) -7,8-difluoro-6,11-dihydro Dibenzo [b, e] thiepin-11-yl] -6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H- [1,4] oxazino [3,4-c] pyrido [ 2,1-f] [1,2,4] Triazin-7-yl} oxy) methylmethyl |
| 2018-700122 (○) | JP5553393 | Name of sale: XOFLUZA Tablet 10 mg Common name: Baloxavir Marboxil Chemical name: Carbonic acid ({(12aR) -12-[(11S) -7,8-difluoro-6,11-dihydro Dibenzo [b, e] thiepin-11-yl] -6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H- [1,4] oxazino [3,4-c] pyrido [ 2,1-f] [1,2,4] Triazin-7-yl} oxy) methylmethyl |
| 2018-700121 (○) | JP5553393 | Name of sale: XOFLUZA Tablet 20 mg Common name: Baloxavir Marboxil Chemical name: Carbonic acid ({(12aR) -12-[(11S) -7,8-difluoro-6,11-dihydro Dibenzo [b, e] thiepin-11-yl] -6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H- [1,4] oxazino [3,4-c] pyrido [ 2,1-f] [1,2,4] Triazin-7-yl} oxy) methylmethyl |
| 2018-700120 (○) | JP6249434 | Name of sale: XOFLUZA Tablet 20 mg Common name: Baloxavir Marboxil Chemical name: Carbonic acid ({(12aR) -12-[(11S) -7,8-difluoro-6,11-dihydro Dibenzo [b, e] thiepin-11-yl] -6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H- [1,4] oxazino [3,4-c] pyrido [ 2,1-f] [1,2,4] Triazin-7-yl} oxy) methylmethyl |
| 2018-700119 (○) | JP6249434 | Name of sale: XOFLUZA Tablet 10 mg Common name: Baloxavir Marboxil Chemical name: Carbonic acid ({(12aR) -12-[(11S) -7,8-difluoro-6,11-dihydro Dibenzo [b, e] thiepin-11-yl] -6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H- [1,4] oxazino [3,4-c] pyrido [ 2,1-f] [1,2,4] Triazin-7-yl} oxy) methylmethyl |
| 2018-700118 (○) | JP6267397 | Name of sale: XOFLUZA Tablet 10 mg Common name: Baloxavir Marboxil Chemical name: Carbonic acid ({(12aR) -12-[(11S) -7,8-difluoro-6,11-dihydrodibenzo [ b, e] thiepin-11-yl] -6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H- [1,4] oxazino [3,4-c] pyrido [2, 1-f] [1,2,4] triazin-7-yl} oxy) methylmethyl |
| 2018-700117 (○) | JP6002663 | An extract of the house dust mites mite and an extract of the house mite mites mite |
| 2018-700116 (○) | JP5442924 | An extract of the house dust mites mite and an extract of the house mite mites mite |
| 2018-700115 (○) | JP5584452 | Torpirate-Nicosulfuron |
| 2018-700114 (○) | JP4426729 | Name of sale: Dovobet gel Active ingredient: Calcipotriol hydrate / Betamethasone dipropionate |
| 2018-700113 (○) | JP4451061 | Name of sale: Dovobet gel Active ingredient: Calcipotriol hydrate / Betamethasone dipropionate |
| 2018-700112 (○) | JP6062582 | Name written in approval letter: Humira subcutaneous injection 20 mg syringe 0.2 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2018-700111 (○) | JP5919606 | Name written in approval letter: Humira subcutaneous injection 20 mg syringe 0.2 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2018-700110 (○) | JP5840364 | Name written in approval letter: Humira subcutaneous injection 20 mg syringe 0.2 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2018-700109 (○) | JP6061747 | Name of sale: Ilaris subcutaneous injection solution 150 mg Active ingredient: canakinumab (genetically modified) |
| 2018-700108 (○) | JP4271936 | Name of sale: Ilaris subcutaneous injection solution 150 mg Active ingredient: canakinumab (genetically modified) |
| 2018-700107 (○) | JP6143416 | Name of sale: Ilaris subcutaneous injection solution 150 mg Active ingredient: canakinumab (genetically modified) |
| 2018-700106 (○) | JP4718462 | Name of sale: Humalog injection Miliopen HD Common name: Insulin Lispro (genetically modified) |
| 2018-700105 (○) | JP5971830 | Name of sale: XOFLUZA Tablets 20 mg General name: Baloxavir Marboxil Chemical name: Carbonic acid ({(12aR) -12-[(11S) -7,8-difluoro-6,11-dihydrodibenzo [ b, e] thiepin-11-yl] -6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H- [1,4] oxazino [3,4-c] pyrido [2, 1-f] [1,2,4] triazin-7-yl} oxy) methylmethyl |
| 2018-700104 (○) | JP5971830 | Name of sale: XOFLUZA Tablet 10 mg Common name: Baloxavir Marboxil Chemical name: Carbonic acid ({(12aR) -12-[(11S) -7,8-difluoro-6,11-dihydrodibenzo [ b, e] thiepin-11-yl] -6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H- [1,4] oxazino [3,4-c] pyrido [2, 1-f] [1,2,4] triazin-7-yl} oxy) methylmethyl |
| 2018-700103 (○) | JP5708917 | Types of pesticides: Glyphosate potassium salt · flupoxam solution Name of pesticides: Roundup Maxroad AL III Types of active ingredients: Potassium = N-(phosphonomethyl) glycinate 1-[4 -Chloro-3- (2,2,3,3,3-pentafluoropropoxymethyl) phenyl] -5-phenyl-1H-1,2,4-triazole-3-carboxamide |
| 2018-700102 (○) | JP5719471 | Name of Sale: Lynparza Tablet 150 mg Active Ingredient: Olaparib |
| 2018-700102 (■) | JP5719471 | Name of Sale: Lynparza Tablet 150 mg Active Ingredient: Olaparib |
| 2018-700101 (○) | JP5719471 | Name of Sale: Lynparza Tablet 100mg Active Ingredient: Olaparib |
| 2018-700101 (■) | JP5719471 | Name of Sale: Lynparza Tablet 100mg Active Ingredient: Olaparib |
| 2018-700100 (○) | JP5547164 | Name of Sale: Lynparza Tablet 150 mg Active Ingredient: Olaparib |
| 2018-700100 (■) | JP5547164 | Name of Sale: Lynparza Tablet 150 mg Active Ingredient: Olaparib |
| 2018-700099 (○) | JP5547164 | Name of Sale: Lynparza Tablet 100mg Active Ingredient: Olaparib |
| 2018-700099 (■) | JP5547164 | Name of Sale: Lynparza Tablet 100mg Active Ingredient: Olaparib |
| 2018-700098 (○) | JP5524220 | Lynparza Tablet 150 mg |
| 2018-700098 (■) | JP5524220 | Lynparza Tablet 150 mg |
| 2018-700097 (○) | JP5524220 | Lynparza Tablet 100 mg |
| 2018-700097 (■) | JP5524220 | Lynparza Tablet 100 mg |
| 2018-700096 (○) | JP5519097 | Name of Sale: Lynparza Tablet 150 mg Active Ingredient: Olaparib |
| 2018-700096 (■) | JP5519097 | Name of Sale: Lynparza Tablet 150 mg Active Ingredient: Olaparib |
| 2018-700095 (○) | JP5519097 | Name of Sale: Lynparza Tablet 100mg Active Ingredient: Olaparib |
| 2018-700095 (■) | JP5519097 | Name of Sale: Lynparza Tablet 100mg Active Ingredient: Olaparib |
| 2018-700094 (○) | JP4268651 | Name of Sale: Lynparza Tablet 150 mg Active Ingredient: Olaparib |
| 2018-700093 (○) | JP4268651 | Name of Sale: Lynparza Tablet 100mg Active Ingredient: Olaparib |
| 2018-700092 (○) | JP4027406 | Name of Sale: Lynparza Tablet 150 mg Active Ingredient: Olaparib |
| 2018-700092 (■) | JP4027406 | Name of Sale: Lynparza Tablet 150 mg Active Ingredient: Olaparib |
| 2018-700091 (○) | JP4027406 | Name of Sale: Lynparza Tablet 100mg Active Ingredient: Olaparib |
| 2018-700091 (■) | JP4027406 | Name of Sale: Lynparza Tablet 100mg Active Ingredient: Olaparib |
| 2018-700090 (○) | JP5004390 | Name of sale: Thecentric intravenous drip infusion 1,200 mg Common name: atezolizumab (genetically modified) |
| 2018-700089 (○) | JP4896327 | Name of sale: Thecentric intravenous drip infusion 1,200 mg Common name: atezolizumab (genetically modified) |
| 2018-700088 (○) | JP5918782 | Etaner Cept BS subcutaneous injection 50 mg pen 1.0 mL "MA" |
| 2018-700088 (■) | JP5918782 | Etaner Cept BS subcutaneous injection 50 mg pen 1.0 mL "MA" |
| 2018-700087 (○) | JP5918782 | Etanercept BS subcutaneous injection 50 mg syringe 1.0 mL "MA" |
| 2018-700087 (■) | JP5918782 | Etanercept BS subcutaneous injection 50 mg syringe 1.0 mL "MA" |
| 2018-700086 (○) | JP5918782 | Etanercept BS subcutaneous injection 25 mg syringe 0.5 mL "MA" |
| 2018-700086 (■) | JP5918782 | Etanercept BS subcutaneous injection 25 mg syringe 0.5 mL "MA" |
| 2018-700085 (○) | JP5918782 | Etanercept BS 25 mg for subcutaneous injection "MA" |
| 2018-700085 (■) | JP5918782 | Etanercept BS 25 mg for subcutaneous injection "MA" |
| 2018-700084 (○) | JP5918782 | 10 mg "MA" for etanercept BS subcutaneous injection |
| 2018-700084 (■) | JP5918782 | 10 mg "MA" for etanercept BS subcutaneous injection |
| 2018-700083 (○) | JP5918850 | Etaner Cept BS subcutaneous injection 50 mg pen 1.0 mL "MA" |
| 2018-700083 (■) | JP5918850 | Etaner Cept BS subcutaneous injection 50 mg pen 1.0 mL "MA" |
| 2018-700082 (○) | JP5918850 | Etanercept BS subcutaneous injection 50 mg syringe 1.0 mL "MA" |
| 2018-700082 (■) | JP5918850 | Etanercept BS subcutaneous injection 50 mg syringe 1.0 mL "MA" |
| 2018-700081 (○) | JP5918850 | Etanercept BS subcutaneous injection 25 mg syringe 0.5 mL "MA" |
| 2018-700081 (■) | JP5918850 | Etanercept BS subcutaneous injection 25 mg syringe 0.5 mL "MA" |
| 2018-700080 (○) | JP6084161 | Rexalti Tablets 2 mg (General name: brexpiprazole) |
| 2018-700079 (○) | JP6084161 | Rexalti Tablets 1 mg (General name: brexpiprazole) |
| 2018-700078 (○) | JP4540700 | Rexalti Tablets 2 mg (General name: brexpiprazole) |
| 2018-700077 (○) | JP4540700 | Rexalti Tablets 1 mg (General name: brexpiprazole) |
| 2018-700076 (○) | JP4315393 | Rexalti Tablets 2 mg (General name: brexpiprazole) |
| 2018-700075 (○) | JP4315393 | Rexalti Tablets 1 mg (General name: brexpiprazole) |
| 2018-700074 (○) | JP4486494 | 1 mg for pesponsa instillation (common name: inotuzumab ozogamicin (genetically modified)) |
| 2018-700073 (○) | JP5756489 | Name of Sale: Vesponsa Intravenous Drip Injection 1mg Active Ingredient: Inotuzumab Ozogamicin |
| 2018-700072 (○) | JP5441971 | Name of Sale: Vesponsa Intravenous Drip Injection 1mg Active Ingredient: Inotuzumab Ozogamicin |
| 2018-700071 (○) | JP5153057 | Name of Sale: Vesponsa Intravenous Drip Injection 1mg Active Ingredient: Inotuzumab Ozogamicin |
| 2018-700070 (○) | JP5770783 | Name of sale: Fasenra hypodermic injection 30 mg syringe Common name: Benlilazumab (genetically modified) |
| 2018-700069 (○) | JP4886010 | Name of sale: Fasenra hypodermic injection 30 mg syringe Common name: Benlilazumab (genetically modified) |
| 2018-700068 (○) | JP4850922 | Name of sale: Fasenra hypodermic injection 30 mg syringe Common name: Benlilazumab (genetically modified) |
| 2018-700067 (○) | JP4368530 | Name of sale: Fasenra hypodermic injection 30 mg syringe Common name: Benlilazumab (genetically modified) |
| 2018-700066 (○) | JP4290423 | Name of sale: Fasenra hypodermic injection 30 mg syringe Common name: Benlilazumab (genetically modified) |
| 2018-700065 (○) | JP6178349 | Name of Sale product: Tecentrik Intravenous Drip Injection 1200 mg Active Ingredient: Atezolizumab (genetically modified) |
| 2018-700065 (■) | JP6178349 | Name of Sale product: Tecentrik Intravenous Drip Injection 1200 mg Active Ingredient: Atezolizumab (genetically modified) |
| 2018-700064 (○) | JP5681638 | Name of Sale product: Tecentrik Intravenous Drip Injection 1200 mg Active Ingredient: Atezolizumab (genetically modified) |
| 2018-700064 (■) | JP5681638 | Name of Sale product: Tecentrik Intravenous Drip Injection 1200 mg Active Ingredient: Atezolizumab (genetically modified) |
| 2018-700063 (○) | JP4870552 | Goufis Tablets 5 mg |
| 2018-700063 (■) | JP4870552 | Goufis Tablets 5 mg |
| 2018-700062 (○) | JP3665055 | Goufis Tablets 5 mg |
| 2018-700062 (■) | JP3665055 | Goufis Tablets 5 mg |
| 2018-700061 (○) | JP5421326 | Goufis Tablets 5 mg |
| 2018-700061 (■) | JP5421326 | Goufis Tablets 5 mg |
| 2018-700060 (○) | JP5894239 | Name of Sale: Saturo Tablet 100mg Active Ingredient: Bedakirin Fumarate |
| 2018-700060 (■) | JP5894239 | Name of Sale: Saturo Tablet 100mg Active Ingredient: Bedakirin Fumarate |
| 2018-700059 (○) | JP5410749 | Name of Sale: Saturo Tablet 100mg Active Ingredient: Bedakirin Fumarate |
| 2018-700058 (○) | JP5675718 | Name of Sale: Saturo Tablet 100mg Active Ingredient: Bedakirin Fumarate |
| 2018-700058 (■) | JP5675718 | Name of Sale: Saturo Tablet 100mg Active Ingredient: Bedakirin Fumarate |
| 2018-700057 (○) | JP5081617 | Name of Sale: Saturo Tablet 100mg Active Ingredient: Bedakirin Fumarate |
| 2018-700056 (○) | JP4484703 | Name of Sale: Saturo Tablet 100mg Active Ingredient: Bedakirin Fumarate |
| 2018-700056 (■) | JP4484703 | Name of Sale: Saturo Tablet 100mg Active Ingredient: Bedakirin Fumarate |
| 2018-700055 (○) | JP5171259 | Name of sale: Granule package for Nexium suspension 20 mg Active ingredient (common name): Esomeprazole magnesium hydrate |
| 2018-700054 (○) | JP5171259 | Name of sale: Granule package for Nexium suspension 10mg Active ingredient (General name): Esomeprazole magnesium hydrate |
| 2018-700053 (○) | JP4829882 | Types of pesticides: chlorantraniliprole thiamethoxam water-dispersible powder Name of pesticide: Duribo flowable Active ingredient (chemical name): 3-bromo-N- [4-chloro-2- Methyl-6- (methylcarbamoyl) phenyl] -1- (3-chloropyridin-2-yl) -1H-pyrazole-5-carboxamide, 3- (2-chloro-1,3-thiazole-5-) Ylmethyl) -5-methyl-1,3,5-oxadiazinan-4-ylidene (nitro) amine |
| 2018-700052 (○) | JP3729825 | Types of pesticides: chlorantraniliprole thiamethoxam water-dispersible powder Name of pesticide: Duribo flowable Active ingredient (chemical name): 3-bromo-N- [4-chloro-2- Methyl-6- (methylcarbamoyl) phenyl] -1- (3-chloropyridin-2-yl) -1H-pyrazole-5-carboxamide, 3- (2-chloro-1,3-thiazole-5-) Ylmethyl) -5-methyl-1,3,5-oxadiazinan-4-ylidene (nitro) amine |
| 2018-700052 (■) | JP3729825 | Types of pesticides: chlorantraniliprole thiamethoxam water-dispersible powder Name of pesticide: Duribo flowable Active ingredient (chemical name): 3-bromo-N- [4-chloro-2- Methyl-6- (methylcarbamoyl) phenyl] -1- (3-chloropyridin-2-yl) -1H-pyrazole-5-carboxamide, 3- (2-chloro-1,3-thiazole-5-) Ylmethyl) -5-methyl-1,3,5-oxadiazinan-4-ylidene (nitro) amine |
| 2018-700051 (○) | JP5465791 | Name of sale: 1.25 units for Herkonia intervertebral disc injection General name: Kondolyase |
| 2018-700050 (○) | JP6231605 | Name (brand name): Dupiccent subcutaneous injection 300 mg syringe Active ingredient name: Dupilumab (genetically modified) |
| 2018-700049 (○) | JP5918246 | Name (brand name): Dupiccent subcutaneous injection 300 mg syringe Active ingredient name: Dupilumab (genetically modified) |
| 2018-700048 (○) | JP5844772 | Name (brand name): Dupiccent subcutaneous injection 300 mg syringe Active ingredient name: Dupilumab (genetically modified) |
| 2018-700047 (○) | JP5291802 | Name (brand name): Dupiccent subcutaneous injection 300 mg syringe Active ingredient name: Dupilumab (genetically modified) |
| 2018-700046 (○) | JP6181044 | Name of Sale: Naelin Capsule 100mg Active Ingredient: Hoslavconazole L-Lysine Ethanol Adduct |
| 2018-700046 (■) | JP6181044 | Name of Sale: Naelin Capsule 100mg Active Ingredient: Hoslavconazole L-Lysine Ethanol Adduct |
| 2018-700045 (○) | JP5058150 | Name of Sale: Naelin Capsule 100mg Active Ingredient: Hoslavconazole L-Lysine Ethanol Adduct |
| 2018-700044 (○) | JP5046959 | Name of Sale: Naelin Capsule 100mg Active Ingredient: Hoslavconazole L-Lysine Ethanol Adduct |
| 2018-700043 (○) | JP4579496 | Name of Sale: Naelin Capsule 100mg Active Ingredient: Hoslavconazole L-Lysine Ethanol Adduct |
| 2018-700042 (○) | JP4015691 | Name of Sale: Naelin Capsule 100mg Active Ingredient: Hoslavconazole L-Lysine Ethanol Adduct |
| 2018-700041 (○) | JP3766804 | Name of Sale: Naelin Capsule 100mg Active Ingredient: Hoslavconazole L-Lysine Ethanol Adduct |
| 2018-700040 (○) | JP4987187 | Name of Sale: Zactran Active Ingredient: Gamithromycin |
| 2018-700040 (■) | JP4987187 | Name of Sale: Zactran Active Ingredient: Gamithromycin |
| 2018-700039 (○) | JP3770500 | Types of pesticides: Cyantrani liprole, pyroxolone granules Name of pesticides: Digital minect box granules Active ingredient (chemical name): 3-bromo-1- (3-chloro-2-pyridyl) -4'-Cyano-2'-methyl-6 '-(methylcarbamoyl) pyrazole-5-carboxanilide, 1,2,5,6-tetrahydropyrrolo [3,2,1-ij] quinoline-4- on |
| 2018-700038 (○) | JP3764895 | Types of pesticides: Cyantrani liprole, pyroxolone granules Name of pesticides: Digital minect box granules Active ingredient (chemical name): 3-bromo-1- (3-chloro-2-pyridyl) -4'-Cyano-2'-methyl-6 '-(methylcarbamoyl) pyrazole-5-carboxanilide, 1,2,5,6-tetrahydropyrrolo [3,2,1-ij] quinoline-4- on |
| 2018-700037 (○) | JP6014116 | General name: Pembrolizumab (genetically modified product) Name: Kiytruda IV infusion 100 mg Active ingredient: Pembrolizumab (genetically modified) |
| 2018-700036 (○) | JP6014116 | General name: Pembrolizumab (genetically modified product) Name: Qiatoruda IV 20 mg Active ingredient: Pembrolizumab (genetically modified) |
| 2018-700035 (○) | JP5191537 | General name: Pembrolizumab (genetically modified product) Name: Kiytruda IV infusion 100 mg Active ingredient: Pembrolizumab (genetically modified) |
| 2018-700034 (○) | JP5191537 | General name: Pembrolizumab (genetically modified product) Name: Qiatoruda IV 20 mg Active ingredient: Pembrolizumab (genetically modified) |
| 2018-700033 (○) | JP5567340 | Name of sale: Tasigna capsule 200 mg Common name: nilotinib hydrochloride hydrate |
| 2018-700032 (○) | JP5567340 | Name of sale: Tasigna capsule 150 mg Common name: nilotinib hydrochloride hydrate |
| 2018-700031 (○) | JP5567340 | Name of sale: Tasigna capsule 50 mg Common name: nilotinib hydrochloride hydrate |
| 2018-700030 (○) | JP5289948 | Name of sale: Tasigna capsule 200 mg Common name: nilotinib hydrochloride hydrate |
| 2018-700029 (○) | JP5289948 | Name of sale: Tasigna capsule 150 mg Common name: nilotinib hydrochloride hydrate |
| 2018-700028 (○) | JP5289948 | Name of sale: Tasigna capsule 50 mg Common name: nilotinib hydrochloride hydrate |
| 2018-700027 (○) | JP5129132 | Name of sale: Tasigna capsule 200 mg Common name: nilotinib hydrochloride hydrate |
| 2018-700026 (○) | JP5129132 | Name of sale: Tasigna capsule 150 mg Common name: nilotinib hydrochloride hydrate |
| 2018-700025 (○) | JP5129132 | Name of sale: Tasigna capsule 50 mg Common name: nilotinib hydrochloride hydrate |
| 2018-700024 (○) | JP4110140 | Name of sale: Tasigna capsule 200 mg Common name: nilotinib hydrochloride hydrate |
| 2018-700023 (○) | JP4110140 | Name of sale: Tasigna capsule 150 mg Common name: nilotinib hydrochloride hydrate |
| 2018-700022 (○) | JP4110140 | Name of sale: Tasigna capsule 50 mg Common name: nilotinib hydrochloride hydrate |
| 2018-700021 (○) | JP5449669 | Cyclaniliprol and flonicamide |
| 2018-700021 (■) | JP5449669 | Cyclaniliprol and flonicamide |
| 2018-700020 (○) | JP4150379 | CYCLANILIPROLE |
| 2018-700020 (■) | JP4150379 | CYCLANILIPROLE |
| 2018-700019 (○) | JP5449855 | (RS) -1- {1-ethyl-4- [4-mesyl-3- (2-methoxyethoxy) -o-toluoyl] -1H-pyrazol-5-yloxy} ethyl = methyl = carbonate |
| 2018-700019 (■) | JP5449855 | (RS) -1- {1-ethyl-4- [4-mesyl-3- (2-methoxyethoxy) -o-toluoyl] -1H-pyrazol-5-yloxy} ethyl = methyl = carbonate |
| 2018-700018 (○) | JP6014116 | General name: Pembrolizumab (genetically modified product) Name: Kiytruda IV infusion 100 mg Active ingredient: Pembrolizumab (genetically modified) |
| 2018-700017 (○) | JP6014116 | General name: Pembrolizumab (genetically modified product) Name: Qiatoruda IV 20 mg Active ingredient: Pembrolizumab (genetically modified) |
| 2018-700016 (○) | JP5191537 | General name: Pembrolizumab (genetically modified product) Name: Kiytruda IV infusion 100 mg Active ingredient: Pembrolizumab (genetically modified) |
| 2018-700015 (○) | JP5191537 | General name: Pembrolizumab (genetically modified product) Name: Qiatoruda IV 20 mg Active ingredient: Pembrolizumab (genetically modified) |
| 2018-700014 (○) | JP4707934 | Clomeprop, tefuryltrione, fentrazamide granules Ileague jumbo (RS) -2- (2,4-dichloro-m-tolyloxy) propionanilide (common name: chromeprop), 2- { 2-Chloro-4-mesyl-3-[(tetrahydrofuran-2-ylmethoxy) methyl] benzoyl} cyclohexane-1,3-dione (general name: tefuryltrione) and 4- (2-chlorophenyl) -N -Cyclohexyl-N-ethyl-4,5-dihydro-5-oxo-1H-tetrazole-1-carboxamide (General name: fentrazamide) |
| 2018-700014 (■) | JP4707934 | Clomeprop, tefuryltrione, fentrazamide granules |
| 2018-700013 (○) | JP4707934 | Clomeprop, tefuryltrione, fentrazamide water dispersible powder Rice League Fleur (RS) -2- (2,4-dichloro-m-tolyloxy) propionanilide (common name: chromeprop), 2- {2-Chloro-4-mesyl-3-[(tetrahydrofuran-2-ylmethoxy) methyl] benzoyl} cyclohexane-1,3-dione (general name: tefuryltrione) and 4- (2-chlorophenyl)- N-Cyclohexyl-N-ethyl-4,5-dihydro-5-oxo-1H-tetrazole-1-carboxamide (General name: fentrazamide) |
| 2018-700013 (■) | JP4707934 | Clomeprop, tefuryltrione, fentrazamide wettable powder |
| 2018-700012 (○) | JP4707934 | Clomeprop, tefuryltrione, fentrazamide granules 1 kg of rice league granules (RS) -2- (2,4-dichloro-m-tolyloxy) propionanilide (General name: clomeprop), 2 -{2-chloro-4-mesyl-3-[(tetrahydrofuran-2-ylmethoxy) methyl] benzoyl} cyclohexane-1,3-dione (general name: tefuryltrione) and 4- (2-chlorophenyl) -N-Cyclohexyl-N-ethyl-4,5-dihydro-5-oxo-1H-tetrazole-1-carboxamide (General name: fentrazamide) |
| 2018-700012 (■) | JP4707934 | Clomeprop, tefuryltrione, fentrazamide granules |
| 2018-700011 (○) | JP5608676 | Name of sale: Crederio Tablets XL General name: Rotarian |
| 2018-700011 (■) | JP5608676 | Name of sale: Crederio Tablets XL General name: Rotarian |
| 2018-700010 (○) | JP5608676 | Name of sale: Crederio Tablets LL Common name: Rocheranel |
| 2018-700010 (■) | JP5608676 | Name of sale: Crederio Tablets LL Common name: Rocheranel |
| 2018-700009 (○) | JP5608676 | Name of sale: Crederio Tablet L Common name: Rotiranall |
| 2018-700009 (■) | JP5608676 | Name of sale: Crederio Tablet L Common name: Rotiranall |
| 2018-700008 (○) | JP5608676 | Name of sale: Crederio Tablet M Common name: Rocheranel |
| 2018-700008 (■) | JP5608676 | Name of sale: Crederio Tablet M Common name: Rocheranel |
| 2018-700007 (○) | JP5608676 | Name of sale: Crederio Tablet S Common name: Rotarian |
| 2018-700007 (■) | JP5608676 | Name of sale: Crederio Tablet S Common name: Rotarian |
| 2018-700006 (○) | JP5173126 | Isofetamide |
| 2018-700006 (■) | JP5173126 | Isofetamide |
| 2018-700005 (○) | JP5134954 | Types of pesticides: Cyantrani liprole thiamethoxam granules Name of pesticides: Minecto Duo granules Active ingredient (chemical name) :: 3-bromo-1- (3-chloro-2-pyridyl) -4 '-Cyano-2'-methyl-6'-(methylcarbamoyl) pyrazole-5-carboxanilide, 3- (2-chloro-1,3-thiazol-5-ylmethyl) -5-methyl-1,3 , 5-Oxadiazinan-4-ylidene (nitro) amine |
| 2018-700004 (○) | JP3770500 | Types of pesticides: Cyantrani liprole thiamethoxam granules Name of pesticides: Minecto Duo granules Active ingredient (chemical name) :: 3-bromo-1- (3-chloro-2-pyridyl) -4 '-Cyano-2'-methyl-6'-(methylcarbamoyl) pyrazole-5-carboxanilide, 3- (2-chloro-1,3-thiazol-5-ylme) tyl-5-methyl-1, 3,5-Oxadiazinan-4-ylidene (nitro) amine |
| 2018-700003 (○) | JP3764895 | Types of pesticides: Cyantrani liprole thiamethoxam granules Name of pesticides: Minecto Duo granules Active ingredient (chemical name) :: 3-bromo-1- (3-chloro-2-pyridyl) -4 '-Cyano-2'-methyl-6'-(methylcarbamoyl) pyrazole-5-carboxanilide, 3- (2-chloro-1,3-thiazol-5-ylmethyl) -5-methyl-1,3,5- Oxadiazinan-4-ylidene (nitro) amine |
| 2018-700002 (○) | JP5142608 | Types of pesticides: Ipphencarbazone, benzobicyclone, benzophenap granules Name of pesticide: Gyro 1 kg granules Active ingredient (chemical name): 1- (2,4-dichlorophenyl)- 2 ', 4'-Difluoro-1,5-dihydro-N-isopropyl-5-oxo-4H-1,2,4-triazole-4-carboxanilide 3- (2-chloro-4-mesylbenzoyl) -2- Phenylthiobicyclo [3.2.1] octa-2-en-4-one 2- [4- (2,4-dichloro-m-toluoyl) -1,3-dimethylpyrazol-5-yloxy] -4 ' -Methylacetophenone |
| 2018-700002 (■) | JP5142608 | Types of pesticides: Ipphencarbazone, benzobicyclone, benzophenap granules Name of pesticide: Gyro 1 kg granules Active ingredient (chemical name): 1- (2,4-dichlorophenyl) -2 ', 4'-Difluoro-1,5-dihydro-N-isopropyl-5-oxo-4H-1,2,4-triazole-4-carboxanilide 3- (2-chloro-4-mesylbenzoyl)- 2-phenylthiobicyclo [3.2.1] octa-2-en-4-one 2- [4- (2,4-dichloro-m-toluoyl) -1,3-dimethylpyrazole-5- Yloxy] -4'-methylacetophenone |
| 2018-300387 (○) | JP5488778 | Types of pesticides: tefuryltrione fentrazamide methazosulfuron granules Name of pesticides: cygnus 1 kg granules type of active ingredient: 1- {3-chloro-1-methyl-4-[(5RS) -5,6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2018- 700381 (○) | JP4093757 | Name of sale: YERVOY Intravenous Drip Solution 50mg Active Ingredient: Ipilimumab (genetically modified) |
| 2017-700451 (○) | JP6159830 | Name of sale: Maviretto combination tablet Active ingredient: Grecaprevir hydrate, Pibrentsville |
| 2017-700451 (■) | JP6159830 | Name of sale: Maviretto combination tablet Active ingredient: Grecaprevir hydrate, Pibrentsville |
| 2017-700450 (○) | JP5911838 | Name of sale: Maviretto combination tablet Active ingredient: Grecaprevir hydrate, Pibrentsville |
| 2017-700450 (■) | JP5911838 | Name of sale: Maviretto combination tablet Active ingredient: Grecaprevir hydrate, Pibrentsville |
| 2017-700449 (○) | JP5857053 | Name of sale: Maviretto combination tablet Active ingredient: Grecaprevir hydrate, Pibrentsville |
| 2017-700449 (■) | JP5857053 | Name of sale: Maviretto combination tablet Active ingredient: Grecaprevir hydrate, Pibrentsville |
| 2017-700448 (○) | JP5834085 | Name of sale: Maviretto combination tablet Active ingredient: Grecaprevir hydrate, Pibrentsville |
| 2017-700448 (■) | JP5834085 | Name of sale: Maviretto combination tablet Active ingredient: Grecaprevir hydrate, Pibrentsville |
| 2017-700447 (○) | JP5475929 | (A) Name given in the approval letter Lupafin tablet 10 mg (b) Active ingredient: Lupatazine fumarate <1 |
| 2017-700446 (○) | JP5905184 | Name of sale: Benlista subcutaneous injection 200 mg syringe Active ingredient: belimumab (genetically modified) |
| 2017-700446 (■) | JP5905184 | Name of sale: Benlista subcutaneous injection 200 mg syringe Active ingredient: belimumab (genetically modified) |
| 2017-700445 (○) | JP5905184 | Name of sale: Benlista subcutaneous injection 200 mg autoinjector Active ingredient: belimumab (genetically modified) |
| 2017-700445 (■) | JP5905184 | Name of sale: Benlista subcutaneous injection 200 mg autoinjector Active ingredient: belimumab (genetically modified) |
| 2017-700444 (○) | JP5905184 | Name of Sale: Benlista Intravenous Drip Injection 400mg Active Ingredient: Belimumab (genetically modified) |
| 2017-700444 (■) | JP5905184 | Name of Sale: Benlista Intravenous Drip Injection 400mg Active Ingredient: Belimumab (genetically modified) |
| 2017-700443 (○) | JP5905184 | Name of Sale: Benlista Intravenous Injection 120mg Active Ingredient: Belimumab (genetically modified) |
| 2017-700443 (■) | JP5905184 | Name of Sale: Benlista Intravenous Injection 120mg Active Ingredient: Belimumab (genetically modified) |
| 2017-700442 (○) | JP5476122 | Name of sale: Darazarex Intravenous Drip Injection 400 mg General name: dalatumumab (genetically modified) |
| 2017-700441 (○) | JP5476122 | Name of sale: Darazarex Intravenous Drip Injection 100 mg Common name: dalatumumab (genetically modified) |
| 2017-700440 (○) | JP5225069 | Name of sale: Darazarex Intravenous Drip Injection 400 mg General name: dalatumumab (genetically modified) |
| 2017-700439 (○) | JP5225069 | Name of sale: Darazarex Intravenous Drip Injection 100 mg Common name: dalatumumab (genetically modified) |
| 2017-700438 (○) | JP4902087 | Name of sale: Benlista subcutaneous injection 200 mg syringe Active ingredient: belimumab (genetically modified) |
| 2017-700438 (■) | JP4902087 | Name of sale: Benlista subcutaneous injection 200 mg syringe Active ingredient: belimumab (genetically modified) |
| 2017-700437 (○) | JP4902087 | Name of sale: Benlista subcutaneous injection 200 mg autoinjector Active ingredient: belimumab (genetically modified) |
| 2017-700437 (■) | JP4902087 | Name of sale: Benlista subcutaneous injection 200 mg autoinjector Active ingredient: belimumab (genetically modified) |
| 2017-700436 (○) | JP4902087 | Name of Sale: Benlista Intravenous Drip Injection 400mg Active Ingredient: Belimumab (genetically modified) |
| 2017-700436 (■) | JP4902087 | Name of Sale: Benlista Intravenous Drip Injection 400mg Active Ingredient: Belimumab (genetically modified) |
| 2017-700435 (○) | JP4902087 | Name of Sale: Benlista Intravenous Injection 120mg Active Ingredient: Belimumab (genetically modified) |
| 2017-700435 (■) | JP4902087 | Name of Sale: Benlista Intravenous Injection 120mg Active Ingredient: Belimumab (genetically modified) |
| 2017-700434 (○) | JP5133937 | (I) Name: Festrodex IM 250 mg (ii) Active Ingredient: Fulvestrant |
| 2017-700433 (○) | JP4363846 | (I) Name: Festrodex IM 250 mg (ii) Active Ingredient: Fulvestrant |
| 2017-700432 (○) | JP3713237 | (I) Name: Festrodex IM 250 mg (ii) Active Ingredient: Fulvestrant |
| 2017-700431 (○) | JP6140777 | Name (sold name): KEVZARA subcutaneous injection 200 mg autoinjector Active ingredient name: Salilumab (genetically modified) |
| 2017-700431 (■) | JP6140777 | Name (marketing name) KEVZARA subcutaneous injection 200 mg autoinjector active ingredient name: salilumab (genetically modified) |
| 2017-700430 (○) | JP6140777 | Name (sold name): KEVZARA subcutaneous injection 200 mg syringe Active ingredient name: Salilumab (genetically modified) |
| 2017-700430 (■) | JP6140777 | Name (brand name) kebazara subcutaneous injection 200 mg syringe active ingredient name: salilumab (genetically modified) |
| 2017-700429 (○) | JP6140777 | Name (sold name): KEVZARA subcutaneous injection 150 mg auto injector Active ingredient name: Salilumab (genetically modified) |
| 2017-700429 (■) | JP6140777 | Name (marketing name) KEVZARA subcutaneous injection 150 mg autoinjector active ingredient name: salilumab (genetically modified) |
| 2017-700428 (○) | JP6140777 | Name (sold name): KEVZARA subcutaneous injection 150 mg syringe Active ingredient name: Salilumab (genetically modified) |
| 2017-700428 (■) | JP6140777 | Name (brand name) kebazara subcutaneous injection 150 mg syringe active ingredient name: salilumab (genetically modified) |
| 2017-700427 (○) | JP6122018 | Name (sold name): KEVZARA subcutaneous injection 200 mg autoinjector Active ingredient name: Salilumab (genetically modified) |
| 2017-700426 (○) | JP6122018 | Name (sold name): KEVZARA subcutaneous injection 200 mg syringe Active ingredient name: Salilumab (genetically modified) |
| 2017-700425 (○) | JP6122018 | Name (sold name): KEVZARA subcutaneous injection 150 mg auto injector Active ingredient name: Salilumab (genetically modified) |
| 2017-700424 (○) | JP6122018 | Name (sold name): KEVZARA subcutaneous injection 150 mg syringe Active ingredient name: Salilumab (genetically modified) |
| 2017-700423 (○) | JP6053886 | Name (sold name): KEVZARA subcutaneous injection 200 mg autoinjector Active ingredient name: Salilumab (genetically modified) |
| 2017-700423 (■) | JP6053886 | Name (marketing name) KEVZARA subcutaneous injection 200 mg autoinjector active ingredient name: salilumab (genetically modified) |
| 2017-700422 (○) | JP6053886 | Name (sold name): KEVZARA subcutaneous injection 200 mg syringe Active ingredient name: Salilumab (genetically modified) |
| 2017-700422 (■) | JP6053886 | Name (marketing name) KEVZARA subcutaneous injection 200 mg syringe active ingredient name: salilumab (genetically modified) |
| 2017-700421 (○) | JP6053886 | Name (sold name): KEVZARA subcutaneous injection 150 mg auto injector Active ingredient name: Salilumab (genetically modified) |
| 2017-700421 (■) | JP6053886 | Name (marketing name) KEVZARA subcutaneous injection 150 mg auto injector active ingredient name: salilumab (genetically modified) |
| 2017-700420 (○) | JP6053886 | Name (sold name): KEVZARA subcutaneous injection 150 mg syringe Active ingredient name: Salilumab (genetically modified) |
| 2017-700420 (■) | JP6053886 | Name (marketing name) KEVZARA subcutaneous injection 150 mg syringe active ingredient name: salilumab (genetically modified) |
| 2017-700419 (○) | JP5805703 | Name (sold name): KEVZARA subcutaneous injection 200 mg autoinjector Active ingredient name: Salilumab (genetically modified) |
| 2017-700419 (■) | JP5805703 | Name (marketing name) KEVZARA subcutaneous injection 200 mg autoinjector active ingredient name: salilumab (genetically modified) |
| 2017-700418 (○) | JP5805703 | Name (sold name): KEVZARA subcutaneous injection 200 mg syringe Active ingredient name: Salilumab (genetically modified) |
| 2017-700418 (■) | JP5805703 | Name (marketing name) KEVZARA subcutaneous injection 200 mg syringe active ingredient name: salilumab (genetically modified) |
| 2017-700417 (○) | JP5805703 | Name (sold name): KEVZARA subcutaneous injection 150 mg auto injector Active ingredient name: Salilumab (genetically modified) |
| 2017-700417 (■) | JP5805703 | Name (marketing name) KEVZARA subcutaneous injection 150 mg auto injector active ingredient name: salilumab (genetically modified) |
| 2017-700416 (○) | JP5805703 | Name (sold name): KEVZARA subcutaneous injection 150 mg syringe Active ingredient name: Salilumab (genetically modified) |
| 2017-700416 (■) | JP5805703 | Name (marketing name) KEVZARA subcutaneous injection 150 mg syringe active ingredient name: salilumab (genetically modified) |
| 2017-700415 (○) | JP5307708 | Name (sold name): KEVZARA subcutaneous injection 200 mg autoinjector Active ingredient name: Salilumab (genetically modified) |
| 2017-700415 (■) | JP5307708 | Name (marketing name) KEVZARA subcutaneous injection 200 mg autoinjector active ingredient name: salilumab (genetically modified) |
| 2017-700414 (○) | JP5307708 | Name (sold name): KEVZARA subcutaneous injection 200 mg syringe Active ingredient name: Salilumab (genetically modified) |
| 2017-700414 (■) | JP5307708 | Name (marketing name) KEVZARA subcutaneous injection 200 mg syringe active ingredient name: salilumab (genetically modified) |
| 2017-700413 (○) | JP5307708 | Name (sold name): KEVZARA subcutaneous injection 150 mg auto injector Active ingredient name: Salilumab (genetically modified) |
| 2017-700413 (■) | JP5307708 | Name (marketing name) KEVZARA subcutaneous injection 150 mg auto injector active ingredient name: salilumab (genetically modified) |
| 2017-700412 (○) | JP5307708 | Name (sold name): KEVZARA subcutaneous injection 150 mg syringe Active ingredient name: Salilumab (genetically modified) |
| 2017-700412 (■) | JP5307708 | Name (marketing name) KEVZARA subcutaneous injection 150 mg syringe active ingredient name: salilumab (genetically modified) |
| 2017-700411 (○) | JP4616620 | General Name: Ezetimibe / Atorvastatin Calcium Hydrate Combination Tablet Name: Atoset Combination Tablet HD Active Ingredient: Ezetimibe / Japanese Pharmacopoeia Atorvastatin Calcium Hydrate |
| 2017-700411 (■) | JP4616620 | General Name: Ezetimibe / Atorvastatin Calcium Hydrate Combination Tablet Name: Atoset Combination Tablet HD Active Ingredient: Ezetimibe / Japanese Pharmacopoeia Atorvastatin Calcium Hydrate |
| 2017-700410 (○) | JP4616620 | General name: Ezetimibe / Atorvastatin calcium hydrate combination tablet Name: Atoset combination tablet LD Active ingredient: Ezetimibe / Japanese Pharmacopoeia Atorvastatin calcium hydrate |
| 2017-700410 (■) | JP4616620 | General Name: Ezetimibe / Atorvastatin Calcium Hydrate Combination Tablet Name: Atoset Combination Tablet LD Active Ingredient: Ezetimibe / Japanese Pharmacopoeia Atorvastatin Calcium Hydrate |
| 2017-700409 (○) | JP3640888 | General Name: Ezetimibe / Atorvastatin Calcium Hydrate Combination Tablet Name: Atoset Combination Tablet HD Active Ingredient: Ezetimibe / Japanese Pharmacopoeia Atorvastatin Calcium Hydrate |
| 2017-700409 (■) | JP3640888 | General Name: Ezetimibe / Atorvastatin Calcium Hydrate Combination Tablet Name: Atoset Combination Tablet HD Active Ingredient: Ezetimibe / Japanese Pharmacopoeia Atorvastatin Calcium Hydrate |
| 2017-700408 (○) | JP3640888 | General name: Ezetimibe / Atorvastatin calcium hydrate combination tablet Name: Atoset combination tablet LD Active ingredient: Ezetimibe / Japanese Pharmacopoeia Atorvastatin calcium hydrate |
| 2017-700408 (■) | JP3640888 | General Name: Ezetimibe / Atorvastatin Calcium Hydrate Combination Tablet Name: Atoset Combination Tablet LD Active Ingredient: Ezetimibe / Japanese Pharmacopoeia Atorvastatin Calcium Hydrate |
| 2017-700407 (○) | JP5648480 | Name of Sale: REMITCH OD Tablet 2.5 Microg Active Ingredient: Nalfurafine Hydrochloride |
| 2017-700407 (■) | JP5648480 | Name of Sale: REMITCH OD Tablet 2.5 Microg Active Ingredient: Nalfurafine Hydrochloride |
| 2017-700406 (○) | JP5549586 | Name of Sale: REMITCH OD Tablet 2.5 Microg Active Ingredient: Nalfurafine Hydrochloride |
| 2017-700406 (■) | JP5549586 | Name of Sale: REMITCH OD Tablet 2.5 Microg Active Ingredient: Nalfurafine Hydrochloride |
| 2017-700405 (○) | JP5337430 | Name of Sale: REMITCH OD Tablet 2.5 Microg Active Ingredient: Nalfurafine Hydrochloride |
| 2017-700405 (■) | JP5337430 | Name of Sale: REMITCH OD Tablet 2.5 Microg Active Ingredient: Nalfurafine Hydrochloride |
| 2017-700404 (○) | JP5367708 | Name of Sale: Visamil IV Injection Active Ingredient: Flute Metamol (18F) Chemical Name: 2- [3- [18F] Fluoro-4- (methylamino) phenyl] -1,3-benzothiazole-6 -All |
| 2017-700404 (■) | JP5367708 | Name of Sale: Visamil IV Injection Active Ingredient: Flute Metamol (18F) Chemical Name: 2- [3- [18F] Fluoro-4- (methylamino) phenyl] -1,3-benzothiazole-6 -All |
| 2017-700403 (○) | JP4875487 | Name of Sale: Visamil IV Injection Active Ingredient: Flute Metamol (18F) Chemical Name: 2- [3- [18F] Fluoro-4- (methylamino) phenyl] -1,3-benzothiazole-6 -All |
| 2017-700403 (■) | JP4875487 | Name of Sale: Visamil IV Injection Active Ingredient: Flute Metamol (18F) Chemical Name: 2- [3- [18F] Fluoro-4- (methylamino) phenyl] -1,3-benzothiazole-6 -All |
| 2017-700402 (○) | JP4311369 | Name: REMITCH OD Tablet 2.5 microg Active Ingredient: Nalfurafine hydrochloride (General name) |
| 2017-700402 (■) | JP4311369 | Name: REMITCH OD Tablet 2.5 microg Active Ingredient: Nalfurafine hydrochloride (General name) |
| 2017-700401 (○) | JP3743449 | Name of sale: REMITCH capsule 2.5 microg Active ingredient: Nalfurafine hydrochloride (General name) |
| 2017-700401 (■) | JP3743449 | Name of sale: REMITCH capsule 2.5 microg Active ingredient: Nalfurafine hydrochloride (General name) |
| 2017-700400 (○) | JP5717300 | (General name) Bezulotoxumab for injection (genetically modified) (brand name) Geneplava intravenous drip 625 mg (active ingredient) bezulotoxumab (genetically modified) |
| 2017-700400 (■) | JP5717300 | (General name) Bezlotoxumab for injection (genetically modified) (brand name) Geneplava intravenous drip 625 mg (active ingredient) bezulotoxumab (genetically modified) |
| 2017-700399 (○) | JP5319622 | (General name) Bezulotoxumab for injection (genetically modified) (brand name) Geneplava intravenous drip 625 mg (active ingredient) bezulotoxumab (genetically modified) |
| 2017-700399 (■) | JP5319622 | (General name) Bezlotoxumab for injection (genetically modified) (brand name) Geneplava intravenous drip 625 mg (active ingredient) bezulotoxumab (genetically modified) |
| 2017-700398 (○) | JP458883 | (General name) Bezulotoxumab for injection (genetically modified) (brand name) Geneplava intravenous drip 625 mg (active ingredient) bezulotoxumab (genetically modified) |
| 2017-700398 (■) | JP458883 | (General name) Bezlotoxumab for injection (genetically modified) (brand name) Geneplava intravenous drip 625 mg (active ingredient) bezulotoxumab (genetically modified) |
| 2017-700397 (○) | JP5916752 | Name of sale: Dicadia Capsule 150 mg General name: seritinib |
| 2017-700396 (○) | JP5837095 | Name of sale: Dicadia Capsule 150 mg General name: seritinib |
| 2017-700396 (■) | JP5837095 | Name of sale: Dicadia Capsule 150 mg General name: seritinib |
| 2017-700395 (○) | JP4634367 | Name of sale: Dicadia Capsule 150 mg General name: seritinib |
| 2017-700395 (■) | JP4634367 | Name of sale: Dicadia Capsule 150 mg General name: seritinib |
| 2017-700394 (○) | JP5208123 | Name of sale: Dicadia Capsule 150 mg General name: seritinib |
| 2017-700394 (■) | JP5208123 | Name of sale: Dicadia Capsule 150 mg General name: seritinib |
| 2017-700393 (○) | JP4607879 | Name of sale: Dicadia Capsule 150 mg General name: seritinib |
| 2017-700393 (■) | JP4607879 | Name of sale: Dicadia Capsule 150 mg General name: seritinib |
| 2017-700392 (○) | JP4796487 | Name of sale: Dicadia Capsule 150 mg General name: seritinib |
| 2017-700392 (■) | JP4796487 | Name of sale: Dicadia Capsule 150 mg General name: seritinib |
| 2017-700391 (○) | JP4896327 | Name of sale: Bafentio Intravenous Drip Injection 200 mg Common name: averumab (genetically modified) |
| 2017-700390 (○) | JP5004390 | Name of sale: Bafentio Intravenous Drip Injection 200 mg Common name: averumab (genetically modified) |
| 2017-700389 (○) | JP4291696 | Name: Ibrance Capsule 125mg Active Ingredient: Parvocyclic Rib |
| 2017-700389 (■) | JP4291696 | Name of Sales: Ibrance Capsule 125mg Active Ingredient: Parvocyclic Rib |
| 2017-700388 (○) | JP4291696 | Name: Ibrance Capsule 25mg Active Ingredient: Parvocyclic Rib |
| 2017-700388 (■) | JP4291696 | Name of Sale: Ibrance Capsule 25mg Active Ingredient: Parvocyclic Rib |
| 2017-700386 (○) | JP5806743 | (I) Drugs subject to disposal (brand name): Simparica 80 (ii) Active ingredients of drug subject to disposition (general name): Salolanel |
| 2017-700385 (○) | JP5806743 | (I) Drugs subject to disposal (brand name): Simparica 40 (ii) Active ingredients of drug subject to disposition (General name): Salolanel |
| 2017-700384 (○) | JP5806743 | (I) Drugs subject to disposal (brand name): Simparica 20 (ii) Active ingredients of drug subject to disposition (General name): Salolanel |
| 2017-700383 (○) | JP5806743 | (I) Drugs subject to disposal (brand name): Simparica 10 (ii) Active ingredients of drug subject to disposition (General name): Salolanel |
| 2017-700382 (○) | JP5806743 | (I) Drugs subject to disposal (brand name): Simparica 5 (ii) Active ingredients of drug subject to disposition (General name): Salolanel |
| 2017-700381 (○) | JP6151640 | Accoran for intravenous injection 1800 antithrombin gamma (genetically modified) |
| 2017-700381 (■) | JP6151640 | Accoran for intravenous injection 1800 antithrombin gamma (genetically modified) |
| 2017-700380 (○) | JP6151640 | Acoran for intravenous injection 600 antithrombin gamma (genetically modified) |
| 2017-700380 (■) | JP6151640 | Acoran for intravenous injection 600 antithrombin gamma (genetically modified) |
| 2017-700379 (○) | JP4361545 | Name of sale: Opdivo IV 100 mg Active ingredient name: Nivolumab (genetically modified) |
| 2017-700379 (■) | JP4361545 | Name of sale: Opdivo IV 100 mg Active ingredient name: Nivolumab (genetically modified) |
| 2017-700378 (○) | JP4361545 | Name of Sale: Opdivo Intravenous Drip Injection 20mg Active Ingredient Name: Nivolumab (genetically modified) |
| 2017-700378 (■) | JP4361545 | Name of Sale: Opdivo Intravenous Drip Injection 20mg Active Ingredient Name: Nivolumab (genetically modified) |
| 2017-700377 (○) | JP5159730 | Name of Sale: Opdivo Intravenous Drip Injection 100mg Active Ingredient: Nivolumab (genetically modified) |
| 2017-700377 (■) | JP5159730 | Name of Sale: Opdivo Intravenous Drip Injection 100mg Active Ingredient: Nivolumab (genetically modified) |
| 2017-700376 (○) | JP5159730 | Name of Sale: Opdivo Intravenous Drip Injection 20mg Active Ingredient: Nivolumab (genetically modified) |
| 2017-700376 (■) | JP5159730 | Name of Sale: Opdivo Intravenous Drip Injection 20mg Active Ingredient: Nivolumab (genetically modified) |
| 2017-700375 (○) | JP5567340 | Name of sale: Tasigna capsule 50 mg Common name: nilotinib hydrochloride hydrate |
| 2017-700374 (○) | JP5289948 | Name of sale: Tasigna capsule 50 mg Common name: nilotinib hydrochloride hydrate |
| 2017-700373 (○) | JP5129132 | Name of sale: Tasigna capsule 50 mg Common name: nilotinib hydrochloride hydrate |
| 2017-700372 (○) | JP4110140 | Name of sale: Tasigna capsule 50 mg Common name: nilotinib hydrochloride hydrate |
| 2017-700371 (○) | JP5134954 | Types of agrochemicals: Cyantrani liprole pimetrozine water dispersible powder Name of pesticides: Minectostar water dispersible powder active ingredient (chemical name): 3-bromo-1- (3-chloro-2-pyridyl) -4'-Cyano-2'-methyl-6 '-(methylcarbamoyl) pyrazole-5-carboxanilide, (E) -4,5-dihydro-6-methyl-4- (3-pyridylmethyleneamino) -1, 2,4-Triazine-3 (2H) -one |
| 2017-700370 (○) | JP3770500 | Types of pesticides: Cyantrani liprole pimetrozin water dispersible powder Name of pesticides: Minecto star water dispersible powder active ingredient (chemical name): 3-bromo-1- (3-chloro-2 -Pyridyl) -4'-cyano-2'-methyl-6 '-(methylcarbamoyl) pyrazole-5-carboxanilide, (E) -4,5-dihydro-6-methyl-4- (3-pyridylmethyleneamino) -1,2,4-Triazine-3 (2H) -one |
| 2017-700370 (■) | JP3770500 | Types of pesticides: Cyantrani liprole pimetrozin water dispersible powder Name of pesticides: Minecto star water dispersible powder active ingredient (chemical name): 3-bromo-1- (3-chloro-2 -Pyridyl) -4'-cyano-2'-methyl-6 '-(methylcarbamoyl) pyrazole-5-carboxanilide, (E) -4,5-dihydro-6-methyl-4- (3-pyridylmethyleneamino) -1,2,4-Triazine-3 (2H) -one |
| 2017-700369 (○) | JP3764895 | Types of agrochemicals: Cyantrani liprole pimetrozine water dispersible powder Name of pesticides: Minectostar water dispersible powder active ingredient (chemical name): 3-bromo-1- (3-chloro-2-pyridyl) -4'-Cyano-2'-methyl-6 '-(methylcarbamoyl) pyrazole-5-carboxanilide, (E) -4,5-dihydro-6-methyl-4- (3-pyridylmethyleneamino) -1, 2,4-Triazine-3 (2H) -one |
| 2017-700369 (■) | JP3764895 | Types of agrochemicals: Cyantrani liprole pimetrozine water dispersible powder Name of pesticides: Minectostar water dispersible powder active ingredient (chemical name): 3-bromo-1- (3-chloro-2-pyridyl) -4'-Cyano-2'-methyl-6 '-(methylcarbamoyl) pyrazole-5-carboxanilide, (E) -4,5-dihydro-6-methyl-4- (3-pyridylmethyleneamino) -1, 2,4-Triazine-3 (2H) -one |
| 2017-700368 (○) | JP5449268 | (I) Name of sale: Actemra subcutaneous injection 162 mg auto injector (ii) General name: tocilizumab (genetically modified) |
| 2017-700368 (■) | JP5449268 | (I) Name of sale: Actemra subcutaneous injection 162 mg auto injector (ii) General name: Tocilizumab (genetically modified) |
| 2017-700367 (○) | JP5449268 | (I) Name of sale: Actemra subcutaneous injection 162 mg syringe (ii) Common name: Tocilizumab (genetically modified) |
| 2017-700367 (■) | JP5449268 | (I) Name of sale: Actemra subcutaneous injection 162 mg syringe (ii) Common name: Tocilizumab (genetically modified) |
| 2017-700366 (○) | JP4869064 | (I) Name of sale: Actemra subcutaneous injection 162 mg auto injector (ii) General name: tocilizumab (genetically modified) |
| 2017-700365 (○) | JP4869064 | (I) Name of sale: Actemra subcutaneous injection 162 mg syringe (ii) Common name: Tocilizumab (genetically modified) |
| 2017-700364 (○) | JP4340062 | (I) Name of sale: Actemra subcutaneous injection 162 mg auto injector (ii) General name: tocilizumab (genetically modified) |
| 2017-700363 (○) | JP4340062 | (I) Name of sale: Actemra subcutaneous injection 162 mg syringe (ii) Common name: Tocilizumab (genetically modified) |
| 2017-700362 (○) | JP5128281 | Bimaput Tablets 100mg (Active Ingredient: Lacosamide) |
| 2017-700362 (■) | JP5128281 | Bimaput Tablets 100mg (Active Ingredient: Lacosamide) |
| 2017-700361 (○) | JP5128281 | Bimaput Tablets 50mg (Active Ingredient: Lacosamide) |
| 2017-700361 (■) | JP5128281 | Bimaput Tablets 50mg (Active Ingredient: Lacosamide) |
| 2017-700360 (○) | JP4865937 | Name of sale: Abraxane 100 mg for intravenous infusion General name: paclitaxel |
| 2017-700360 (■) | JP4865937 | Name of Sale: Abraxane 100 mg for intravenous infusion Common name: paclitaxel |
| 2017-700359 (○) | JP6144713 | Name of sale: Levorade Tablets 25 mg General name: Elthrombopag Oramine |
| 2017-700358 (○) | JP6144713 | Name of sale: Levorade Tablets 12.5 mg Common name: Elthrombopag Oramine |
| 2017-700357 (○) | JP5735078 | Name of sale: Levorade Tablets 25 mg General name: Elthrombopag Oramine |
| 2017-700357 (■) | JP5735078 | Name of sale: Levorade Tablets 25 mg General name: Elthrombopag Oramine |
| 2017-700356 (○) | JP5735078 | Name of sale: Levorade Tablets 12.5 mg Common name: Elthrombopag Oramine |
| 2017-700356 (■) | JP5735078 | Name of sale: Levorade Tablets 12.5 mg Common name: Elthrombopag Oramine |
| 2017-700355 (○) | JP5419866 | Name of sale: Levorade Tablets 25 mg General name: Elthrombopag Oramine |
| 2017-700354 (○) | JP5419866 | Name of sale: Levorade Tablets 12.5 mg Common name: Elthrombopag Oramine |
| 2017-700353 (○) | JP3813875 | Name of sale: Levorade Tablets 25 mg General name: Elthrombopag Oramine |
| 2017-700352 (○) | JP3813875 | Name of sale: Levorade Tablets 12.5 mg Common name: Elthrombopag Oramine |
| 2017-700351 (○) | JP4612414 | Name of sale: Levorade Tablets 25 mg General name: Elthrombopag Oramine |
| 2017-700350 (○) | JP4612414 | Name of sale: Levorade Tablets 12.5 mg Common name: Elthrombopag Oramine |
| 2017-700349 (○) | JP6166717 | Name of sale: Repatha subcutaneous injection 420 mg auto mini dozer Active ingredient: Evolocumab (genetically modified) |
| 2017-700349 (■) | JP6166717 | Name of sale: Repatha subcutaneous injection 420 mg auto mini dozer Active ingredient: Evolocumab (genetically modified) |
| 2017-700348 (○) | JP5441905 | Name of sale: Repatha subcutaneous injection 420 mg auto mini dozer Active ingredient: Evolocumab (genetically modified) |
| 2017-700348 (■) | JP5441905 | Name of sale: Repatha subcutaneous injection 420 mg auto mini dozer Active ingredient: Evolocumab (genetically modified) |
| 2017-700347 (○) | JP5562926 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700347 (■) | JP5562926 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700346 (○) | JP5562926 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700346 (■) | JP5562926 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700345 (○) | JP5485489 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700345 (■) | JP5485489 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700344 (○) | JP5485489 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700344 (■) | JP5485489 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700343 (○) | JP5906067 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700343 (■) | JP5906067 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700342 (○) | JP5906067 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700342 (■) | JP5906067 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700341 (○) | JP6134370 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700341 (■) | JP6134370 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700340 (○) | JP6134370 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700340 (■) | JP6134370 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700339 (○) | JP5450508 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700339 (■) | JP5450508 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700338 (○) | JP5450508 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700338 (■) | JP5450508 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700337 (○) | JP4937358 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700336 (○) | JP4937358 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700335 (○) | JP4937358 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700334 (○) | JP4937358 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700333 (○) | JP4937358 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700332 (○) | JP4937358 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700331 (○) | JP5687469 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700330 (○) | JP5687469 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700329 (○) | JP5525118 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700328 (○) | JP5525118 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700327 (○) | JP5036679 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700326 (○) | JP5036679 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700325 (○) | JP4391086 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700324 (○) | JP4391086 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700323 (○) | JP5982024 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700323 (■) | JP5982024 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700322 (○) | JP5982024 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700322 (■) | JP5982024 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700321 (○) | JP5711751 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700320 (○) | JP5711751 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700319 (○) | JP4785534 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700318 (○) | JP4785534 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700317 (○) | JP4785534 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700317 (■) | JP4785534 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700316 (○) | JP4785534 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700316 (■) | JP4785534 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700315 (○) | JP4785534 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700314 (○) | JP4785534 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700313 (○) | JP4097395 | Name of sale: Revatio OD film 20 mg Common name: sildenafil citrate |
| 2017-700313 (■) | JP4097395 | Name of sale: Revatio OD film 20 mg Common name: sildenafil citrate |
| 2017-700312 (○) | JP4097395 | Name of sale: Dry syrup for Revatio suspension 900 mg Common name: Sildenafil citrate |
| 2017-700312 (■) | JP4097395 | Name of sale: Dry syrup for Revatio suspension 900 mg Common name: Sildenafil citrate |
| 2017-700311 (○) | JP4097395 | Name: Revatio Tablet 20 mg Common Name: Sildenafil Citrate |
| 2017-700311 (■) | JP4097395 | Name: Revatio Tablet 20 mg Common Name: Sildenafil Citrate |
| 2017-700310 (○) | JP3531170 | Name of Sale: REMITCH OD Tablet 2.5ug Active Ingredient: Nalfurafine Hydrochloride |
| 2017-700310 (■) | JP3531170 | Name of Sale: REMITCH OD Tablet 2.5 Microg Active Ingredient: Nalfurafine Hydrochloride |
| 2017-700309 (○) | JP3531170 | Name of Sale: REMITCH Capsule 2.5ug Active Ingredient: Nalfurafine Hydrochloride |
| 2017-700309 (■) | JP3531170 | Name of sale: REMITCH capsule 2.5 microg Active ingredient: Nalfurafine hydrochloride |
| 2017-700308 (○) | JP5680898 | Zonisamide (brand name: TRERIEF OD tablet 50 mg) |
| 2017-700307 (○) | JP3364481 | Zonisamide (brand name: TRERIEF OD tablet 50 mg) |
| 2017-700306 (○) | JP4939218 | Oxycontin TR tablet 40 mg |
| 2017-700306 (■) | JP4939218 | Oxycontin TR tablet 40 mg (active ingredient: oxycodone hydrochloride hydrate) |
| 2017-700305 (○) | JP4939218 | Oxycontin TR tablet 20 mg |
| 2017-700305 (■) | JP4939218 | Oxycontin TR tablet 20 mg (active ingredient: oxycodone hydrochloride hydrate) |
| 2017-700304 (○) | JP4939218 | Oxycontin TR Tablet 10 mg |
| 2017-700304 (■) | JP4939218 | Oxycontin TR tablet 10 mg (active ingredient: oxycodone hydrochloride hydrate) |
| 2017-700303 (○) | JP4939218 | Oxycontin TR tablet 5 mg |
| 2017-700303 (■) | JP4939218 | Oxycontin TR tablet 5 mg (active ingredient: oxycodone hydrochloride hydrate) |
| 2017-700302 (○) | JP5642736 | Name of Sale: Oxycontin TR Tablet 40 mg Active Ingredient: Oxycodone Hydrochloride Hydrate Hydrate |
| 2017-700302 (■) | JP5642736 | Name of Sale: Oxycontin TR Tablet 40 mg Active Ingredient: Oxycodone Hydrochloride Hydrate Hydrate |
| 2017-700301 (○) | JP5642736 | Name of sale: Oxycontin TR tablet 20 mg Active ingredient: Oxycodone hydrochloride hydrate |
| 2017-700301 (■) | JP5642736 | Name of sale: Oxycontin TR tablet 20 mg Active ingredient: Oxycodone hydrochloride hydrate |
| 2017-700300 (○) | JP5642736 | Name of sale: Oxycontin TR tablet 10 mg Active ingredient: Oxycodone hydrochloride hydrate |
| 2017-700300 (■) | JP5642736 | Name of sale: Oxycontin TR tablet 10 mg Active ingredient: Oxycodone hydrochloride hydrate |
| 2017-700299 (○) | JP5642736 | Name of sale: Oxycontin TR tablet 5mg Active ingredient: Oxycodone hydrochloride hydrate |
| 2017-700299 (■) | JP5642736 | Name of sale: Oxycontin TR tablet 5mg Active ingredient: Oxycodone hydrochloride hydrate |
| 2017-700298 (○) | JP5069300 | Name of Sale: Oxycontin TR Tablet 40 mg Active Ingredient: Oxycodone Hydrochloride Hydrate Hydrate |
| 2017-700298 (■) | JP5069300 | Name of Sale: Oxycontin TR Tablet 40 mg Active Ingredient: Oxycodone Hydrochloride Hydrate Hydrate |
| 2017-700297 (○) | JP5069300 | Name of sale: Oxycontin TR tablet 20 mg Active ingredient: Oxycodone hydrochloride hydrate |
| 2017-700297 (■) | JP5069300 | Name of sale: Oxycontin TR tablet 20 mg Active ingredient: Oxycodone hydrochloride hydrate |
| 2017-700296 (○) | JP5069300 | Name of sale: Oxycontin TR tablet 10 mg Active ingredient: Oxycodone hydrochloride hydrate |
| 2017-700296 (■) | JP5069300 | Name of sale: Oxycontin TR tablet 10 mg Active ingredient: Oxycodone hydrochloride hydrate |
| 2017-700295 (○) | JP5069300 | Name of sale: Oxycontin TR tablet 5mg Active ingredient: Oxycodone hydrochloride hydrate |
| 2017-700295 (■) | JP5069300 | Name of sale: Oxycontin TR tablet 5mg Active ingredient: Oxycodone hydrochloride hydrate |
| 2017-700294 (○) | JP6138813 | Name of sale: Babenchio Intravenous Drip Injection 200 mg Active Ingredient: Averumab (genetically modified) |
| 2017-700294 (■) | JP6138813 | Name of sale: Babenchio Intravenous Drip Injection 200 mg Active Ingredient: Averumab (genetically modified) |
| 2017-700293 (○) | JP3820485 | Name of sale: Leuplin SR Injection Kit 11.25mg Active Ingredient: Leuplorelin Acetate |
| 2017-700293 (■) | JP3820485 | Name of sale: Leuplin SR Injection Kit 11.25mg Active Ingredient: Leuplorelin Acetate |
| 2017-700292 (○) | JP5701971 | Name of sale: Cremezin quick-release tablet 500 mg Active ingredient: Cremezin bulk Ingredient : Pullulan |
| 2017-700291 (○) | JP5254957 | Pesticide name: nemaclean granules active ingredient: (common name) fluopyram (chemical name) N- {2- [3-chloro-5- (trifluoromethyl) -2-pyridyl] ethyl}- α, α, α-Trifluoro-ο-toluamide (IUPAC name) |
| 2017-700291 (■) | JP5254957 | Pesticide Name: Nemaclean Granules Active Ingredients: (Common Name) Fluopyram (Chemical Name) N- {2- [3-chloro-5- (trifluoromethyl) -2-pyridyl] ethyl}- α, α, α-Trifluoro-ο-toluamide (IUPAC name) |
| 2017-700290 (○) | JP5254957 | Pesticide name: Beeram granules Active ingredient: (common name) fluopyram (chemical name) N- {2- [3-chloro-5- (trifluoromethyl) -2-pyridyl] ethyl}- α, α, α-Trifluoro-ο-toluamide (IUPAC name) |
| 2017-700290 (■) | JP5254957 | Pesticide name: Beeram granules Active ingredient: (Common name) fluopyram (chemical name) N- {2- [3-chloro-5- (trifluoromethyl) -2-pyridyl] ethyl}- α, α, α-Trifluoro-ο-toluamide (IUPAC name) |
| 2017-700289 (○) | JP4782418 | General Name: Fluopyram Chemical Name: N- {2- [3-Chloro-5- (trifluoromethyl) -2-pyridyl] ethyl} -α, α, α-trifluoro-ο-toluamide Types of pesticides: Fluopyram granules Name of pesticides: Beeram granules |
| 2017-700289 (■) | JP4782418 | Common Name: Fluopyram Chemical Name: N- {2- [3-Chloro-5- (trifluoromethyl) -2-pyridyl] ethyl} -α, α, α-trifluoro --- toluamide Types of Pesticides Fluopyram Granules Name of Pesticides: Beeram Granules |
| 2017-700288 (○) | JP6061438 | Name of sale: LIXIANA OD Tablet 60mg Active Ingredient: Edoxaban tosylate hydrate |
| 2017-700288 (■) | JP6061438 | Name of sale: LIXIANA OD Tablet 60mg Active Ingredient: Edoxaban tosylate hydrate |
| 2017-700287 (○) | JP6061438 | Name of sale: LIXIANA OD Tablet 60mg Active Ingredient: Edoxaban tosylate hydrate |
| 2017-700287 (■) | JP6061438 | Name of sale: LIXIANA OD Tablet 60mg Active Ingredient: Edoxaban tosylate hydrate |
| 2017-700286 (○) | JP6061438 | Name of Sale: LIXIANA OD Tablet 30mg Active Ingredient: Edoxaban tosylate Hydrate Hydrate |
| 2017-700286 (■) | JP6061438 | Name of Sale: LIXIANA OD Tablet 30mg Active Ingredient: Edoxaban tosylate Hydrate Hydrate |
| 2017-700285 (○) | JP6061438 | Name of Sale: LIXIANA OD Tablet 30mg Active Ingredient: Edoxaban tosylate Hydrate Hydrate |
| 2017-700285 (■) | JP6061438 | Name of Sale: LIXIANA OD Tablet 30mg Active Ingredient: Edoxaban tosylate Hydrate Hydrate |
| 2017-700284 (○) | JP6061438 | Name of Sale: LIXIANA OD Tablet 30mg Active Ingredient: Edoxaban tosylate Hydrate Hydrate |
| 2017-700284 (■) | JP6061438 | Name of Sale: LIXIANA OD Tablet 30mg Active Ingredient: Edoxaban tosylate Hydrate Hydrate |
| 2017-700283 (○) | JP6061438 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700283 (■) | JP6061438 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700282 (○) | JP6061438 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700282 (■) | JP6061438 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700281 (○) | JP6061438 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700281 (■) | JP6061438 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700280 (○) | JP5390014 | Name of sale: LIXIANA OD Tablet 60mg Active Ingredient: Edoxaban tosylate hydrate |
| 2017-700280 (■) | JP5390014 | Name of sale: LIXIANA OD Tablet 60mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700279 (○) | JP5390014 | Name of sale: LIXIANA OD Tablet 60mg Active Ingredient: Edoxaban tosylate hydrate |
| 2017-700279 (■) | JP5390014 | Name of sale: LIXIANA OD Tablet 60mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700278 (○) | JP5390014 | Name of Sale: LIXIANA OD Tablet 30mg Active Ingredient: Edoxaban tosylate Hydrate Hydrate |
| 2017-700278 (■) | JP5390014 | Name of sale: LIXIANA OD Tablet 30mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700277 (○) | JP5390014 | Name of Sale: LIXIANA OD Tablet 30mg Active Ingredient: Edoxaban tosylate Hydrate Hydrate |
| 2017-700277 (■) | JP5390014 | Name of sale: LIXIANA OD Tablet 30mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700276 (○) | JP5390014 | Name of Sale: LIXIANA OD Tablet 30mg Active Ingredient: Edoxaban tosylate Hydrate Hydrate |
| 2017-700276 (■) | JP5390014 | Name of sale: LIXIANA OD Tablet 30mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700275 (○) | JP5390014 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700275 (■) | JP5390014 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700274 (○) | JP5390014 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700274 (■) | JP5390014 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700273 (○) | JP5390014 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700273 (■) | JP5390014 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700272 (○) | JP5305421 | Name of sale: LIXIANA OD Tablet 60 mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700272 (■) | JP5305421 | Name of sale: LIXIANA OD Tablet 60mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700271 (○) | JP5305421 | Name of sale: LIXIANA OD Tablet 60 mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700271 (■) | JP5305421 | Name of sale: LIXIANA OD Tablet 60mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700270 (○) | JP5305421 | Name of sale: LIXIANA OD Tablet 30 mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700270 (■) | JP5305421 | Name of sale: LIXIANA OD Tablet 30mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700269 (○) | JP5305421 | Name of sale: LIXIANA OD Tablet 30 mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700269 (■) | JP5305421 | Name of sale: LIXIANA OD Tablet 30mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700268 (○) | JP5305421 | Name of sale: LIXIANA OD Tablet 30 mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700268 (■) | JP5305421 | Name of Sale: LIXIANA OD Tablet 30mg Active Ingredient: Edoxaban tosylate Hydrate Hydrate |
| 2017-700267 (○) | JP5305421 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700267 (■) | JP5305421 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700266 (○) | JP5305421 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700266 (■) | JP5305421 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700265 (○) | JP5305421 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700265 (■) | JP5305421 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700264 (○) | JP4510088 | Name of sale: LIXIANA OD Tablet 60 mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700264 (■) | JP4510088 | Name of sale: LIXIANA OD Tablet 60mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700263 (○) | JP4510088 | Name of sale: LIXIANA OD Tablet 60 mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700263 (■) | JP4510088 | Name of sale: LIXIANA OD Tablet 60mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700262 (○) | JP4510088 | Name of sale: LIXIANA OD Tablet 30 mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700262 (■) | JP4510088 | Name of sale: LIXIANA OD Tablet 30mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700261 (○) | JP4510088 | Name of sale: LIXIANA OD Tablet 30 mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700261 (■) | JP4510088 | Name of sale: LIXIANA OD Tablet 30mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700260 (○) | JP4510088 | Name of sale: LIXIANA OD Tablet 30 mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700260 (■) | JP4510088 | Name of sale: LIXIANA OD Tablet 30mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700259 (○) | JP4510088 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700259 (■) | JP4510088 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700258 (○) | JP4510088 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700258 (■) | JP4510088 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700257 (○) | JP4510088 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700257 (■) | JP4510088 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700256 (○) | JP4109288 | Name of sale: LIXIANA OD Tablet 60 mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700256 (■) | JP4109288 | Name of sale: LIXIANA OD Tablet 60mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700255 (○) | JP4109288 | Name of sale: LIXIANA OD Tablet 60 mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700255 (■) | JP4109288 | Name of sale: LIXIANA OD Tablet 60mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700254 (○) | JP4109288 | Name of sale: LIXIANA OD Tablet 30 mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700254 (■) | JP4109288 | Name of sale: LIXIANA OD Tablet 30mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700253 (○) | JP4109288 | Name of sale: LIXIANA OD Tablet 30 mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700253 (■) | JP4109288 | Name of sale: LIXIANA OD Tablet 30mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700252 (○) | JP4109288 | Name of sale: LIXIANA OD Tablet 30 mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700252 (■) | JP4109288 | Name of sale: LIXIANA OD Tablet 30mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700251 (○) | JP4109288 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700251 (■) | JP4109288 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700250 (○) | JP4109288 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700250 (■) | JP4109288 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700249 (○) | JP4109288 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700249 (■) | JP4109288 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700248 (○) | JP4128138 | Name of sale: LIXIANA OD Tablet 60 mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700248 (■) | JP4128138 | Name of sale: LIXIANA OD Tablet 60mg Active Ingredient: Edoxaban tosylate hydrate |
| 2017-700247 (○) | JP4128138 | Name of sale: LIXIANA OD Tablet 60 mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700247 (■) | JP4128138 | Name of sale: LIXIANA OD Tablet 60mg Active Ingredient: Edoxaban tosylate hydrate |
| 2017-700246 (○) | JP4128138 | Name of sale: LIXIANA OD Tablet 30 mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700246 (■) | JP4128138 | Name of Sale: LIXIANA OD Tablet 30mg Active Ingredient: Edoxaban tosylate Hydrate Hydrate |
| 2017-700245 (○) | JP4128138 | Name of sale: LIXIANA OD Tablet 30 mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700245 (■) | JP4128138 | Name of Sale: LIXIANA OD Tablet 30mg Active Ingredient: Edoxaban tosylate Hydrate Hydrate |
| 2017-700244 (○) | JP4128138 | Name of sale: LIXIANA OD Tablet 30 mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700244 (■) | JP4128138 | Name of sale: LIXIANA OD Tablet 30mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700243 (○) | JP4128138 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700243 (■) | JP4128138 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700242 (○) | JP4128138 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700242 (■) | JP4128138 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700241 (○) | JP4128138 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700241 (■) | JP4128138 | Name of sale: LIXIANA OD Tablet 15mg Active ingredient: Edoxaban tosylate hydrate |
| 2017-700240 (○) | JP5472819 | Name of Sale: Aragrio Granule 1.5g Active Ingredient: Aminolevulinic Acid Salt |
| 2017-700240 (■) | JP5472819 | Name of sale: Alaguerio granules package 1.5g Active ingredient: Aminolevulinic acid salt |
| 2017-700239 (○) | JP6025824 | Common name: Fibrinogen combination drug Product name: Tako seal tissue adhesive sheet Active ingredient: Human fibrinogen Thrombin fraction |
| 2017-700239 (■) | JP6025824 | Common name: Fibrinogen combination drug Sales name: Tako seal tissue adhesion sheet Active ingredient: Human fibrinogen Thrombin fraction |
| 2017-700238 (○) | JP6027710 | Name of sale: CANALIA combination tablets Active ingredient: (General name) tenelligliptin hydrobromide hydrate, (General name) canagliflozin hydrate |
| 2017-700238 (■) | JP6027710 | Name of sale: CANALIA combination tablets Active ingredient: (General name) tenelligliptin hydrobromide hydrate, (General name) canagliflozin hydrate |
| 2017-700237 (○) | JP5775463 | Name of sale: CANALIA combination tablets Active ingredient: (General name) tenelligliptin hydrobromide hydrate, (General name) canagliflozin hydrate |
| 2017-700237 (■) | JP5775463 | Name of sale: CANALIA combination tablets Active ingredient: (General name) tenelligliptin hydrobromide hydrate, (General name) canagliflozin hydrate |
| 2017-700236 (○) | JP5863789 | Name of sale: CANALIA combination tablets Active ingredient: (General name) tenelligliptin hydrobromide hydrate, (General name) canagliflozin hydrate |
| 2017-700236 (■) | JP5863789 | Name of sale: CANALIA combination tablets Active ingredient: (General name) tenelligliptin hydrobromide hydrate, (General name) canagliflozin hydrate |
| 2017-700235 (○) | JP4208938 | Name of sale: CANALIA combination tablets Active ingredient: (General name) tenelligliptin hydrobromide hydrate, (General name) canagliflozin hydrate |
| 2017-700235 (■) | JP4208938 | Name of sale: CANALIA combination tablets Active ingredient: (General name) tenelligliptin hydrobromide hydrate, (General name) canagliflozin hydrate |
| 2017-700234 (○) | JP4101053 | Name of sale: CANALIA combination tablets Active ingredient: (General name) tenelligliptin hydrobromide hydrate, (General name) canagliflozin hydrate |
| 2017-700234 (■) | JP4101053 | Name of sale: CANALIA combination tablets Active ingredient: (General name) tenelligliptin hydrobromide hydrate, (General name) canagliflozin hydrate |
| 2017-700233 (○) | JP6029472 | Name of Sale: Somatulin Subcutaneous Injection 120mg Active Ingredient: Lanreotide Acetate |
| 2017-700233 (■) | JP6029472 | Name of Sale: Somatulin Subcutaneous Injection 120 mg Active Ingredient: Lanreotide Acetate |
| 2017-700232 (○) | JP4162381 | Name of Sale: Somatulin Subcutaneous Injection 120mg Active Ingredient: Lanreotide Acetate |
| 2017-700232 (■) | JP4162381 | Name of Sale: Somatulin Subcutaneous Injection 120mg Active Ingredient: Lanreotide Acetate |
| 2017-700231 (○) | JP5204849 | Name of sale: CANALIA combination tablets Active ingredient: Tenelligliptin hydrobromide hydrate Canagliflozin hydrate |
| 2017-700230 (○) | JP5159788 | Name of sale: CANALIA combination tablets Active ingredient: Tenelligliptin hydrobromide hydrate Canagliflozin hydrate |
| 2017-700229 (○) | JP4496174 | Name of sale: CANALIA combination tablets Active ingredient: Tenelligliptin hydrobromide hydrate Canagliflozin hydrate |
| 2017-700229 (■) | JP4496174 | Name of sale: CANALIA combination tablets Active ingredient: Tenelligliptin hydrobromide hydrate Canagliflozin hydrate |
| 2017-700228 (○) | JP4130466 | Name of sale: CANALIA combination tablets Active ingredient: Tenelligliptin hydrobromide hydrate Canagliflozin hydrate |
| 2017-700228 (■) | JP4130466 | Name of sale: CANALIA combination tablets Active ingredient: Tenelligliptin hydrobromide hydrate Canagliflozin hydrate |
| 2017-700227 (○) | JP5775114 | Name of sale: istodax 10 mg for intravenous infusion General name: romidepsin |
| 2017-700227 (■) | JP5775114 | Name of sale: istodax 10 mg for intravenous infusion General name: romidepsin |
| 2017-700226 (○) | JP5005532 | Diforta Injection 20 mg |
| 2017-700226 (■) | JP5005532 | Diforta Injection 20 mg |
| 2017-700225 (○) | JP5275371 | Name of Sale: Olumiant Tablet 2mg Active Ingredient: Varisitinib |
| 2017-700225 (■) | JP5275371 | Name of Sale: Olumiant Tablet 2mg Active Ingredient: Varisitinib |
| 2017-700224 (○) | JP5275371 | Name of Sale: Olumiant Tablet 4mg Active Ingredient: Varisitinib |
| 2017-700224 (■) | JP5275371 | Name of Sale: Olumiant Tablet 4mg Active Ingredient: Varisitinib |
| 2017-700223 (○) | JP5381978 | Name of Sale: Amenalief Tablet 200 mg Common Name: Amenamevir |
| 2017-700223 (■) | JP5381978 | Name of Sale: Amenalief Tablet 200 mg Common Name: Amenamevir |
| 2017-700222 (○) | JP5011739 | Name of Sale: Amenalief Tablet 200 mg Common Name: Amenamevir |
| 2017-700222 (■) | JP5011739 | Name of Sale: Amenalief Tablet 200 mg Common Name: Amenamevir |
| 2017-700221 (○) | JP4832093 | Name of Sale: Amenalief Tablet 200 mg Common Name: Amenamevir |
| 2017-700221 (■) | JP4832093 | Name of Sale: Amenalief Tablet 200 mg Common Name: Amenamevir |
| 2017-700220 (○) | JP3623228 | Name of Sale: Amenalief Tablet 200 mg Common Name: Amenamevir |
| 2017-700220 (■) | JP3623228 | Name of Sale: Amenalief Tablet 200 mg Common Name: Amenamevir |
| 2017-700219 (○) | JP5679458 | Name of sale: Parmodia Tablets 0.1 mg Active Ingredient: Pemafibrate |
| 2017-700219 (■) | JP5679458 | Name of sale: Parmodia Tablets 0.1 mg Active Ingredient: Pemafibrate |
| 2017-700218 (○) | JP4871259 | Name of sale: Parmodia Tablets 0.1 mg Active Ingredient: Pemafibrate |
| 2017-700218 (■) | JP4871259 | Name of sale: Parmodia Tablets 0.1 mg Active Ingredient: Pemafibrate |
| 2017-700217 (○) | JP4226005 | Name of sale: Parmodia Tablets 0.1 mg Active Ingredient: Pemafibrate |
| 2017-700217 (■) | JP4226005 | Name of sale: Parmodia Tablets 0.1 mg Active Ingredient: Pemafibrate |
| 2017-700216 (○) | JP6064139 | Nucinersen sodium |
| 2017-700216 (■) | JP6064139 | Nucinersen sodium |
| 2017-700215 (○) | JP5707396 | Nucinersen sodium |
| 2017-700215 (■) | JP5707396 | Nucinersen sodium |
| 2017-700214 (○) | JP4401613 | General name of active ingredient: Denosumab (genetically modified) Name of sale: Praria subcutaneous injection 60 mg syringe |
| 2017-700214 (■) | JP4401613 | General name of active ingredient: Denosumab (genetically modified) Name of sale: Praria subcutaneous injection 60 mg syringe |
| 2017-700213 (○) | JP5449268 | (I) Name of sale: Actemra subcutaneous injection 162 mg auto injector (ii) General name: tocilizumab (genetically modified) |
| 2017-700213 (■) | JP5449268 | (I) Name of sale: Actemra subcutaneous injection 162 mg auto injector (ii) General name: Tocilizumab (genetically modified) |
| 2017-700212 (○) | JP5449268 | (I) Name of sale: Actemra subcutaneous injection 162 mg syringe (ii) Common name: Tocilizumab (genetically modified) |
| 2017-700212 (■) | JP5449268 | (I) Name of sale: Actemra subcutaneous injection 162 mg syringe (ii) Common name: Tocilizumab (genetically modified) |
| 2017-700211 (○) | JP4869064 | (I) Name of sale: Actemra subcutaneous injection 162 mg auto injector (ii) General name: tocilizumab (genetically modified) |
| 2017-700211 (■) | JP4869064 | (I) Name of sale: Actemra subcutaneous injection 162 mg auto injector (ii) General name: Tocilizumab (genetically modified) |
| 2017-700210 (○) | JP4869064 | (I) Name of sale: Actemra subcutaneous injection 162 mg syringe (ii) Common name: Tocilizumab (genetically modified) |
| 2017-700210 (■) | JP4869064 | (I) Name of sale: Actemra subcutaneous injection 162 mg syringe (ii) Common name: Tocilizumab (genetically modified) |
| 2017-700209 (○) | JP4340062 | (I) Name of sale: Actemra subcutaneous injection 162 mg auto injector (ii) General name: tocilizumab (genetically modified) |
| 2017-700209 (■) | JP4340062 | (I) Name of sale: Actemra subcutaneous injection 162 mg auto injector (ii) General name: Tocilizumab (genetically modified) |
| 2017-700208 (○) | JP4340062 | (I) Name of sale: Actemra subcutaneous injection 162 mg syringe (ii) Common name: Tocilizumab (genetically modified) |
| 2017-700208 (■) | JP4340062 | (I) Name of sale: Actemra subcutaneous injection 162 mg syringe (ii) Common name: Tocilizumab (genetically modified) |
| 2017-700207 (○) | JP6134370 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700207 (■) | JP6134370 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700206 (○) | JP6134370 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700206 (■) | JP6134370 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700205 (○) | JP5450508 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700205 (■) | JP5450508 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700204 (○) | JP5450508 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700204 (■) | JP5450508 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700203 (○) | JP5065529 | Name of sale: PRARIA subcutaneous injection 60 mg syringe Common name of active ingredient: Denosumab (genetically modified) |
| 2017-700203 (■) | JP5065529 | Name of sale: PRARIA subcutaneous injection 60 mg syringe Common name of active ingredient: Denosumab (genetically modified) |
| 2017-700202 (○) | JP4358282 | Name of sale: PRARIA subcutaneous injection 60 mg syringe Common name of active ingredient: Denosumab (genetically modified) |
| 2017-700202 (■) | JP4358282 | Name of sale: PRARIA subcutaneous injection 60 mg syringe Common name of active ingredient: Denosumab (genetically modified) |
| 2017-700201 (○) | JP4212470 | Common Name: Denosumab (genetically modified) Name: Pralia subcutaneous injection 60 mg syringe |
| 2017-700201 (■) | JP4212470 | Common name: Denosumab (genetically engineered) Name of sale: Pralia subcutaneous injection 60 mg syringe |
| 2017-700200 (○) | JP6143664 | Name of sale: Rituxan injection 10 mg / mL Active ingredient: Rituximab (genetically modified) |
| 2017-700200 (■) | JP6143664 | Name of sale: Rituxan injection 10 mg / mL Active ingredient: Rituximab (genetically modified) |
| 2017-700199 (○) | JP5906067 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700199 (■) | JP5906067 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700198 (○) | JP5906067 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700198 (■) | JP5906067 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700197 (○) | JP4937358 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700197 (■) | JP4937358 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700196 (○) | JP4937358 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700196 (■) | JP4937358 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700195 (○) | JP5562926 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700195 (■) | JP5562926 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700194 (○) | JP5562926 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700194 (■) | JP5562926 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700193 (○) | JP5485489 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700193 (■) | JP5485489 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700192 (○) | JP5485489 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700192 (■) | JP5485489 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700191 (○) | JP5687469 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700190 (○) | JP5687469 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700189 (○) | JP5525118 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700188 (○) | JP5525118 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700187 (○) | JP5036679 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700186 (○) | JP5036679 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700185 (○) | JP4391086 | Actemra subcutaneous injection 162 mg auto injector |
| 2017-700184 (○) | JP4391086 | Actemra subcutaneous injection 162 mg syringe |
| 2017-700183 (○) | JP5934182 | Legorafenib hydrate (brand name: Stivarga tablet 40 mg) |
| 2017-700183 (■) | JP5934182 | Legorafenib hydrate (brand name: Stivarga tablet 40 mg) |
| 2017-700182 (○) | JP5346293 | Legorafenib hydrate (brand name: Stivarga tablet 40 mg) |
| 2017-700182 (■) | JP5346293 | Legorafenib hydrate (brand name: Stivarga tablet 40 mg) |
| 2017-700181 (○) | JP5017115 | Legorafenib hydrate (brand name: Stivarga tablet 40 mg) |
| 2017-700181 (■) | JP5017115 | Legorafenib hydrate (brand name: Stivarga tablet 40 mg) |
| 2017-700180 (○) | JP4777887 | Legorafenib hydrate (brand name: Stivarga tablet 40 mg) |
| 2017-700180 (■) | JP4777887 | Legorafenib hydrate (brand name: Stivarga tablet 40 mg) |
| 2017-700179 (○) | JP4472669 | Legorafenib hydrate (brand name: Stivarga tablet 40 mg) |
| 2017-700179 (■) | JP4472669 | Legorafenib hydrate (brand name: Stivarga tablet 40 mg) |
| 2017-700178 (○) | JP4330313 | Pesticide type: picalbutrazox water dispersible powder Name of pesticide: naefine flowable active ingredient:: tert-butyl = (6-{[(Z)-(1-methyl-1H-5-5] Tetrazolyl) (phenyl) methylene] aminooxymethyl} -2-pyridyl) carbamate |
| 2017-700178 (■) | JP4330313 | Pesticide type: picalbutrazox water dispersible powder Name of pesticide: naefine flowable active ingredient:: tert-butyl = (6-{[(Z)-(1-methyl-1H-5-5] Tetrazolyl) (phenyl) methylene] aminooxymethyl} -2-pyridyl) carbamate |
| 2017-700177 (○) | JP4330313 | Types of Pesticides: Picalbutrazox Powder Name of Pesticides: Nae Fine Powder Active Ingredients:: tert-Butyl = (6-{[(Z)-(1-methyl-1H-5-tetrazolyl) ( Phenyl) methylene] aminooxymethyl} -2-pyridyl) carbamate |
| 2017-700177 (■) | JP4330313 | Type of pesticide: Picalbutrazox powder Name of pesticide: Naefine powder Active ingredient:: tert-butyl = (6-{[(Z)-(1-methyl-1H-5-tetrazolyl) (phenyl) methylene] aminooxy Methyl} -2-pyridyl) carbamate |
| 2017-700176 (○) | JP4330313 | Pesticide type: picalbutrazox water-dispersible powder pesticide name: pycroc water-dispersible powder active ingredient:: tert-butyl = (6-{[(Z)-(1-methyl-1H-) 5-Tetrazolyl) (phenyl) methylene] aminooxymethyl} -2-pyridyl) carbamate |
| 2017-700176 (■) | JP4330313 | Pesticide type: picalbutrazox water-dispersible powder pesticide name: pycroc water-dispersible powder active ingredient:: tert-butyl = (6-{[(Z)-(1-methyl-1H-) 5-Tetrazolyl) (phenyl) methylene] aminooxymethyl} -2-pyridyl) carbamate |
| 2017-700175 (○) | JP4330313 | Pesticide type: Picalbutrazox water dispersible powder Pesticide name: Picilox flowable Active ingredient:: tert-butyl = (6-{[(Z)-(1-methyl-1H-5-5] Tetrazolyl) (phenyl) methylene] aminooxymethyl} -2-pyridyl) carbamate |
| 2017-700175 (■) | JP4330313 | Pesticide type: Picalbutrazox water dispersible powder Pesticide name: Picilox flowable Active ingredient:: tert-butyl = (6-{[(Z)-(1-methyl-1H-5-5] Tetrazolyl) (phenyl) methylene] aminooxymethyl} -2-pyridyl) carbamate |
| 2017-700174 (○) | JP5488778 | Types of pesticides: Dimron, pyraclonyl, benzobicyclon, metazosulfuron granules Name of pesticides: Geppard 1 kg granules Types of active ingredients: 1- {3-chloro-1-methyl-4-[( 5RS) -5,6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2017-700174 (■) | JP5488778 | Types of pesticides: Dimron, pyraclonyl, benzobicyclon, metazosulfuron granules Name of pesticides: Geppard 1 kg granules Types of active ingredients: 1- {3-chloro-1-methyl-4-[( 5RS) -5,6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2017-700173 (○) | JP3982542 | Types of pesticides: tefuryltrione, pyraclonyl, metazosulfuron wettable powder Name of pesticide: comet flowable type of active ingredient: 1- {3-chloro-1-methyl-4-[(5RS) -5 , 6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2017-700173 (■) | JP3982542 | Types of pesticides: tefuryltrione, pyraclonyl, metazosulfuron wettable powder Name of pesticide: comet flowable type of active ingredient: 1- {3-chloro-1-methyl-4-[(5RS) -5 , 6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2017-700172 (○) | JP5793197 | Fosterra PRRS |
| 2017-700172 (■) | JP5793197 | Fosterra PRRS |
| 2017-700171 (○) | JP4695588 | Name of sale: Zakori Capsule 250 mg Active Ingredient: Crizotinib |
| 2017-700171 (■) | JP4695588 | Name of Sale: Zakori Capsule 250mg Active Ingredient: Crizotinib |
| 2017-700170 (○) | JP4695588 | Name of sale: Zakori Capsule 200 mg Active Ingredient: Crizotinib |
| 2017-700170 (■) | JP4695588 | Name of Sale: Zakori Capsule 200mg Active Ingredient: Crizotinib |
| 2017-700169 (○) | JP4663619 | Name of sale: Zakori Capsule 250 mg Active Ingredient: Crizotinib |
| 2017-700169 (■) | JP4663619 | Name of Sale: Zakori Capsule 250mg Active Ingredient: Crizotinib |
| 2017-700168 (○) | JP4663619 | Name of sale: Zakori Capsule 200 mg Active Ingredient: Crizotinib |
| 2017-700168 (■) | JP4663619 | Name of sale: Zacoli capsule 200 mg Active ingredient: crizotinib |
| 2017-700167 (○) | JP4242911 | Name of sale: Zakori Capsule 250 mg Active Ingredient: Crizotinib |
| 2017-700167 (■) | JP4242911 | Name of Sale: Zakori Capsule 250mg Active Ingredient: Crizotinib |
| 2017-700166 (○) | JP4242911 | Name of sale: Zakori Capsule 200 mg Active Ingredient: Crizotinib |
| 2017-700166 (■) | JP4242911 | Name of Sale: Zakori Capsule 200mg Active Ingredient: Crizotinib |
| 2017-700165 (○) | JP5734656 | (Name) Kaiprolith Intravenous Drip Injection 40 mg (Active ingredient) Carfilzomib |
| 2017-700165 (■) | JP5734656 | (Name) Kaiprolith Intravenous Drip Injection 40 mg (Active ingredient) Carfilzomib |
| 2017-700164 (○) | JP5734656 | (Name) Kaiproris 10 mg for intravenous drip infusion (active ingredient) carfilzomib |
| 2017-700164 (■) | JP5734656 | (Name) Kaiproris 10 mg for intravenous drip infusion (active ingredient) carfilzomib |
| 2017-700163 (○) | JP4990155 | (Name) Kaiprolith Intravenous Drip Injection 40 mg (Active ingredient) Carfilzomib |
| 2017-700163 (■) | JP4990155 | (Name) Kaiprolith Intravenous Drip Injection 40 mg (Active ingredient) Carfilzomib |
| 2017-700162 (○) | JP4990155 | (Name) Kaiproris 10 mg for intravenous drip infusion (active ingredient) carfilzomib |
| 2017-700162 (■) | JP4990155 | (Name) Kaiproris 10 mg for intravenous drip infusion (active ingredient) carfilzomib |
| 2017-700161 (○) | JP5394423 | (Name) Kaiprolith Intravenous Drip Injection 40 mg (Active ingredient) Carfilzomib |
| 2017-700161 (■) | JP5394423 | (Name) Kaiprolith Intravenous Drip Injection 40 mg (Active ingredient) Carfilzomib |
| 2017-700160 (○) | JP5394423 | (Name) Kaiproris 10 mg for intravenous drip infusion (active ingredient) carfilzomib |
| 2017-700160 (■) | JP5394423 | (Name) Kaiproris 10 mg for intravenous drip infusion (active ingredient) carfilzomib |
| 2017-700159 (○) | JP4743720 | (Name) Kaiprolith Intravenous Drip Injection 40 mg (Active ingredient) Carfilzomib |
| 2017-700159 (■) | JP4743720 | (Name) Kaiprolith Intravenous Drip Injection 40 mg (Active ingredient) Carfilzomib |
| 2017-700158 (○) | JP4743720 | (Name) Kaiproris 10 mg for intravenous drip infusion (active ingredient) carfilzomib |
| 2017-700158 (■) | JP4743720 | (Name) Kaiproris 10 mg for intravenous drip infusion (active ingredient) carfilzomib |
| 2017-700157 (○) | JP5818219 | Product Name: Suploic Tablet 0.2 mg Common Name: Nardemedin Tosylate Chemical Name: (5R) -17- (Cyclopropylmethyl) -6,7-Didehydro-4,5-Epoxy- 3,6,14-Trihydroxy-N- [2- (3-phenyl-1,2,4-oxadiazol-5-yl) propan-2-yl] morphinan-7-carboxamide mono (4 -Methyl benzene sulfonate |
| 2017-700157 (■) | JP5818219 | Product Name: Suploic Tablet 0.2 mg Common Name: Nardemedin Tosylate Chemical Name: (5R) -17- (Cyclopropylmethyl) -6,7-Didehydro-4,5-Epoxy- 3,6,14-Trihydroxy-N- [2- (3-phenyl-1,2,4-oxadiazol-5-yl) propan-2-yl] morphinan-7-carboxamide mono (4 -Methyl benzene sulfonate |
| 2017-700156 (○) | JP5070364 | Product Name: Suploic Tablet 0.2 mg Common Name: Nardemedin Tosylate Chemical Name: (5R) -17- (Cyclopropylmethyl) -6,7-Didehydro-4,5-Epoxy- 3,6,14-Trihydroxy-N- [2- (3-phenyl-1,2,4-oxadiazol-5-yl) propan-2-yl] morphinan-7-carboxamide mono (4-methylbenzene) Sulfonate) |
| 2017-700156 (■) | JP5070364 | Product Name: Suploic Tablet 0.2 mg Common Name: Nardemedin Tosylate Chemical Name: (5R) -17- (Cyclopropylmethyl) -6,7-Didehydro-4,5-Epoxy- 3,6,14-Trihydroxy-N- [2- (3-phenyl-1,2,4-oxadiazol-5-yl) propan-2-yl] morphinan-7-carboxamide mono (4-methylbenzene) Sulfonate) |
| 2017-700155 (○) | JP4323547 | Product Name: Suploic Tablet 0.2 mg Common Name: Nardemedin Tosylate Chemical Name: (5R) -17- (Cyclopropylmethyl) -6,7-Didehydro-4,5-Epoxy- 3,6,14-Trihydroxy-N- [2- (3-phenyl-1,2,4-oxadiazol-5-yl) propan-2-yl] morphinan-7-carboxamide mono (4-methylbenzene) Sulfonate) |
| 2017-700155 (■) | JP4323547 | Product Name: Suploic Tablet 0.2 mg Common Name: Nardemedin Tosylate Chemical Name: (5R) -17- (Cyclopropylmethyl) -6,7-Didehydro-4,5-Epoxy- 3,6,14-Trihydroxy-N- [2- (3-phenyl-1,2,4-oxadiazol-5-yl) propan-2-yl] morphinan-7-carboxamide mono (4-methylbenzene) Sulfonate) |
| 2017-700154 (○) | JP3531170 | Name of Sale: REMITCH OD Tablet 2.5 Microg Active Ingredient: Nalfurafine Hydrochloride |
| 2017-700153 (○) | JP5648480 | Name of Sale: REMITCH OD Tablet 2.5 Microg Active Ingredient: Nalfurafine Hydrochloride |
| 2017-700153 (■) | JP5648480 | Name of Sale: REMITCH OD Tablet 2.5 Microg Active Ingredient: Nalfurafine Hydrochloride |
| 2017-700152 (○) | JP5549586 | Name of Sale: REMITCH OD Tablet 2.5 Microg Active Ingredient: Nalfurafine Hydrochloride |
| 2017-700152 (■) | JP5549586 | Name of Sale: REMITCH OD Tablet 2.5 Microg Active Ingredient: Nalfurafine Hydrochloride |
| 2017-700151 (○) | JP5337430 | Name of Sale: REMITCH OD Tablet 2.5 Microg Active Ingredient: Nalfurafine Hydrochloride |
| 2017-700151 (■) | JP5337430 | Name of Sale: REMITCH OD Tablet 2.5 Microg Active Ingredient: Nalfurafine Hydrochloride |
| 2017-700150 (○) | JP5749247 | Name of Sale: Narsus Tablets 24 mg Active Ingredient: Hydromorphone Hydrochloride |
| 2017-700150 (■) | JP5749247 | Name of Sale: Narsus Tablets 24 mg Active Ingredient: Hydromorphone Hydrochloride |
| 2017-700149 (○) | JP5749247 | Name of Sale: Narsus Tablet 12 mg Active Ingredient: Hydromorphone Hydrochloride |
| 2017-700149 (■) | JP5749247 | Name of Sale: Narsus Tablet 12 mg Active Ingredient: Hydromorphone Hydrochloride |
| 2017-700148 (○) | JP5749247 | Name of Sale: Narsus Tablets 6 mg Active Ingredient: Hydromorphone Hydrochloride |
| 2017-700148 (■) | JP5749247 | Name of Sale: Narsus Tablets 6 mg Active Ingredient: Hydromorphone Hydrochloride |
| 2017-700147 (○) | JP5749247 | Name of Sale: Narsus Tablet 2 mg Active Ingredient: Hydromorphone Hydrochloride |
| 2017-700147 (■) | JP5749247 | Name of Sale: Narsus Tablet 2 mg Active Ingredient: Hydromorphone Hydrochloride |
| 2017-700146 (○) | JP5792307 | Name of Sale: Annuity 200 Microg Elliptor 30 For Inhaled Active Ingredient: Fluticasone Furonic Acid Ester |
| 2017-700146 (■) | JP5792307 | Name of Sale: Annuity 200 Microg Elliptor 30 For Inhaled Active Ingredient: Fluticasone Furonic Acid Ester |
| 2017-700145 (○) | JP5792307 | Name of Sales: Annuity 200 Microg Elliptor 14 For Inhalation Active Ingredient: Fluticasone Furonic Acid Ester |
| 2017-700144 (○) | JP5792307 | Name of Sale: Annuity 100 Microg Elliptor 30 For Inhaled Active Ingredient: Fluticasone Furonic Acid Ester |
| 2017-700144 (■) | JP5792307 | Name of Sale: Annuity 100 Microg Elliptor 30 For Inhaled Active Ingredient: Fluticasone Furonic Acid Ester |
| 2017-700143 (○) | JP5792307 | Name of Sale: Annuity 100 Microg Elliptor 14 For Inhaled Active Ingredient: Fluticasone Furonic Acid Ester |
| 2017-700142 (○) | JP6010066 | Name of sale: Ninarao capsule 4 mg Common name: ixazomib citrate |
| 2017-700142 (■) | JP6010066 | Name of sale: Ninarao capsule 4 mg Common name: ixazomib citrate |
| 2017-700141 (○) | JP6010066 | Name of sale: Ninarao capsule 3 mg Common name: ixazomib citrate |
| 2017-700141 (■) | JP6010066 | Name of sale: Ninarao capsule 3 mg Common name: ixazomib citrate |
| 2017-700140 (○) | JP6010066 | Name of sale: Ninarao capsule 2.3 mg Common name: ixazomib citrate |
| 2017-700140 (■) | JP6010066 | Name of sale: Ninarao capsule 2.3 mg Common name: ixazomib citrate |
| 2017-700139 (○) | JP5566380 | Name of sale: Ninarao capsule 4 mg Common name: ixazomib citrate |
| 2017-700139 (■) | JP5566380 | Name of sale: Ninarao capsule 4 mg Common name: ixazomib citrate |
| 2017-700138 (○) | JP5566380 | Name of sale: Ninarao capsule 3 mg Common name: ixazomib citrate |
| 2017-700138 (■) | JP5566380 | Name of sale: Ninarao capsule 3 mg Common name: ixazomib citrate |
| 2017-700137 (○) | JP5566380 | Name of sale: Ninarao capsule 2.3 mg Common name: ixazomib citrate |
| 2017-700137 (■) | JP5566380 | Name of sale: Ninarao capsule 2.3 mg Common name: ixazomib citrate |
| 2017-700136 (○) | JP5261488 | Name of sale: Ninarao capsule 4 mg Common name: ixazomib citrate |
| 2017-700136 (■) | JP5261488 | Name of sale: Ninarao capsule 4 mg Common name: ixazomib citrate |
| 2017-700135 (○) | JP5261488 | Name of sale: Ninarao capsule 3 mg Common name: ixazomib citrate |
| 2017-700135 (■) | JP5261488 | Name of sale: Ninarao capsule 3 mg Common name: ixazomib citrate |
| 2017-700134 (○) | JP5261488 | Name of sale: Ninarao capsule 2.3 mg Common name: ixazomib citrate |
| 2017-700134 (■) | JP5261488 | Name of sale: Ninarao capsule 2.3 mg Common name: ixazomib citrate |
| 2017-700133 (○) | JP4731094 | Drugs subject to disposal (brand name): Stelara hypodermic injection 45 mg syringe Active ingredient of medications subject to disposal (general name): Ustekinumab |
| 2017-700133 (■) | JP4731094 | Drugs subject to disposal (brand name): Stelara hypodermic injection 45 mg syringe Active ingredient of medications subject to disposal (general name): Ustekinumab |
| 2017-700132 (○) | JP4731094 | Drugs subject to disposal (brand name): Stelara IV intravenous infusion 130 mg active ingredient of medications subject to disposal (general name): ustekinumab |
| 2017-700132 (■) | JP4731094 | Drugs subject to disposal (brand name): Stelara IV intravenous infusion 130 mg active ingredient of medications subject to disposal (general name): ustekinumab |
| 2017-700131 (○) | JP4430247 | (I) Drugs subject to disposal (brand name): mundesin capsule 100 mg (ii) Active ingredient of medications subject to disposal (general name): phorodecin hydrochloride |
| 2017-700131 (■) | JP4430247 | (I) Drugs subject to disposal (brand name): mundesin capsule 100 mg (ii) Active ingredient of medications subject to disposal (general name): phorodecin hydrochloride |
| 2017-700130 (○) | JP4311369 | Name: REMITCH OD Tablet 2.5 μg Active Ingredient: Nalfurafine Hydrochloride (General name) |
| 2017-700129 (○) | JP5191574 | Product Name: Suploic Tablet 0.2 mg Common Name: Nardemedin Tosylate Chemical Name: (5R) -17- (Cyclopropylmethyl) -6,7-Didehydro-4,5-Epoxy- 3,6,14-Trihydroxy-N- [2- (3-phenyl-1,2,4-oxadiazol-5-yl) propan-2-yl] morphinan-7-carboxamide mono (4-methylbenzene) Sulfonate) |
| 2017-700129 (■) | JP5191574 | Product Name: Suploic Tablet 0.2 mg Common Name: Nardemedin Tosylate Chemical Name: (5R) -17- (Cyclopropylmethyl) -6,7-Didehydro-4,5-Epoxy- 3,6,14-Trihydroxy-N- [2- (3-phenyl-1,2,4-oxadiazol-5-yl) propan-2-yl] morphinan-7-carboxamide mono (4-methylbenzene) Sulfonate) |
| 2017-700128 (○) | JP4738713 | (I) Drugs subject to disposal (brand name): Exede S (ii) Active ingredients of drug subject to disposition (General name): ceftiofur |
| 2017-700128 (■) | JP4738713 | (I) Drugs subject to disposal (brand name): Exede S (ii) Active ingredients of drug subject to disposition (general name): ceftiofur |
| 2017-700127 (○) | JP4738713 | (I) Drugs subject to disposal (brand name): Exede C (ii) Active ingredients of drug subject to disposal (General name): ceftiofur |
| 2017-700127 (■) | JP4738713 | (I) Drugs subject to disposal (brand name): Exede C (ii) Active ingredients of drug subject to disposition (general name): ceftiofur |
| 2017-700126 (○) | JP4365222 | (I) Drugs subject to disposal (brand name): Exede S (ii) Active ingredients of drug subject to disposition (General name): ceftiofur |
| 2017-700126 (■) | JP4365222 | (I) Drugs subject to disposal (brand name): Exede S (ii) Active ingredients of drug subject to disposition (General name): ceftiofur |
| 2017-700125 (○) | JP4365222 | (I) Drugs subject to disposal (brand name): Exede C (ii) Active ingredients of drug subject to disposal (General name): ceftiofur |
| 2017-700125 (■) | JP4365222 | (I) Drugs subject to disposal (brand name): Exede C (ii) Active ingredients of drug subject to disposal (General name): ceftiofur |
| 2017-700124 (○) | JP4451983 | (I) Drugs subject to disposal (brand name): mundesin capsule 100 mg (ii) Active ingredient of medications subject to disposal (general name): phorodecin hydrochloride |
| 2017-700124 (■) | JP4451983 | (I) Drugs subject to disposal (brand name): mundesin capsule 100 mg (ii) Active ingredient of medications subject to disposal (general name): phorodecin hydrochloride |
| 2017-700123 (○) | JP4361545 | Name of sale: Opdivo IV 100 mg Active ingredient name: Nivolumab (genetically modified) |
| 2017-700123 (■) | JP4361545 | Name of sale: Opdivo IV 100 mg Active ingredient name: Nivolumab (genetically modified) |
| 2017-700122 (○) | JP4361545 | Name of Sale: Opdivo Intravenous Drip Injection 20mg Active Ingredient Name: Nivolumab (genetically modified) |
| 2017-700122 (■) | JP4361545 | Name of Sale: Opdivo Intravenous Drip Injection 20mg Active Ingredient Name: Nivolumab (genetically modified) |
| 2017-700121 (○) | JP5255429 | Tamiflu dry syrup 3% (brand name) |
| 2017-700121 (■) | JP5255429 | Tamiflu dry syrup 3% (brand name) |
| 2017-700120 (○) | JP3502342 | Tamiflu dry syrup 3% (brand name) |
| 2017-700120 (■) | JP3502342 | Tamiflu dry syrup 3% (brand name) |
| 2017-700119 (○) | JP5341962 | Iminoctadine albesylate (15.0%) Pyrophenone (4.0%) |
| 2017-700119 (■) | JP5341962 | Iminoctadine albesylate (15.0%) Pyrophenone (4.0%) |
| 2017-700118 (○) | JP4608140 | Pyrophenon |
| 2017-700118 (■) | JP4608140 | Pyrophenon |
| 2017-700117 (○) | JP5726401 | Name of Sale: Intunib Tablet 3mg Active Ingredient: Guanfacine Hydrochloride |
| 2017-700117 (■) | JP5726401 | Name of Sale: Intunib Tablet 3mg Active Ingredient: Guanfacine Hydrochloride |
| 2017-700116 (○) | JP5726401 | Name of Sale: Intunib Tablet 1mg Active Ingredient: Guanfacine Hydrochloride |
| 2017-700116 (■) | JP5726401 | Name of Sale: Intunib Tablet 1mg Active Ingredient: Guanfacine Hydrochloride |
| 2017-700115 (○) | JP4340840 | Name of Sale: Intunib Tablet 3mg Active Ingredient: Guanfacine Hydrochloride |
| 2017-700115 (■) | JP4340840 | Name of Sale: Intunib Tablet 3mg Active Ingredient: Guanfacine Hydrochloride |
| 2017-700114 (○) | JP4340840 | Name of Sale: Intunib Tablet 1mg Active Ingredient: Guanfacine Hydrochloride |
| 2017-700114 (■) | JP4340840 | Name of Sale: Intunib Tablet 1mg Active Ingredient: Guanfacine Hydrochloride |
| 2017-700113 (○) | JP6066351 | Name of sale: Narrapido Tablet 4 mg Active ingredient: Hydromorphone hydrochloride |
| 2017-700113 (■) | JP6066351 | Name of sale: Narrapido Tablet 4 mg Active ingredient: Hydromorphone hydrochloride |
| 2017-700112 (○) | JP6066351 | Name of sale: Narrapide Tablets 2 mg Active ingredient: Hydromorphone hydrochloride |
| 2017-700112 (■) | JP6066351 | Name of sale: Narrapide Tablets 2 mg Active ingredient: Hydromorphone hydrochloride |
| 2017-700111 (○) | JP6066351 | Name of Sale: Narrapido Tablet 1 mg Active Ingredient: Hydromorphone Hydrochloride |
| 2017-700111 (■) | JP6066351 | Name of Sale: Narrapido Tablet 1 mg Active Ingredient: Hydromorphone Hydrochloride |
| 2017-700110 (○) | JP5150607 | Name of Sale: Annuity 200μg Elipta 30 for Inhalation Active Ingredient: Fluticasone Furonic Acid Ester |
| 2017-700110 (■) | JP5150607 | Name of Sales: Annuity 200μg ELIPTA 30 For Inhaled Active Ingredient: Fluticasone Furonic Acid Ester |
| 2017-700109 (○) | JP5150607 | Name of Sale: Annuity 200μg Ellipta 14 For Inhalation Active Ingredient: Fluticasone Furonic Acid Ester |
| 2017-700109 (■) | JP5150607 | Name of Sales: Annuity 200μg ELIPTA 14 For Inhaled Active Ingredient: Fluticasone Furonic Acid Ester |
| 2017-700108 (○) | JP5150607 | Name of Sale: Annuity 100μg Eliputa 30 for Inhalation Active Ingredient: Fluticasone Furonic Acid Ester |
| 2017-700108 (■) | JP5150607 | Name of Sales: Annuity 100μg ELIPTA 30 For Inhaled Active Ingredient: Fluticasone Furonic Acid Ester |
| 2017-700107 (○) | JP5150607 | Name of Sale: Annuity 100μg Ellipta 14 For Inhalation Active Ingredient: Fluticasone Furonic Acid Ester |
| 2017-700107 (■) | JP5150607 | Name of Sales: Annuity 100μg ELIPTA 14 For Inhaled Active Ingredient: Fluticasone Furonic Acid Ester |
| 2017-700106 (○) | JP4436041 | Name of Sale: Annuity 200μg Elipta 30 for Inhalation Active Ingredient: Fluticasone Furonic Acid Ester |
| 2017-700106 (■) | JP4436041 | Name of sale: Anuity 200 μg Elipta 30 for inhalation Active ingredient: Fluticasone furan carboxylic acid ester |
| 2017-700105 (○) | JP4436041 | Name of Sale: Annuity 200μg Ellipta 14 For Inhalation Active Ingredient: Fluticasone Furonic Acid Ester |
| 2017-700105 (■) | JP4436041 | Name of sale: Anuity 200 μg for Ellipta 14 inhalation Active ingredient: Fluticasone furan carboxylic acid ester |
| 2017-700104 (○) | JP4436041 | Name of Sale: Annuity 100μg Eliputa 30 for Inhalation Active Ingredient: Fluticasone Furonic Acid Ester |
| 2017-700104 (■) | JP4436041 | Name of sale: Anuity 100 μg Ellipta 30 for inhalation Active ingredient: Fluticasone furan carboxylic acid ester |
| 2017-700103 (○) | JP4436041 | Name of Sale: Annuity 100μg Ellipta 14 For Inhalation Active Ingredient: Fluticasone Furonic Acid Ester |
| 2017-700103 (■) | JP4436041 | Name of sale: Annuiti 100 μg Ellipta 14 for inhalation Active ingredient: Fluticasone furan carboxylic acid ester |
| 2017-700102 (○) | JP5159730 | Name of sale: Opdivo IV 100mg Active Ingredient: Nivolumab (genetically modified) |
| 2017-700102 (■) | JP5159730 | Name of sale: Opdivo IV 100 mg Active ingredient: Nivolumab (genetically modified) |
| 2017-700101 (○) | JP5159730 | Name of Sale: Opdivo Intravenous Drip Injection 20mg Active Ingredient: Nivolumab (genetically modified) |
| 2017-700101 (■) | JP5159730 | Name of sale: Opdivo Intravenous Drip Injection 20 mg Active Ingredient: Nivolumab (genetically modified) |
| 2017-700100 (○) | JP4748920 | Name of sale: Simponi subcutaneous injection 50 mg syringe Active ingredient: golimumab FB (as golimumab (genetically modified)) |
| 2017-700100 (■) | JP4748920 | Name of sale: Simponi subcutaneous injection 50 mg syringe Active ingredient: golimumab FB (as golimumab (genetically modified)) |
| 2017-700099 (○) | JP4748920 | Name of sale: Simponi subcutaneous injection 100 mg syringe Active ingredient: golimumab FB (as golimumab (genetically modified)) |
| 2017-700099 (■) | JP4748920 | Name of sale: Simponi subcutaneous injection 100 mg syringe Active ingredient: golimumab FB (as golimumab (genetically modified)) |
| 2017-700098 (○) | JP4091257 | COMCLO Shampoo 0.05% |
| 2017-700098 (■) | JP4091257 | COMCLO Shampoo 0.05% |
| 2017-700097 (○) | JP6114257 | Name of Sale: Zarutrap Intravenous Drip Injection 200mg Active Ingredients: (Common Name) Aflibercept Beta (genetically modified) |
| 2017-700097 (■) | JP6114257 | Name of Sale: Zarutrap Intravenous Drip Injection 200mg Active Ingredients: (Common Name) Aflibercept Beta (genetically modified) |
| 2017-700096 (○) | JP6114257 | Name of Sale: Zarutrap Intravenous Drip 100 mg Active Ingredients: (Common Name) Aflibercept Beta (genetically modified) |
| 2017-700096 (■) | JP6114257 | Name of Sale: Zarutrap Intravenous Drip 100 mg Active Ingredients: (Common Name) Aflibercept Beta (genetically modified) |
| 2017-700095 (○) | JP4980236 | Name of Sale: Zarutrap Intravenous Drip Injection 200mg Active Ingredients: (Common Name) Aflibercept Beta (genetically modified) |
| 2017-700095 (■) | JP4980236 | Name of Sale: Zarutrap Intravenous Drip Injection 200mg Active Ingredients: (Common Name) Aflibercept Beta (genetically modified) |
| 2017-700094 (○) | JP4980236 | Name of Sale: Zarutrap Intravenous Drip 100 mg Active Ingredients: (Common Name) Aflibercept Beta (genetically modified) |
| 2017-700094 (■) | JP4980236 | Name of Sale: Zarutrap Intravenous Drip 100 mg Active Ingredients: (Common Name) Aflibercept Beta (genetically modified) |
| 2017-700093 (○) | JP5376573 | Name of Sale: Zarutrap Intravenous Drip Injection 200mg Active Ingredients: (Common Name) Aflibercept Beta (genetically modified) |
| 2017-700093 (■) | JP5376573 | Name of Sale: Zarutrap Intravenous Drip Injection 200mg Active Ingredients: (Common Name) Aflibercept Beta (genetically modified) |
| 2017-700092 (○) | JP5376573 | Name of Sale: Zarutrap Intravenous Drip 100 mg Active Ingredients: (Common Name) Aflibercept Beta (genetically modified) |
| 2017-700092 (■) | JP5376573 | Name of Sale: Zarutrap Intravenous Drip 100 mg Active Ingredients: (Common Name) Aflibercept Beta (genetically modified) |
| 2017-700091 (○) | JP4723140 | Name of Sale: Zarutrap Intravenous Drip Injection 200mg Active Ingredients: (Common Name) Aflibercept Beta (genetically modified) |
| 2017-700091 (■) | JP4723140 | Name of Sale: Zarutrap Intravenous Drip Injection 200mg Active Ingredients: (Common Name) Aflibercept Beta (genetically modified) |
| 2017-700090 (○) | JP4723140 | Name of Sale: Zarutrap Intravenous Drip 100 mg Active Ingredients: (Common Name) Aflibercept Beta (genetically modified) |
| 2017-700090 (■) | JP4723140 | Name of Sale: Zarutrap Intravenous Drip 100 mg Active Ingredients: (Common Name) Aflibercept Beta (genetically modified) |
| 2017-700089 (○) | JP5710430 | Name of sale: Jabi tablet 10 mg Active ingredient: Luxotitinib phosphate |
| 2017-700089 (■) | JP5710430 | Name of Sale: Jacubi Tablets 10 mg Active Ingredient: Luxolitinib Phosphate |
| 2017-700088 (○) | JP5475653 | Name of sale: Jabi tablet 10 mg Active ingredient: Luxotitinib phosphate |
| 2017-700088 (■) | JP5475653 | Name of Sale: Jacubi Tablets 10 mg Active Ingredient: Luxolitinib Phosphate |
| 2017-700087 (○) | JP5017278 | Name of sale: Jabi tablet 10 mg Active ingredient: Luxotitinib phosphate |
| 2017-700087 (■) | JP5017278 | Name of Sale: Jacubi Tablets 10 mg Active Ingredient: Luxolitinib Phosphate |
| 2017-700086 (○) | JP5415771 | Common Name: Epoprostenol Sodium for Injection Name: 1.5 mg "ACT" for intravenous injection of epoprostenol |
| 2017-700086 (■) | JP5415771 | Common Name: Epoprostenol Sodium for Injection Name: 1.5 mg "ACT" for intravenous injection of epoprostenol |
| 2017-700085 (○) | JP5415771 | Common Name: Epoprostenol Sodium for Injection Name: 0.5 mg "ACT" for intravenous injection of epoprostenol |
| 2017-700085 (■) | JP5415771 | Common Name: Epoprostenol Sodium for Injection Name: 0.5 mg "ACT" for intravenous injection of epoprostenol |
| 2017-700084 (○) | JP5893083 | Name of Sale: Samsuka Granule 1% Active Ingredient: Tolvaptan |
| 2017-700084 (■) | JP5893083 | Name of Sale: Samsuka Granule 1% Active Ingredient: Tolvaptan |
| 2017-700083 (○) | JP5830005 | Name of sale: Revlimid capsule 5 mg Active ingredient: Lenalidomide hydrate |
| 2017-700083 (■) | JP5830005 | Name of sale: Revlimid capsule 5 mg Active ingredient: Lenalidomide hydrate |
| 2017-700082 (○) | JP5830005 | Name of sale: Revlimid Capsule 2.5mg Active Ingredient: Lenalidomide Hydrate |
| 2017-700082 (■) | JP5830005 | Name of sale: Revlimid Capsule 2.5mg Active Ingredient: Lenalidomide Hydrate |
| 2017-700081 (○) | JP4733037 | Name of sale: Revlimid capsule 5 mg Active ingredient: Lenalidomide hydrate |
| 2017-700081 (■) | JP4733037 | Name of sale: Revlimid capsule 5 mg Active ingredient: Lenalidomide hydrate |
| 2017-700080 (○) | JP4733037 | Name of sale: Revlimid Capsule 2.5mg Active Ingredient: Lenalidomide Hydrate |
| 2017-700080 (■) | JP4733037 | Name of sale: Revlimid capsule 2.5 mg Active ingredient: Lenalidomide hydrate |
| 2017-700079 (○) | JP4065567 | Name of sale: Revlimid capsule 5 mg Active ingredient: Lenalidomide hydrate |
| 2017-700079 (■) | JP4065567 | Name of sale: Revlimid capsule 5 mg Active ingredient: Lenalidomide hydrate |
| 2017-700078 (○) | JP4065567 | Name of sale: Revlimid Capsule 2.5mg Active Ingredient: Lenalidomide Hydrate |
| 2017-700078 (■) | JP4065567 | Name of sale: Revlimid capsule 2.5 mg Active ingredient: Lenalidomide hydrate |
| 2017-700077 (○) | JP5488778 | Types of pesticides: Fentrazamide, benzobicyclone Metazosulfuron granules Name of pesticides: Sky 1 kg granules Types of active ingredients: 1- {3-Chloro-1-methyl-4- [ (5RS) -5,6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2017-700077 (■) | JP5488778 | Types of pesticides: Fentrazamide, benzobicyclone Metazosulfuron granules Name of pesticides: Sky 1 kg granules Types of active ingredients: 1- {3-Chloro-1-methyl-4- [ (5RS) -5,6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2017-700076 (■) | JP5488778 | Types of pesticides: tefuryl trione, fentrazamide metazosulfuron granules pesticide names: cygnus 1 kg granules type of active ingredient: 1- {3-chloro-1-methyl-4- [ (5RS) -5,6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2017-700075 (■) | JP5018478 | Types of pesticides: tefuryl trione, fentrazamide metazosulfuron granules pesticide names: cygnus 1 kg granules type of active ingredient: 1- {3-chloro-1-methyl-4- [ (5RS) -5,6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2017-700074 (○) | JP3743289 | Disposal: Sales Name: Lapros Active Ingredient: Bellaprost Sodium (General name) |
| 2017-700074 (■) | JP3743289 | Disposal: Sales Name: Lapros Active Ingredient: Bellaprost Sodium (General name) |
| 2017-700073 (○) | JP4330313 | Types of pesticides: Picalbutrazox water-dispersible powder Name of pesticides: Quintecto water-dispersible powder active ingredient:: tert-butyl = (6- {[(Z)-(1-methyl-1H- 5-Tetrazolyl) (phenyl) methylene] aminooxymethyl} -2-pyridyl) carbamate |
| 2017-700073 (■) | JP4330313 | Types of pesticides: picalbutrazox water dispersible powder Name of pesticides: Quintecto water dispersible powder active ingredient: tert-butyl = (6-{[(Z)-(1-methyl-1H-5) -Tetrazolyl) (phenyl) methylene] aminooxymethyl} -2-pyridyl) carbamate |
| 2017-700072 (○) | JP5845092 | Item: Procox Common name: mixed oil of Emodepside and Toltrazuril |
| 2017-700072 (■) | JP5845092 | Item: Procox Common name: Emodepside and Toltrazuril mixed oil |
| 2017-700071 (○) | JP5651275 | Name of sale: Bemlidi Tablet 25 mg Active ingredient: Tenofovir alafenamide fumarate |
| 2017-700071 (■) | JP5651275 | Name of sale: Bemlidi Tablet 25 mg Active ingredient: Tenofovir alafenamide fumarate |
| 2017-700070 (○) | JP5111551 | Name of sale: Bemlidi Tablet 25 mg Active ingredient: Tenofovir alafenamide fumarate |
| 2017-700070 (■) | JP5111551 | Name of sale: Bemlidi Tablet 25 mg Active ingredient: Tenofovir alafenamide fumarate |
| 2017-700069 (○) | JP4651264 | Name of sale: Bemlidi Tablet 25 mg Active ingredient: Tenofovir alafenamide fumarate |
| 2017-700069 (■) | JP4651264 | Name of sale: Bemlidi Tablet 25 mg Active ingredient: Tenofovir alafenamide fumarate |
| 2017-700068 (○) | JP6034327 | Name of sale: Linzess Tablet 0.25 mg General name: linaclotide |
| 2017-700068 (■) | JP6034327 | Name of sale: Linzess Tablet 0.25 mg General name: linaclotide |
| 2017-700067 (○) | JP5770629 | Name of sale: Linzess Tablet 0.25 mg General name: linaclotide |
| 2017-700067 (■) | JP5770629 | Name of sale: Linzess Tablet 0.25 mg General name: linaclotide |
| 2017-700066 (○) | JP5748791 | Name of sale: Linzess Tablet 0.25 mg General name: linaclotide |
| 2017-700066 (■) | JP5748791 | Name of sale: Linzess Tablet 0.25 mg General name: linaclotide |
| 2017-700065 (○) | JP5563384 | Name of sale: Linzess Tablet 0.25 mg General name: linaclotide |
| 2017-700065 (■) | JP5563384 | Name of sale: Linzess Tablet 0.25 mg General name: linaclotide |
| 2017-700064 (○) | JP4584911 | Name of sale: Linzess Tablet 0.25 mg General name: linaclotide |
| 2017-700064 (■) | JP4584911 | Name of sale: Linzess Tablet 0.25 mg General name: linaclotide |
| 2017-700063 (○) | JP5553132 | Name of sale: Linzess Tablet 0.25 mg General name: linaclotide |
| 2017-700063 (■) | JP5553132 | Name of sale: Linzess Tablet 0.25 mg General name: linaclotide |
| 2017-700062 (○) | JP4312710 | Name of sale: Dimentia combination tablet Active ingredient ・ General name: daclatasvir hydrochloride, asunaprevir, beclavevir hydrochloride |
| 2017-700062 (■) | JP4312710 | Name of sale: Dimentia combination tablet Active ingredient ・ General name: daclatasvir hydrochloride, asunaprevir, beclavevir hydrochloride |
| 2017-700061 (○) | JP5324574 | Name of sale: Dimentia combination tablet Active ingredient ・ General name: daclatasvir hydrochloride, asunaprevir, beclavevir hydrochloride |
| 2017-700061 (■) | JP5324574 | Name of sale: Dimentia combination tablet Active ingredient ・ General name: daclatasvir hydrochloride, asunaprevir, beclavevir hydrochloride |
| 2017-700060 (○) | JP5244179 | Name of sale: Dimentia combination tablet Active ingredient ・ General name: daclatasvir hydrochloride, asunaprevir, beclavevir hydrochloride |
| 2017-700060 (■) | JP5244179 | Name of sale: Dimentia combination tablet Active ingredient ・ General name: daclatasvir hydrochloride, asunaprevir, beclavevir hydrochloride |
| 2017-700059 (○) | JP5235882 | Name of sale: Dimentia combination tablet Active ingredient ・ General name: daclatasvir hydrochloride, asunaprevir, beclavevir hydrochloride |
| 2017-700059 (■) | JP5235882 | Name of sale: Dimentia combination tablet Active ingredient ・ General name: daclatasvir hydrochloride, asunaprevir, beclavevir hydrochloride |
| 2017-700058 (○) | JP5566907 | Name of sale: Dimentia combination tablet Active ingredient ・ General name: daclatasvir hydrochloride, asunaprevir, beclavevir hydrochloride |
| 2017-700058 (■) | JP5566907 | Name of sale: Dimentia combination tablet Active ingredient ・ General name: daclatasvir hydrochloride, asunaprevir, beclavevir hydrochloride |
| 2017-700057 (○) | JP5769749 | Name of sale: Dimentia combination tablet Active ingredient ・ General name: daclatasvir hydrochloride, asunaprevir, beclavevir hydrochloride |
| 2017-700057 (■) | JP5769749 | Name of sale: Dimentia combination tablet Active ingredient ・ General name: daclatasvir hydrochloride, asunaprevir, beclavevir hydrochloride |
| 2017-700056 (○) | JP5284952 | Name of sale: Dimentia combination tablet Active ingredient ・ General name: daclatasvir hydrochloride, asunaprevir, beclavevir hydrochloride |
| 2017-700056 (■) | JP5284952 | Name of sale: Dimentia combination tablet Active ingredient ・ General name: daclatasvir hydrochloride, asunaprevir, beclavevir hydrochloride |
| 2017-700055 (○) | JP4332314 | Name of sale: Liquismia injection 300ug Active ingredient: Lixisenatide |
| 2017-700055 (■) | JP4332314 | Name of sale: Liquismia injection 300ug Active ingredient: Lixisenatide |
| 2017-700054 (○) | JP5828614 | Name of sale: Techfidella Capsule 240 mg Common name of active ingredient: Dimethyl fumarate |
| 2017-700054 (■) | JP5828614 | Name of sale: Techfidella Capsule 240 mg Common name of active ingredient: Dimethyl fumarate |
| 2017-700053 (○) | JP5828614 | Name of sale: Techfidella Capsule 120 mg Common name of active ingredient: Dimethyl fumarate |
| 2017-700053 (■) | JP5828614 | Name of sale: Techfidella Capsule 120 mg Common name of active ingredient: Dimethyl fumarate |
| 2017-700052 (○) | JP5345843 | General name: Drospirenone and ethynyl estradiol Betadex Name: Yazflex combination tablets |
| 2017-700051 (○) | JP5015976 | General name: Drospirenone and ethynyl estradiol Betadex Name: Yazflex combination tablets |
| 2017-700050 (○) | JP4782364 | General name: Drospirenone and ethynyl estradiol Betadex Name: Yazflex combination tablets |
| 2017-700049 (○) | JP4354667 | General name: Drospirenone and ethynyl estradiol Betadex Name: Yazflex combination tablets |
| 2017-700048 (○) | JP5474043 | Name: Otezura Tablet 30mg Active Ingredient: Apremilast |
| 2017-700048 (■) | JP5474043 | Name: Otezura Tablet 30mg Active Ingredient: Apremilast |
| 2017-700047 (○) | JP5474043 | Name of sale: Otezla Tablets 20 mg Active ingredient: Apremilast |
| 2017-700047 (■) | JP5474043 | Name of sale: Otezla Tablets 20 mg Active ingredient: Apremilast |
| 2017-700046 (○) | JP5474043 | Name of sale: Otezura Tablet 10 mg Active ingredient: Apremilast |
| 2017-700046 (■) | JP5474043 | Name of sale: Otezura Tablet 10 mg Active ingredient: Apremilast |
| 2017-700045 (○) | JP4530543 | Name: Otezura Tablet 30mg Active Ingredient: Apremilast |
| 2017-700045 (■) | JP4530543 | Name: Otezura Tablet 30mg Active Ingredient: Apremilast |
| 2017-700044 (○) | JP4530543 | Name of sale: Otezla Tablets 20 mg Active ingredient: Apremilast |
| 2017-700044 (■) | JP4530543 | Name of sale: Otezla Tablets 20 mg Active ingredient: Apremilast |
| 2017-700043 (○) | JP4530543 | Name of sale: Otezura Tablet 10 mg Active ingredient: Apremilast |
| 2017-700043 (■) | JP4530543 | Name of sale: Otezura Tablet 10 mg Active ingredient: Apremilast |
| 2017-700042 (○) | JP5717650 | Name of sale: Amivid I.V. Active ingredient: Florbetapir (18F) |
| 2017-700042 (■) | JP5717650 | Name of sale: Amivid I.V. Active ingredient: Florbetapir (18F) |
| 2017-700041 (○) | JP5290954 | Name of sale: Amivid I.V. Active ingredient: Florbetapir (18F) |
| 2017-700041 (■) | JP5290954 | Name of sale: Amivid I.V. Active ingredient: Florbetapir (18F) |
| 2017-700040 (○) | JP5982473 | Name of sale: Parserbib 10 mg for intravenous dialysis Active ingredient · General name: Etelcalcetide hydrochloride |
| 2017-700039 (○) | JP5982473 | Name of sale: 5 mg for Parserbib intravenous dialysis Active ingredient · General name: Etelcalcetide hydrochloride |
| 2017-700038 (○) | JP5982473 | Name of sale: Parserbib for intravenous dialysis 2.5 mg Active ingredient · General name: Etelcalcetide hydrochloride |
| 2017-700037 (○) | JP5270799 | Name of sale: Parserbib 10 mg for intravenous dialysis Active ingredient · General name: Etelcalcetide hydrochloride |
| 2017-700037 (■) | JP5270799 | Name of sale: Parserbib 10 mg for intravenous dialysis Active ingredient · General name: Etelcalcetide hydrochloride |
| 2017-700036 (○) | JP5270799 | Name of sale: 5 mg for Parserbib intravenous dialysis Active ingredient · General name: Etelcalcetide hydrochloride |
| 2017-700036 (■) | JP5270799 | Name of sale: 5 mg for Parserbib intravenous dialysis Active ingredient · General name: Etelcalcetide hydrochloride |
| 2017-700035 (○) | JP5270799 | Name of sale: Parserbib for intravenous dialysis 2.5 mg Active ingredient · General name: Etelcalcetide hydrochloride |
| 2017-700035 (■) | JP5270799 | Name of sale: Parserbib for intravenous dialysis 2.5 mg Active ingredient · General name: Etelcalcetide hydrochloride |
| 2017-700034 (○) | JP6027708 | Name of sale: Parserbib 10 mg for intravenous dialysis Active ingredient · General name: Etelcalcetide hydrochloride |
| 2017-700034 (■) | JP6027708 | Name of sale: Parserbib 10 mg for intravenous dialysis Active ingredient · General name: Etelcalcetide hydrochloride |
| 2017-700033 (○) | JP6027708 | Name of sale: 5 mg for Parserbib intravenous dialysis Active ingredient · General name: Etelcalcetide hydrochloride |
| 2017-700033 (■) | JP6027708 | Name of sale: 5 mg for Parserbib intravenous dialysis Active ingredient · General name: Etelcalcetide hydrochloride |
| 2017-700032 (○) | JP6027708 | Name of sale: Parserbib for intravenous dialysis 2.5 mg Active ingredient · General name: Etelcalcetide hydrochloride |
| 2017-700032 (■) | JP6027708 | Name of sale: Parserbib for intravenous dialysis 2.5 mg Active ingredient · General name: Etelcalcetide hydrochloride |
| 2017-700031 (○) | JP6014116 | General name: Pembrolizumab (genetically modified) preparation Name of sale: Kiytruda IV infusion 100 mg Active ingredient: Pembrolizumab (genetically modified) |
| 2017-700031 (■) | JP6014116 | General name: Pembrolizumab (genetically modified) preparation Name of sale: Kiytruda IV infusion 100 mg Active ingredient: Pembrolizumab (genetically modified) |
| 2017-700030 (○) | JP6014116 | General name: Pembrolizumab (genetically modified product) Name: Kiytruda IV infusion 20 mg Active ingredient: Pembrolizumab (genetically modified) |
| 2017-700030 (■) | JP6014116 | General name: Pembrolizumab (genetically modified) preparation Name of sale: Kiytruda IV infusion 20 mg Active ingredient: Pembrolizumab (genetically modified) |
| 2017-700029 (○) | JP5191537 | General name: Pembrolizumab (genetically modified) preparation Name of sale: Kiytruda IV infusion 100 mg Active ingredient: Pembrolizumab (genetically modified) |
| 2017-700029 (■) | JP5191537 | General name: Pembrolizumab (genetically modified product) Name: Kiytruda IV infusion 100 mg Active ingredient: Pembrolizumab (genetically modified) |
| 2017-700028 (○) | JP5191537 | General name: Pembrolizumab (genetically modified) preparation Name of sale: Kiytruda IV infusion 20 mg Active ingredient: Pembrolizumab (genetically modified) |
| 2017-700028 (■) | JP5191537 | General name: Pembrolizumab (genetically modified product) Name: Qiatoruda IV 20 mg Active ingredient: Pembrolizumab (genetically modified) |
| 2017-700027 (○) | JP5137288 | Name (brand name): Mozovir subcutaneous injection 24 mg Active ingredient name: Prelixaphor |
| 2017-700027 (■) | JP5137288 | Name (brand name): Mozovir subcutaneous injection 24 mg Active ingredient name: Prelixahol |
| 2017-700026 (○) | JP5651275 | Name of sale: Tablet combination tablets HT Active ingredient: Emtricitabine, and Tenofovir alafenamide fumarate |
| 2017-700026 (■) | JP5651275 | Name of sale: Tablet combination tablets HT Active ingredient: Emtricitabine, and Tenofovir alafenamide fumarate |
| 2017-700025 (○) | JP5651275 | Name of sale: Dish kov combination tablet LT Active ingredient: Emtricitabine, and Tenofovir alafenamide fumarate |
| 2017-700025 (■) | JP5651275 | Name of sale: Dish kov combination tablet LT Active ingredient: Emtricitabine, and Tenofovir alafenamide fumarate |
| 2017-700024 (○) | JP5111551 | Name of sale: Tablet combination tablets HT Active ingredient: Emtricitabine, and Tenofovir alafenamide fumarate |
| 2017-700024 (■) | JP5111551 | Name of sale: Tablet combination tablets HT Active ingredient: Emtricitabine, and Tenofovir alafenamide fumarate |
| 2017-700023 (○) | JP5111551 | Name of sale: Dish kov combination tablet LT Active ingredient: Emtricitabine, and Tenofovir alafenamide fumarate |
| 2017-700023 (■) | JP5111551 | Name of sale: Dish kov combination tablet LT Active ingredient: Emtricitabine, and Tenofovir alafenamide fumarate |
| 2017-700022 (○) | JP4651264 | Name of sale: Tablet combination tablets HT Active ingredient: Emtricitabine, and Tenofovir alafenamide fumarate |
| 2017-700022 (■) | JP4651264 | Name of sale: Tablet combination tablets HT Active ingredient: Emtricitabine, and Tenofovir alafenamide fumarate |
| 2017-700021 (○) | JP4651264 | Name of sale: Dish kov combination tablet LT Active ingredient: Emtricitabine, and Tenofovir alafenamide fumarate |
| 2017-700021 (■) | JP4651264 | Name of sale: Dish kov combination tablet LT Active ingredient: Emtricitabine, and Tenofovir alafenamide fumarate |
| 2017-700020 (○) | JP4271936 | Name of sale: Ilaris for subcutaneous injection 150 mg Active ingredient: canakinumab (genetically modified) |
| 2017-700020 (■) | JP4271936 | Name of sale: Ilaris for subcutaneous injection 150 mg Active ingredient: canakinumab (genetically modified) |
| 2017-700019 (○) | JP5841998 | Name: IMBRUVICA Capsule 140mg Active Ingredient: Ibrutinib |
| 2017-700018 (○) | JP4934197 | Name: IMBRUVICA Capsule 140mg Active Ingredient: Ibrutinib |
| 2017-700017 (○) | JP4361545 | Name of sale: Opdivo IV 100 mg Active ingredient name: Nivolumab (genetically modified) |
| 2017-700017 (■) | JP4361545 | Name of sale: Opdivo IV 100 mg Active ingredient name: Nivolumab (genetically modified) |
| 2017-700016 (○) | JP4361545 | Name of Sale: Opdivo Intravenous Drip Injection 20mg Active Ingredient Name: Nivolumab (genetically modified) |
| 2017-700016 (■) | JP4361545 | Name of sale: Opdivo IV infusion 20 mg Active ingredient name: nivolumab (genetically modified) |
| 2017-700015 (○) | JP5159730 | Name of sale: Opdivo IV 100mg Active Ingredient: Nivolumab (genetically modified) |
| 2017-700015 (■) | JP5159730 | Name of sale: Opdivo IV 100 mg Active ingredient: Nivolumab (genetically modified) |
| 2017-700014 (○) | JP5159730 | Name of Sale: Opdivo Intravenous Drip Injection 20mg Active Ingredient: Nivolumab (genetically modified) |
| 2017-700014 (■) | JP5159730 | Name of sale: Opdivo Intravenous Drip Injection 20 mg Active Ingredient: Nivolumab (genetically modified) |
| 2017-700013 (○) | JP4191034 | Name of sale: Lerva 100 Ellipta 30 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2017-700013 (■) | JP4191034 | Name of sale: Lerberg 100 Ellipta 30 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2017-700012 (○) | JP4191034 | Name of sale: Lerva 100 Ellipta 14 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2017-700012 (■) | JP4191034 | Name of sale: Lerberg 100 Elipta 14 for inhalation Active ingredient: Bilanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2017-700011 (○) | JP5150607 | Name of sale: Lerva 100 Ellipta 30 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2017-700011 (■) | JP5150607 | Name of sale: Lerberg 100 Ellipta 30 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2017-700010 (○) | JP5150607 | Name of sale: Lerva 100 Ellipta 14 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2017-700010 (■) | JP5150607 | Name of sale: Lerberg 100 Elipta 14 for inhalation Active ingredient: Bilanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2017-700009 (○) | JP4436041 | Name of sale: Lerva 100 Ellipta 30 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2017-700009 (■) | JP4436041 | Name of sale: Lerberg 100 Ellipta 30 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2017-700008 (○) | JP4436041 | Name of sale: Lerva 100 Ellipta 14 for inhalation Active ingredient: Billanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2017-700008 (■) | JP4436041 | Name of sale: Lerberg 100 Elipta 14 for inhalation Active ingredient: Bilanterol triphenyl acetate Active ingredient: Fluticasone furan carboxylic acid ester |
| 2017-700007 (○) | JP5986599 | Name of sale: Predicocox combination tablet Active ingredient: Darunavir Ethanol adduct, Cobicistat / Silicon dioxide mixture |
| 2017-700006 (○) | JP5612662 | Name of sale: Predicocox combination tablet Active ingredient: Darunavir Ethanol adduct, Cobicistat / Silicon dioxide mixture |
| 2017-700005 (○) | JP5925171 | Name of sale: Predicocox combination tablet Active ingredient: Darunavir Ethanol adduct, Cobicistat / Silicon dioxide mixture |
| 2017-700005 (■) | JP5925171 | Name of sale: Predicocox combination tablet Active ingredient: Darunavir Ethanol adduct, Cobicistat / Silicon dioxide mixture |
| 2017-700004 (○) | JP5722213 | Name of sale: Predicocox combination tablet Active ingredient: Darunavir Ethanol adduct, Cobicistat / Silicon dioxide mixture |
| 2017-700004 (■) | JP5722213 | Name of sale: Predicocox combination tablet Active ingredient: Darunavir Ethanol adduct, Cobicistat / Silicon dioxide mixture |
| 2017-700003 (○) | JP4881446 | Name of sale: Predicocox combination tablet Active ingredient: Darunavir Ethanol adduct, Cobicistat / Silicon dioxide mixture |
| 2017-700003 (■) | JP4881446 | Name of sale: Predicocox combination tablet Active ingredient: Darunavir Ethanol adduct, Cobicistat / Silicon dioxide mixture |
| 2017-700002 (○) | JP5488778 | Types of pesticides: tefuryltrione, pyraclonyl metazosulfuron granules Name of pesticides: comet 1 kg granules type of active ingredient: 1- {3-chloro-1-methyl-4- [ (5RS) -5,6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2017-700002 (■) | JP5488778 | Types of pesticides: tefuryltrione, pyraclonyl metazosulfuron granules Name of pesticides: comet 1 kg granules type of active ingredient: 1- {3-chloro-1-methyl-4- [ (5RS) -5,6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2017-700001 (○) | JP5449855 | (RS) -1- {1-ethyl-4- [4-mesyl-3- (2-methoxyethoxy) -o-toluoyl] -1H-pyrazol-5-yloxy} ethyl = methyl = carbonate |
| 2017-700001 (■) | JP5449855 | (RS) -1- {1-ethyl-4- [4-mesyl-3- (2-methoxyethoxy) -o-toluoyl] -1H-pyrazol-5-yloxy} ethyl = methyl = carbonate |
| 2017-300387 (○) | JP5442924 | Sugi pollen extract |
| 2016-700459 (○) | JP5801342 | Name of sale: VIEKIRAX formulated tablets Active ingredients: Ombitasvir, Paritaprevir, Ritonavir |
| 2016-700459 (■) | JP5801342 | Name of sale: VIEKIRAX formulated tablets Active ingredients: Ombitasvir, Paritaprevir, Ritonavir |
| 2016-700458 (○) | JP5488778 | Types of pesticides: Dimron, pyraclonyl, metazosulfuron granules Name of pesticides: Galaxy 1 kg granules Types of active ingredients: 1- {3-Chloro-1-methyl-4-[(5RS) -5 , 6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2016-700458 (■) | JP5488778 | Types of pesticides: Dimron, pyraclonyl, metazosulfuron granules Name of pesticides: Galaxy 1 kg granules Types of active ingredients: 1- {3-Chloro-1-methyl-4-[(5RS) -5 , 6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2016-700457 (○) | JP6005205 | Name of sale: Emplicity for intravenous injection 400 mg Active ingredient · Common name: Elotuzumab (genetically modified) |
| 2016-700457 (■) | JP6005205 | Name of sale: Emplicity for intravenous injection 400 mg Active ingredient · Common name: Elotuzumab (genetically modified) |
| 2016-700456 (○) | JP6005205 | Name of Sale: Empricity Intravenous Drip Injection 300mg Active Ingredient · Common Name: Elotuzumab (genetically modified) |
| 2016-700456 (■) | JP6005205 | Name of Sale: Empricity Intravenous Drip Injection 300mg Active Ingredient · Common Name: Elotuzumab (genetically modified) |
| 2016-700455 (○) | JP5340935 | Name of sale: Emplicity for intravenous injection 400 mg Active ingredient · Common name: Elotuzumab (genetically modified) |
| 2016-700455 (■) | JP5340935 | Name of sale: Emplicity for intravenous injection 400 mg Active ingredient · Common name: Elotuzumab (genetically modified) |
| 2016-700454 (○) | JP5340935 | Name of Sale: Empricity Intravenous Drip Injection 300mg Active Ingredient · Common Name: Elotuzumab (genetically modified) |
| 2016-700454 (■) | JP5340935 | Name of Sale: Empricity Intravenous Drip Injection 300mg Active Ingredient · Common Name: Elotuzumab (genetically modified) |
| 2016-700453 (○) | JP5976288 | Name of sale: Emplicity for intravenous injection 400 mg Active ingredient · Common name: Elotuzumab (genetically modified) |
| 2016-700453 (■) | JP5976288 | Name of sale: Emplicity for intravenous injection 400 mg Active ingredient · Common name: Elotuzumab (genetically modified) |
| 2016-700452 (○) | JP5976288 | Name of Sale: Empricity Intravenous Drip Injection 300mg Active Ingredient · Common Name: Elotuzumab (genetically modified) |
| 2016-700452 (■) | JP5976288 | Name of Sale: Empricity Intravenous Drip Injection 300mg Active Ingredient · Common Name: Elotuzumab (genetically modified) |
| 2016-700451 (○) | JP4887152 | Name of sale: Emplicity for intravenous injection 400 mg Active ingredient · Common name: Elotuzumab (genetically modified) |
| 2016-700451 (■) | JP4887152 | Name of sale: Emplicity for intravenous injection 400 mg Active ingredient · Common name: Elotuzumab (genetically modified) |
| 2016-700450 (○) | JP4887152 | Name of Sale: Empricity Intravenous Drip Injection 300mg Active Ingredient · Common Name: Elotuzumab (genetically modified) |
| 2016-700450 (■) | JP4887152 | Name of Sale: Empricity Intravenous Drip Injection 300mg Active Ingredient · Common Name: Elotuzumab (genetically modified) |
| 2016-700449 (○) | JP5575923 | Name of sale: Prisbind IV solution 2.5 g Active ingredient: Idarcizumab (genetically modified) |
| 2016-700449 (■) | JP5575923 | Name of sale: Prisbind IV solution 2.5 g Active ingredient: Idarcizumab (genetically modified) |
| 2016-700448 (○) | JP3866715 | Name of sale: Prisbind IV solution 2.5 g Active ingredient: Idarcizumab (genetically modified) |
| 2016-700448 (■) | JP3866715 | Name of sale: Prisbind IV solution 2.5 g Active ingredient: Idarcizumab (genetically modified) |
| 2016-700447 (○) | JP3343359 | Name of sale: Prisbind IV solution 2.5 g Active ingredient: Idarcizumab (genetically modified) |
| 2016-700447 (■) | JP3343359 | Name of sale: Prisbind IV solution 2.5 g Active ingredient: Idarcizumab (genetically modified) |
| 2016-700446 (○) | JP5134963 | "Micatrio-containing tablets" (active ingredients: telmisartan, amlodipine besylate, hydrochlorothiazide) |
| 2016-700445 (○) | JP4606166 | "Micatrio-containing tablets" (active ingredients: telmisartan, amlodipine besylate, hydrochlorothiazide) |
| 2016-700445 (■) | JP4606166 | "Micatrio-containing tablets" (active ingredients: telmisartan, amlodipine besylate, hydrochlorothiazide) |
| 2016-700444 (○) | JP5919606 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700444 (■) | JP5919606 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700443 (○) | JP5840364 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700442 (○) | JP5748317 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700442 (■) | JP5748317 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700441 (○) | JP5951056 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700441 (■) | JP5951056 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700440 (○) | JP5759526 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700440 (■) | JP5759526 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700439 (○) | JP4890997 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700439 (■) | JP4890997 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700438 (○) | JP4404181 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700438 (■) | JP4404181 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700437 (○) | JP3861118 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700437 (■) | JP3861118 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700436 (○) | JP5919606 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700436 (■) | JP5919606 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700435 (○) | JP5840364 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700434 (○) | JP5748317 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700434 (■) | JP5748317 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700433 (○) | JP5951056 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700433 (■) | JP5951056 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700432 (○) | JP5759526 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700432 (■) | JP5759526 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700431 (○) | JP4890997 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700431 (■) | JP4890997 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700430 (○) | JP4404181 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700430 (■) | JP4404181 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700429 (○) | JP3861118 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700429 (■) | JP3861118 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700428 (○) | JP5919606 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700428 (■) | JP5919606 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700427 (○) | JP5840364 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700426 (○) | JP5951056 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700426 (■) | JP5951056 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700425 (○) | JP5759526 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700425 (■) | JP5759526 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700424 (○) | JP4890997 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700424 (■) | JP4890997 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700423 (○) | JP4404181 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700423 (■) | JP4404181 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700422 (○) | JP3861118 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700422 (■) | JP3861118 | Name of sale: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700421 (○) | JP5919606 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700421 (■) | JP5919606 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700420 (○) | JP5840364 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700419 (○) | JP5951056 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700419 (■) | JP5951056 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700418 (○) | JP5759526 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700418 (■) | JP5759526 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700417 (○) | JP4890997 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700417 (■) | JP4890997 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700416 (○) | JP4404181 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700416 (■) | JP4404181 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700415 (○) | JP3861118 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700415 (■) | JP3861118 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as adalimumab (genetically modified)) |
| 2016-700414 (○) | JP4925582 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: adalimumab (genetically modified) |
| 2016-700414 (■) | JP4925582 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: adalimumab (genetically modified) |
| 2016-700413 (○) | JP5951056 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: adalimumab (genetically modified) |
| 2016-700413 (■) | JP5951056 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: adalimumab (genetically modified) |
| 2016-700412 (○) | JP5759526 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: adalimumab (genetically modified) |
| 2016-700412 (■) | JP5759526 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: adalimumab (genetically modified) |
| 2016-700411 (○) | JP4890997 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: adalimumab (genetically modified) |
| 2016-700411 (■) | JP4890997 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: adalimumab (genetically modified) |
| 2016-700410 (○) | JP4404181 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: adalimumab (genetically modified) |
| 2016-700410 (■) | JP4404181 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: adalimumab (genetically modified) |
| 2016-700409 (○) | JP3861118 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: adalimumab (genetically modified) |
| 2016-700409 (■) | JP3861118 | Name of sale: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: adalimumab (genetically modified) |
| 2016-700408 (○) | JP5814356 | Name of sale: VIEKIRAX formulated tablets Active ingredients: Ombitasvir, Paritaprevir, Ritonavir |
| 2016-700408 (■) | JP5814356 | Name of sale: VIEKIRAX formulated tablets Active ingredients: Ombitasvir, Paritaprevir, Ritonavir |
| 2016-700407 (○) | JP5890553 | Name of sale: VIEKIRAX formulated tablets Active ingredients: Ombitasvir, Paritaprevir, Ritonavir |
| 2016-700407 (■) | JP5890553 | Name of sale: VIEKIRAX formulated tablets Active ingredients: Ombitasvir, Paritaprevir, Ritonavir |
| 2016-700406 (○) | JP5717768 | Name of sale: VIEKIRAX formulated tablets Active ingredients: Ombitasvir, Paritaprevir, Ritonavir |
| 2016-700406 (■) | JP5717768 | Name of sale: VIEKIRAX formulated tablets Active ingredients: Ombitasvir, Paritaprevir, Ritonavir |
| 2016-700405 (○) | JP5534533 | Name of sale: VIEKIRAX formulated tablets Active ingredients: Ombitasvir, Paritaprevir, Ritonavir |
| 2016-700405 (■) | JP5534533 | Name of sale: VIEKIRAX formulated tablets Active ingredients: Ombitasvir, Paritaprevir, Ritonavir |
| 2016-700404 (○) | JP5259537 | Name of sale: VIEKIRAX formulated tablets Active ingredients: Ombitasvir, Paritaprevir, Ritonavir |
| 2016-700404 (■) | JP5259537 | Name of sale: VIEKIRAX formulated tablets Active ingredients: Ombitasvir, Paritaprevir, Ritonavir |
| 2016-700403 (○) | JP5530514 | Name of sale: VIEKIRAX formulated tablets Active ingredients: Ombitasvir, Paritaprevir, Ritonavir |
| 2016-700403 (■) | JP5530514 | Name of sale: VIEKIRAX formulated tablets Active ingredients: Ombitasvir, Paritaprevir, Ritonavir |
| 2016-700402 (○) | JP5902760 | Drugs subject to disposal (brand name): Jacstapid capsule 20 mg Active ingredient of medications subject to disposal (general name): Lomitapidomesylate |
| 2016-700402 (■) | JP5902760 | Drugs subject to disposal (brand name): Jacstapid capsule 20 mg Active ingredient of medications subject to disposal (general name): Lomitapidomesylate |
| 2016-700401 (○) | JP5902760 | Drugs subject to disposal (brand name): Jacstapid capsule 10 mg Active ingredient of medications subject to disposal (general name): Lomitapidomesylate |
| 2016-700401 (■) | JP5902760 | Drugs subject to disposal (brand name): Jacstapid capsule 10 mg Active ingredient of medications subject to disposal (general name): Lomitapidomesylate |
| 2016-700400 (○) | JP5902760 | Drugs subject to disposal (brand name): Jacstapid capsule 5 mg Active ingredient of medications subject to disposal (general name): Lomitapidomesylate |
| 2016-700400 (■) | JP5902760 | Drugs subject to disposal (brand name): Jacstapid capsule 5 mg Active ingredient of medications subject to disposal (general name): Lomitapidomesylate |
| 2016-700399 (○) | JP5697296 | Drugs subject to disposal (brand name): Jacstapid capsule 20 mg Active ingredient of medications subject to disposal (general name): Lomitapidomesylate |
| 2016-700399 (■) | JP5697296 | Drugs subject to disposal (brand name): Jacstapid capsule 20 mg Active ingredient of medications subject to disposal (general name): Lomitapidomesylate |
| 2016-700398 (○) | JP5697296 | Drugs subject to disposal (brand name): Jacstapid capsule 10 mg Active ingredient of medications subject to disposal (general name): Lomitapidomesylate |
| 2016-700398 (■) | JP5697296 | Drugs subject to disposal (brand name): Jacstapid capsule 10 mg Active ingredient of medications subject to disposal (general name): Lomitapidomesylate |
| 2016-700397 (○) | JP5697296 | Drugs subject to disposal (brand name): Jacstapid capsule 5 mg Active ingredient of medications subject to disposal (general name): Lomitapidomesylate |
| 2016-700397 (■) | JP5697296 | Drugs subject to disposal (brand name): Jacstapid capsule 5 mg Active ingredient of medications subject to disposal (general name): Lomitapidomesylate |
| 2016-700396 (○) | JP4218991 | Name of sale: Villanore Tablet 20 mg General name: Bilastin |
| 2016-700396 (■) | JP4218991 | Name of sale: Villanore Tablet 20 mg General name: Bilastin |
| 2016-700395 (○) | JP4920797 | General name: Grazoprevir Tablet Name: Glagina Tablet 50 mg Active Ingredient: Glazoprevir Hydrate |
| 2016-700395 (■) | JP4920797 | General name: Grazoprevir Tablet Name: Glagina Tablet 50 mg Active Ingredient: Glazoprevir Hydrate |
| 2016-700394 (○) | JP4621082 | Common Name: Desloratadine Tablet Name: Desarex Tablet 5 mg Active Ingredients: Desloratadine |
| 2016-700394 (■) | JP4621082 | Common Name: Desloratadine Tablet Name: Desarex Tablet 5 mg Active Ingredients: Desloratadine |
| 2016-700393 (○) | JP4160739 | Common Name: Desloratadine Tablet Name: Desarex Tablet 5 mg Active Ingredients: Desloratadine |
| 2016-700393 (■) | JP4160739 | Common Name: Desloratadine Tablet Name: Desarex Tablet 5 mg Active Ingredients: Desloratadine |
| 2016-700392 (○) | JP3224379 | Common Name: Desloratadine Tablet Name: Desarex Tablet 5 mg Active Ingredients: Desloratadine |
| 2016-700392 (■) | JP3224379 | Common Name: Desloratadine Tablet Name: Desarex Tablet 5 mg Active Ingredients: Desloratadine |
| 2016-700391 (○) | JP3996944 | Name of Sale: Kickrin Granule 86.2% Common Name of Active Ingredient: Bixalomer |
| 2016-700390 (○) | JP4580928 | Name of sale: SIGNIFOR LAR intramuscular injection kit 60 mg Active ingredient: Pasireotide pamoate |
| 2016-700390 (■) | JP4580928 | Name of sale: SIGNIFOR LAR intramuscular injection kit 60 mg Active ingredient: Pasireotide pamoate |
| 2016-700389 (○) | JP4580928 | Name of sale: SIGNIFOR LAR intramuscular injection kit 40 mg Active ingredient: Pasireotide pamoate |
| 2016-700389 (■) | JP4580928 | Name of sale: SIGNIFOR LAR intramuscular injection kit 40 mg Active ingredient: Pasireotide pamoate |
| 2016-700388 (○) | JP4580928 | Name of sale: SIGNIFOR LAR intramuscular injection kit 20 mg Active ingredient: Pasireotide pamoate |
| 2016-700388 (■) | JP4580928 | Name of sale: SIGNIFOR LAR intramuscular injection kit 20 mg Active ingredient: Pasireotide pamoate |
| 2016-700387 (○) | JP5507447 | Name of sale: SIGNIFOR LAR intramuscular injection kit 60 mg Active ingredient: Pasireotide pamoate |
| 2016-700387 (■) | JP5507447 | Name of sale: SIGNIFOR LAR intramuscular injection kit 60 mg Active ingredient: Pasireotide pamoate |
| 2016-700386 (○) | JP5507447 | Name of sale: SIGNIFOR LAR intramuscular injection kit 40 mg Active ingredient: Pasireotide pamoate |
| 2016-700386 (■) | JP5507447 | Name of sale: SIGNIFOR LAR intramuscular injection kit 40 mg Active ingredient: Pasireotide pamoate |
| 2016-700385 (○) | JP5507447 | Name of sale: SIGNIFOR LAR intramuscular injection kit 20 mg Active ingredient: Pasireotide pamoate |
| 2016-700385 (■) | JP5507447 | Name of sale: SIGNIFOR LAR intramuscular injection kit 20 mg Active ingredient: Pasireotide pamoate |
| 2016-700384 (○) | JP4682145 | Name of sale: SIGNIFOR LAR intramuscular injection kit 60 mg Active ingredient: Pasireotide pamoate |
| 2016-700384 (■) | JP4682145 | Name of sale: SIGNIFOR LAR intramuscular injection kit 60 mg Active ingredient: Pasireotide pamoate |
| 2016-700383 (○) | JP4682145 | Name of sale: SIGNIFOR LAR intramuscular injection kit 40 mg Active ingredient: Pasireotide pamoate |
| 2016-700383 (■) | JP4682145 | Name of sale: SIGNIFOR LAR intramuscular injection kit 40 mg Active ingredient: Pasireotide pamoate |
| 2016-700382 (○) | JP4682145 | Name of sale: SIGNIFOR LAR intramuscular injection kit 20 mg Active ingredient: Pasireotide pamoate |
| 2016-700382 (■) | JP4682145 | Name of sale: SIGNIFOR LAR intramuscular injection kit 20 mg Active ingredient: Pasireotide pamoate |
| 2016-700381 (○) | JP3829118 | Name of sale: SIGNIFOR LAR intramuscular injection kit 60 mg Active ingredient: Pasireotide pamoate |
| 2016-700381 (■) | JP3829118 | Name of sale: SIGNIFOR LAR intramuscular injection kit 60 mg Active ingredient: Pasireotide pamoate |
| 2016-700380 (○) | JP3829118 | Name of sale: SIGNIFOR LAR intramuscular injection kit 40 mg Active ingredient: Pasireotide pamoate |
| 2016-700380 (■) | JP3829118 | Name of sale: SIGNIFOR LAR intramuscular injection kit 40 mg Active ingredient: Pasireotide pamoate |
| 2016-700379 (○) | JP3829118 | Name of sale: SIGNIFOR LAR intramuscular injection kit 20 mg Active ingredient: Pasireotide pamoate |
| 2016-700379 (■) | JP3829118 | Name of sale: SIGNIFOR LAR intramuscular injection kit 20 mg Active ingredient: Pasireotide pamoate |
| 2016-700378 (○) | JP5567650 | Name of sale: IniSink combination tablets Active ingredient: Alogliptin benzoate and metformin hydrochloride |
| 2016-700378 (■) | JP5567650 | Name of sale: IniSink combination tablets Active ingredient: Alogliptin benzoate and metformin hydrochloride |
| 2016-700377 (○) | JP3895349 | Name of sale: IniSink combination tablets Active ingredient: Alogliptin benzoate and metformin hydrochloride |
| 2016-700377 (■) | JP3895349 | Name of sale: IniSink combination tablets Active ingredient: Alogliptin benzoate and metformin hydrochloride |
| 2016-700376 (○) | JP5843986 | Kickrin granules 86.2% (bixalomer as active ingredient) |
| 2016-700376 (■) | JP5843986 | Kickrin granules 86.2% (bixalomer as active ingredient) |
| 2016-700375 (○) | JP5191537 | General name pembrolizumab (genetically modified product) Product name: Kiytruda IV infusion 20 mg Active ingredient: pembrolizumab (genetically modified) |
| 2016-700375 (■) | JP5191537 | General name: Pembrolizumab (genetically modified product) Name: Qiatoruda IV 20 mg Active ingredient: Pembrolizumab (genetically modified) |
| 2016-700374 (○) | JP5191537 | General name pembrolizumab (genetically modified product) Product name: Kiytruda IV infusion 100 mg Active ingredient: pembrolizumab (genetically modified) |
| 2016-700374 (■) | JP5191537 | General name: Pembrolizumab (genetically modified product) Name: Kiytruda IV infusion 100 mg Active ingredient: Pembrolizumab (genetically modified) |
| 2016-700373 (○) | JP4250087 | Name of sale: Ligros dental fluid kit 1200 micro g Active ingredient: Trafermin (genetically modified) |
| 2016-700373 (■) | JP4250087 | Name of sale: Ligros dental fluid kit 1200 micro g Active ingredient: Trafermin (genetically modified) |
| 2016-700372 (○) | JP4250087 | Name of sale: Ligros dental fluid kit 600 microg Active ingredient: Trafermin (genetically modified) |
| 2016-700372 (■) | JP4250087 | Name of sale: Ligros dental fluid kit 600 microg Active ingredient: Trafermin (genetically modified) |
| 2016-700371 (○) | JP4187406 | (I) Name: Brillinta tablet 60 mg (ii) Active ingredient: Tikagrelor |
| 2016-700371 (■) | JP4187406 | (I) Name: Brillinta tablet 60 mg (ii) Active ingredient: Tikagrelor |
| 2016-700370 (○) | JP4187406 | (I) Name: Brillinta tablet 90 mg (ii) Active ingredient: Tikagrelor |
| 2016-700370 (■) | JP4187406 | (I) Name: Brillinta tablet 90 mg (ii) Active ingredient: Tikagrelor |
| 2016-700369 (○) | JP5656837 | (I) Name: Brillinta tablet 60 mg (ii) Active ingredient: Tikagrelor |
| 2016-700369 (■) | JP5656837 | (I) Name: Brillinta tablet 60 mg (ii) Active ingredient: Tikagrelor |
| 2016-700368 (○) | JP5656837 | (I) Name: Brillinta tablet 90 mg (ii) Active ingredient: Tikagrelor |
| 2016-700368 (■) | JP5656837 | (I) Name: Brillinta tablet 90 mg (ii) Active ingredient: Tikagrelor |
| 2016-700367 (○) | JP4947870 | (I) Name: Brillinta tablet 60 mg (ii) Active ingredient: Tikagrelor |
| 2016-700367 (■) | JP4947870 | (I) Name: Brillinta tablet 60 mg (ii) Active ingredient: Tikagrelor |
| 2016-700366 (○) | JP4947870 | (I) Name: Brillinta tablet 90 mg (ii) Active ingredient: Tikagrelor |
| 2016-700366 (■) | JP4947870 | (I) Name: Brillinta tablet 90 mg (ii) Active ingredient: Tikagrelor |
| 2016-700365 (○) | JP4202607 | (I) Name: Brillinta tablet 60 mg (ii) Active ingredient: Tikagrelor |
| 2016-700365 (■) | JP4202607 | (I) Name: Brillinta tablet 60 mg (ii) Active ingredient: Tikagrelor |
| 2016-700364 (○) | JP4202607 | (I) Name: Brillinta tablet 90 mg (ii) Active ingredient: Tikagrelor |
| 2016-700364 (■) | JP4202607 | (I) Name: Brillinta tablet 90 mg (ii) Active ingredient: Tikagrelor |
| 2016-700363 (○) | JP5036947 | (I) Name: Brillinta tablet 60 mg (ii) Active ingredient: Tikagrelor |
| 2016-700363 (■) | JP5036947 | (I) Name: Brillinta tablet 60 mg (ii) Active ingredient: Tikagrelor |
| 2016-700362 (○) | JP5036947 | (I) Name: Brillinta tablet 90 mg (ii) Active ingredient: Tikagrelor |
| 2016-700362 (■) | JP5036947 | (I) Name: Brillinta tablet 90 mg (ii) Active ingredient: Tikagrelor |
| 2016-700361 (○) | JP5385139 | (I) Name: Brillinta tablet 60 mg (ii) Active ingredient: Tikagrelor |
| 2016-700361 (■) | JP5385139 | (I) Name: Brillinta tablet 60 mg (ii) Active ingredient: Tikagrelor |
| 2016-700360 (○) | JP5385139 | (I) Name: Brillinta tablet 90 mg (ii) Active ingredient: Tikagrelor |
| 2016-700360 (■) | JP5385139 | (I) Name: Brillinta tablet 90 mg (ii) Active ingredient: Tikagrelor |
| 2016-700359 (○) | JP4727875 | Name of sale: Realda Tablet 1200 mg General name: Mesalazine |
| 2016-700359 (■) | JP4727875 | Name of sale: Realda Tablet 1200 mg General name: Mesalazine |
| 2016-700358 (○) | JP5932929 | General name: Elvasvir Tablets Name: Elersa Tablets 50mg Active Ingredients: Elvasvir |
| 2016-700358 (■) | JP5932929 | General name: Elvasville Tablets Name: Elersa Tablets 50mg Active Ingredients: Elvasvir |
| 2016-700357 (○) | JP5268927 | General name: Grazoprevir Tablet Name: Glagina Tablet 50 mg Active Ingredients: Glazoprevir Hydrate |
| 2016-700357 (■) | JP5268927 | General name: Grazoprevir Tablet Name: Glagina Tablet 50 mg Active Ingredient: Glazoprevir Hydrate |
| 2016-700356 (○) | JP5661456 | Micerna combination eye drops |
| 2016-700356 (■) | JP5661456 | Micerna combination eye drops |
| 2016-700355 (○) | JP5199576 | Name of Sale: Rifixima Tablet 200 mg Active Ingredient: Rifaximin |
| 2016-700355 (■) | JP5199576 | Name of Sale: Rifixima Tablet 200 mg Active Ingredient: Rifaximin |
| 2016-700354 (○) | JP5537740 | Name of sale: Cosentix subcutaneous injection 150 mg pen Common name: seckinumab (genetically modified) |
| 2016-700354 (■) | JP5537740 | Name of sale: Cosentix subcutaneous injection 150 mg pen Common name: seckinumab (genetically modified) |
| 2016-700353 (○) | JP4682200 | Name of sale: Cosentix subcutaneous injection 150 mg pen Common name: seckinumab (genetically modified) |
| 2016-700353 (■) | JP4682200 | Name of sale: Cosentix subcutaneous injection 150 mg pen Common name: seckinumab (genetically modified) |
| 2016-700352 (○) | JP5790629 | Name of sale: Eicursig Tablets 15 mg Active Ingredient · Common Name: Ponatinib hydrochloride |
| 2016-700352 (■) | JP5790629 | Name of sale: Eicursig Tablets 15 mg Active Ingredient · Common Name: Ponatinib hydrochloride |
| 2016-700351 (○) | JP5200939 | Name of sale: Eicursig Tablets 15 mg Active Ingredient · Common Name: Ponatinib hydrochloride |
| 2016-700351 (■) | JP5200939 | Name of sale: Eicursig Tablets 15 mg Active Ingredient · Common Name: Ponatinib hydrochloride |
| 2016-700350 (○) | JP4479152 | Name of sale: UPTRAVI Tablet 0.4 mg Active ingredient: Celexipag |
| 2016-700350 (■) | JP4479152 | Name of sale: UPTRAVI Tablet 0.4mg Active Ingredient: Celexipag |
| 2016-700349 (○) | JP4479152 | Name of sale: UPTRAVI Tablet 0.2mg Active Ingredient: Celexipag |
| 2016-700349 (■) | JP4479152 | Name of sale: UPTRAVI Tablet 0.2mg Active ingredient: Celexipag |
| 2016-700348 (○) | JP4802096 | Name of sale: Riclast IV solution 5mg Active ingredient: Zoledronic acid hydrate |
| 2016-700348 (■) | JP4802096 | Name of sale: Riclast IV solution 5mg Active ingredient: Zoledronic acid hydrate |
| 2016-700347 (○) | JP5005188 | Name of sale: Riclast IV solution 5mg Active ingredient: Zoledronic acid hydrate |
| 2016-700347 (■) | JP5005188 | Name of sale: Riclast IV solution 5mg Active ingredient: Zoledronic acid hydrate |
| 2016-700346 (○) | JP4722375 | Name of sale: Riclast IV solution 5mg Active ingredient: Zoledronic acid hydrate |
| 2016-700346 (■) | JP4722375 | Name of sale: Riclast IV solution 5mg Active ingredient: Zoledronic acid hydrate |
| 2016-700345 (○) | JP4361545 | Name of sale: Opdivo IV 100 mg Active ingredient name: Nivolumab (genetically modified) |
| 2016-700345 (■) | JP4361545 | Name of sale: Opdivo IV 100 mg Active ingredient name: Nivolumab (genetically modified) |
| 2016-700344 (○) | JP4361545 | Name of Sale: Opdivo Intravenous Drip Injection 20mg Active Ingredient Name: Nivolumab (genetically modified) |
| 2016-700344 (■) | JP4361545 | Name of Sale: Opdivo Intravenous Drip Injection 20mg Active Ingredient Name: Nivolumab (genetically modified) |
| 2016-700343 (○) | JP5210861 | "Spiriva 2.5 micro g repimat 60 inhalation" (active ingredient: tiotropium bromide hydrate) |
| 2016-700343 (■) | JP5210861 | "Spiriva 2.5 μg respimat 60 inhalation" (active ingredient: tiotropium bromide hydrate) |
| 2016-700342 (○) | JP5210861 | "Spiriva 1.25 microg respimat 60 inhalation" (active ingredient: tiotropium bromide hydrate) |
| 2016-700342 (■) | JP5210861 | "Spiriva 1.25 μg respimat 60 inhalation" (active ingredient: tiotropium bromide hydrate) |
| 2016-700341 (○) | JP4344135 | "Spiriva 2.5 micro g repimat 60 inhalation" (active ingredient: tiotropium bromide hydrate) |
| 2016-700341 (■) | JP4344135 | "Spiriva 2.5 μg respimat 60 inhalation" (active ingredient: tiotropium bromide hydrate) |
| 2016-700340 (○) | JP4344135 | "Spiriva 1.25 microg respimat 60 inhalation" (active ingredient: tiotropium bromide hydrate) |
| 2016-700340 (■) | JP4344135 | "Spiriva 1.25 μg respimat 60 inhalation" (active ingredient: tiotropium bromide hydrate) |
| 2016-700339 (○) | JP5159730 | Name of sale: Opdivo IV 100mg Active Ingredient: Nivolumab (genetically modified) |
| 2016-700339 (■) | JP5159730 | Name of sale: Opdivo IV 100mg Active Ingredient: Nivolumab (genetically modified) |
| 2016-700338 (○) | JP5159730 | Name of Sale: Opdivo Intravenous Drip Injection 20mg Active Ingredient: Nivolumab (genetically modified) |
| 2016-700338 (■) | JP5159730 | Name of Sale: Opdivo Intravenous Drip Injection 20mg Active Ingredient: Nivolumab (genetically modified) |
| 2016-700337 (○) | JP5963836 | Name of Sale: Afinitor Tablet 2.5 mg Active Ingredient: Everolimus |
| 2016-700337 (■) | JP5963836 | Name of Sale: Afinitor Tablet 2.5 mg Active Ingredient: Everolimus |
| 2016-700336 (○) | JP5963836 | Name of Sale: Afinitor Tablet 5 mg Active Ingredient: Everolimus |
| 2016-700336 (■) | JP5963836 | Name of Sale: Afinitor Tablet 5 mg Active Ingredient: Everolimus |
| 2016-700335 (○) | JP4902945 | ABILIFY OD tablets 12 mg (General name: aripiprazole) |
| 2016-700335 (■) | JP4902945 | ABILIFY OD tablets 12 mg (General name: aripiprazole) |
| 2016-700334 (○) | JP4902945 | ABILIFY OD Tablet 6 mg (General name: aripiprazole) |
| 2016-700334 (■) | JP4902945 | ABILIFY OD Tablet 6 mg (General name: aripiprazole) |
| 2016-700333 (○) | JP4902945 | ABILIFY OD tablet 3 mg (General name: aripiprazole) |
| 2016-700333 (■) | JP4902945 | ABILIFY OD tablet 3 mg (General name: aripiprazole) |
| 2016-700332 (○) | JP4902945 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2016-700332 (■) | JP4902945 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2016-700331 (○) | JP4902945 | ABILIFY powder 1% (General name: aripiprazole) |
| 2016-700331 (■) | JP4902945 | ABILIFY powder 1% (General name: aripiprazole) |
| 2016-700330 (○) | JP4902945 | ABILIFY Tablet 12 mg (General name: aripiprazole) |
| 2016-700330 (■) | JP4902945 | ABILIFY Tablet 12 mg (General name: aripiprazole) |
| 2016-700329 (○) | JP4902945 | ABILIFY Tablet 6 mg (General name: aripiprazole) |
| 2016-700329 (■) | JP4902945 | ABILIFY Tablet 6 mg (General name: aripiprazole) |
| 2016-700328 (○) | JP4902945 | ABILIFY Tablet 3 mg (General name: aripiprazole) |
| 2016-700328 (■) | JP4902945 | ABILIFY Tablet 3 mg (General name: aripiprazole) |
| 2016-700327 (○) | JP4902945 | ABILIFY Tablet 1 mg (General name: aripiprazole) |
| 2016-700327 (■) | JP4902945 | ABILIFY Tablet 1 mg (General name: aripiprazole) |
| 2016-700326 (○) | JP4896831 | ABILIFY OD tablets 12 mg (General name: aripiprazole) |
| 2016-700326 (■) | JP4896831 | ABILIFY OD tablets 12 mg (General name: aripiprazole) |
| 2016-700325 (○) | JP4896831 | ABILIFY OD Tablet 6 mg (General name: aripiprazole) |
| 2016-700325 (■) | JP4896831 | ABILIFY OD Tablet 6 mg (General name: aripiprazole) |
| 2016-700324 (○) | JP4896831 | ABILIFY OD tablet 3 mg (General name: aripiprazole) |
| 2016-700324 (■) | JP4896831 | ABILIFY OD tablet 3 mg (General name: aripiprazole) |
| 2016-700323 (○) | JP4896831 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2016-700323 (■) | JP4896831 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2016-700322 (○) | JP4896831 | ABILIFY powder 1% (General name: aripiprazole) |
| 2016-700322 (■) | JP4896831 | ABILIFY powder 1% (General name: aripiprazole) |
| 2016-700321 (○) | JP4896831 | ABILIFY Tablet 12 mg (General name: aripiprazole) |
| 2016-700321 (■) | JP4896831 | ABILIFY Tablet 12 mg (General name: aripiprazole) |
| 2016-700320 (○) | JP4896831 | ABILIFY Tablet 6 mg (General name: aripiprazole) |
| 2016-700320 (■) | JP4896831 | ABILIFY Tablet 6 mg (General name: aripiprazole) |
| 2016-700319 (○) | JP4896831 | ABILIFY Tablet 3 mg (General name: aripiprazole) |
| 2016-700319 (■) | JP4896831 | ABILIFY Tablet 3 mg (General name: aripiprazole) |
| 2016-700318 (○) | JP4896831 | ABILIFY Tablet 1 mg (General name: aripiprazole) |
| 2016-700318 (■) | JP4896831 | ABILIFY Tablet 1 mg (General name: aripiprazole) |
| 2016-700317 (○) | JP4401077 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2016-700317 (■) | JP4401077 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2016-700316 (○) | JP3760264 | ABILIFY OD Tablet 12 mg (Common name: aripiprazole) |
| 2016-700316 (■) | JP3760264 | ABILIFY OD Tablet 12 mg (Common name: aripiprazole) |
| 2016-700315 (○) | JP3760264 | ABILIFY OD Tablet 6 mg (General name: aripiprazole) |
| 2016-700315 (■) | JP3760264 | ABILIFY OD Tablet 6 mg (General name: aripiprazole) |
| 2016-700314 (○) | JP3760264 | ABILIFY OD Tablet 3mg (General name: aripiprazole) |
| 2016-700314 (■) | JP3760264 | ABILIFY OD Tablet 3mg (General name: aripiprazole) |
| 2016-700313 (○) | JP3760264 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2016-700313 (■) | JP3760264 | ABILIFY internal solution 0.1% (General name: aripiprazole) |
| 2016-700312 (○) | JP3760264 | ABILIFY powder 1% (common name: aripiprazole) |
| 2016-700312 (■) | JP3760264 | ABILIFY powder 1% (common name: aripiprazole) |
| 2016-700311 (○) | JP3760264 | ABILIFY Tablet 12 mg (General name: aripiprazole) |
| 2016-700311 (■) | JP3760264 | ABILIFY Tablet 12 mg (General name: aripiprazole) |
| 2016-700310 (○) | JP3760264 | ABILIFY Tablet 6 mg (General name: aripiprazole) |
| 2016-700310 (■) | JP3760264 | ABILIFY Tablet 6 mg (General name: aripiprazole) |
| 2016-700309 (○) | JP3760264 | ABILIFY Tablet 3mg (General name: aripiprazole) |
| 2016-700309 (■) | JP3760264 | ABILIFY Tablet 3mg (General name: aripiprazole) |
| 2016-700308 (○) | JP3760264 | ABILIFY Tablet 1 mg (General name: aripiprazole) |
| 2016-700308 (■) | JP3760264 | ABILIFY Tablet 1 mg (General name: aripiprazole) |
| 2016-700307 (○) | JP5686420 | General name: Raninamivir octanoate hydrate Name (sales name): Inavir inhalation powder 20 mg |
| 2016-700307 (■) | JP5686420 | General name: Raninamivir octanoate hydrate Name (sales name): Inavir inhalation powder 20 mg |
| 2016-700306 (○) | JP5249947 | General name: Raninamivir octanoate hydrate Name (sales name): Inavir inhalation powder 20 mg |
| 2016-700306 (■) | JP5249947 | General name: Raninamivir octanoate hydrate Name (sales name): Inavir inhalation powder 20 mg |
| 2016-700305 (○) | JP4205314 | General name: Raninamivir octanoate hydrate Name (sales name): Inavir inhalation powder 20 mg |
| 2016-700305 (■) | JP4205314 | General name: Raninamivir octanoate hydrate Name (sales name): Inavir inhalation powder 20 mg |
| 2016-700304 (○) | JP3920041 | General name: Raninamivir octanoate hydrate Name (sales name): Inavir inhalation powder 20 mg |
| 2016-700304 (■) | JP3920041 | General name: Raninamivir octanoate hydrate Name (sales name): Inavir inhalation powder 20 mg |
| 2016-700303 (○) | JP3209946 | General name: Raninamivir octanoate hydrate Name (sales name): Inavir inhalation powder 20 mg |
| 2016-700303 (■) | JP3209946 | General name: Raninamivir octanoate hydrate Name (sales name): Inavir inhalation powder 20 mg |
| 2016-700302 (○) | JP3982542 | Types of pesticides: Fentrazamide, benzobicyclon, metazosulfuron granules Name of pesticides: Heavenly jumbo Types of active ingredients: 1- {3-chloro-1-methyl-4-[(5RS) -5, 6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2016-700302 (■) | JP3982542 | Types of pesticides: Fentrazamide, benzobicyclon, metazosulfuron granules Name of pesticides: Heavenly jumbo Types of active ingredients: 1- {3-chloro-1-methyl-4-[(5RS) -5, 6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2016-700301 (○) | JP3982542 | Types of pesticides: Tefuryltrione, fentrazamide, metazosulfuron granules Name of pesticides: Cygnus jumbo Types of active ingredients: 1- {3-chloro-1-methyl-4-[(5RS) -5, 6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2016-700301 (■) | JP3982542 | Types of pesticides: Tefuryltrione, fentrazamide, metazosulfuron granules Name of pesticides: Cygnus jumbo Types of active ingredients: 1- {3-chloro-1-methyl-4-[(5RS) -5, 6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2016-700300 (○) | JP5729564 | Types of pesticides: Fentrazamide, benzobicyclon, metazosulfuron wettable powder Name of pesticides: Sky flowable Types of active ingredients: 1- {3-chloro-1-methyl-4-[(5RS) -5 , 6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2016-700300 (■) | JP5729564 | Type of pesticide: Fentrazamide, benzobicyclon, metazosulfuron water-dispersible powder Name of the pesticide: Heavenly flowable Type of active ingredient: 1- {3-chloro-1-methyl-4-[(5RS) -5,6-dihydro-5 -Methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2016-700299 (○) | JP5729564 | Types of pesticides: tefuryltrione fentrazamide methazosulfuron wettable powder Name of pesticides: Cygnus flowable type of active ingredient: 1- {3-chloro-1-methyl-4-[(5RS) -5 , 6-Dihydro-5-methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2016-700299 (■) | JP5729564 | Types of pesticides: tefuryltrione fentrazamide methazosulfuron water-dispersible powder Pesticide name: Cygnus flowable Type of active ingredients: 1- {3-chloro-1-methyl-4-[(5RS) -5,6-dihydro-5 -Methyl-1,4,2-dioxazin-3-yl] pyrazol-5-ylsulfonyl} -3- (4,6-dimethoxypyrimidin-2-yl) urea |
| 2016-700298 (○) | JP5749247 | Name of Sale: Oxycodone Extended Release Tablet 40mg "Daisankyo" Active Ingredient: Oxycodone Hydrochloride Hydrate |
| 2016-700298 (■) | JP5749247 | Name of Sale: Oxycodone Extended Release Tablet 40mg "Daisankyo" Active Ingredient: Oxycodone Hydrochloride Hydrate |
| 2016-700297 (○) | JP5749247 | Name of sale: Oxycodone Extended Release Tablet 20mg "Daisankyo" Active ingredient: Oxycodone hydrochloride hydrate |
| 2016-700297 (■) | JP5749247 | Name of sale: Oxycodone Extended Release Tablet 20mg "Daisankyo" Active ingredient: Oxycodone hydrochloride hydrate |
| 2016-700296 (○) | JP5749247 | Name of sale: Oxycodone Extended Release Tablet 10mg "Daisankyo" Active ingredient: Oxycodone hydrochloride hydrate |
| 2016-700296 (■) | JP5749247 | Name of sale: Oxycodone Extended Release Tablet 10mg "Daisankyo" Active ingredient: Oxycodone hydrochloride hydrate |
| 2016-700295 (○) | JP5749247 | Name of sale: Oxycodone slow release tablet 5mg "Daisankyo" Active ingredient: Oxycodone hydrochloride hydrate |
| 2016-700295 (■) | JP5749247 | Name of sale: Oxycodone slow release tablet 5mg "Daisankyo" Active ingredient: Oxycodone hydrochloride hydrate |
| 2016-700294 (○) | JP4949555 | Bopriva |
| 2016-700294 (■) | JP4949555 | Bopriva |
| 2016-700293 (○) | JP5128281 | Bimaput Tablets 100mg (Active Ingredient: Lacosamide) |
| 2016-700293 (■) | JP5128281 | Bimaput Tablets 100mg (Active Ingredient: Lacosamide) |
| 2016-700292 (○) | JP5128281 | Bimaput Tablets 50mg (Active Ingredient: Lacosamide) |
| 2016-700292 (■) | JP5128281 | Bimaput Tablets 50mg (Active Ingredient: Lacosamide) |
| 2016-700291 (○) | JP5318965 | Name (sales name): PLARENT subcutaneous injection 150 mg syringe Active ingredient name: Alilocumab (genetically modified) |
| 2016-700291 (■) | JP5318965 | Name (sales name) PRURALENT subcutaneous injection 150 mg syringe Active ingredient name: Alilocumab (genetically modified) |
| 2016-700290 (○) | JP5318965 | Name (sales name): Pralurent subcutaneous injection 75 mg syringe Active ingredient name: Alilocumab (genetically modified) |
| 2016-700290 (■) | JP5318965 | Name (sales name) PRURALENT subcutaneous injection 75 mg syringe Active ingredient name: Alilocumab (genetically modified) |
| 2016-700289 (○) | JP5318965 | Name (sales name): Praluert subcutaneous injection 150 mg pen Active ingredient name: Alilocumab (genetically modified) |
| 2016-700289 (■) | JP5318965 | Name (sales name) Praluento subcutaneous injection 150 mg pen Active ingredient name: Alilocumab (genetically modified) |
| 2016-700288 (○) | JP5318965 | Name (sales name): Praluert subcutaneous injection 75 mg pen Active ingredient name: Alilocumab (genetically modified) |
| 2016-700288 (■) | JP5318965 | Name (sales name) Praruerto subcutaneous injection 75 mg pen Active ingredient name: Alilocumab (genetically modified) |
| 2016-700287 (○) | JP5063612 | Name of sale: Taltz subcutaneous injection 80 mg autoinjector Active ingredient: Ixekizumab (genetically modified) |
| 2016-700287 (■) | JP5063612 | Name of sale: Taltz subcutaneous injection 80 mg autoinjector Active ingredient: Ixekizumab (genetically modified) |
| 2016-700286 (○) | JP5063612 | Name of sale: Taltz subcutaneous injection 80 mg syringe Active ingredient: Ixekizumab (genetically modified) |
| 2016-700286 (■) | JP5063612 | Name of sale: Taltz subcutaneous injection 80 mg syringe Active ingredient: Ixekizumab (genetically modified) |
| 2016-700285 (○) | JP5743234 | (Name): Lumicef subcutaneous injection 210 mg syringe (active ingredient): brodarumab (genetically modified) |
| 2016-700285 (■) | JP5743234 | (Name): Lumicef subcutaneous injection 210 mg syringe (active ingredient): brodarumab (genetically modified) |
| 2016-700284 (○) | JP5647748 | (Name): Lumicef subcutaneous injection 210 mg syringe (active ingredient): brodarumab (genetically modified) |
| 2016-700284 (■) | JP5647748 | (Name): Lumicef subcutaneous injection 210 mg syringe (active ingredient): brodarumab (genetically modified) |
| 2016-700283 (○) | JP5013383 | (Name): Lumicef subcutaneous injection 210 mg syringe (active ingredient): brodarumab (genetically modified) |
| 2016-700283 (■) | JP5013383 | (Name): Lumicef subcutaneous injection 210 mg syringe (active ingredient): brodarumab (genetically modified) |
| 2016-700282 (○) | JP5734656 | (Name) Kaiprolith Intravenous Drip Injection 40 mg (Active ingredient) Carfilzomib |
| 2016-700282 (■) | JP5734656 | (Name) Kaiprolith Intravenous Drip Injection 40 mg (Active ingredient) Carfilzomib |
| 2016-700281 (○) | JP5734656 | (Name) Kaiproris 10 mg for intravenous drip infusion (active ingredient) carfilzomib |
| 2016-700281 (■) | JP5734656 | (Name) Kaiproris 10 mg for intravenous drip infusion (active ingredient) carfilzomib |
| 2016-700280 (○) | JP5394423 | (Name) Kaiprolith Intravenous Drip Injection 40 mg (Active ingredient) Carfilzomib |
| 2016-700280 (■) | JP5394423 | (Name) Kaiprolith Intravenous Drip Injection 40 mg (Active ingredient) Carfilzomib |
| 2016-700279 (○) | JP5394423 | (Name) Kaiproris 10 mg for intravenous drip infusion (active ingredient) carfilzomib |
| 2016-700279 (■) | JP5394423 | (Name) Kaiproris 10 mg for intravenous drip infusion (active ingredient) carfilzomib |
| 2016-700278 (○) | JP4990155 | (Name) Kaiprolith Intravenous Drip Injection 40 mg (Active ingredient) Carfilzomib |
| 2016-700278 (■) | JP4990155 | (Name) Kaiprolith Intravenous Drip Injection 40 mg (Active ingredient) Carfilzomib |
| 2016-700277 (○) | JP4990155 | (Name) Kaiproris 10 mg for intravenous drip infusion (active ingredient) carfilzomib |
| 2016-700277 (■) | JP4990155 | (Name) Kaiproris 10 mg for intravenous drip infusion (active ingredient) carfilzomib |
| 2016-700276 (○) | JP4743720 | (Name) Kaiprolith Intravenous Drip Injection 40 mg (Active ingredient) Carfilzomib |
| 2016-700276 (■) | JP4743720 | (Name) Kaiprolith Intravenous Drip Injection 40 mg (Active ingredient) Carfilzomib |
| 2016-700275 (○) | JP4743720 | (Name) Kaiproris 10 mg for intravenous drip infusion (active ingredient) carfilzomib |
| 2016-700275 (■) | JP4743720 | (Name) Kaiproris 10 mg for intravenous drip infusion (active ingredient) carfilzomib |
| 2016-700274 (○) | JP5527921 | Name of product: Estac ibu TT Active ingredient: Ibuprofen Magnesium oxide Glycyrrhizinic acid Ingredient: Low substituted hydroxypropyl cellulose |
| 2016-700273 (○) | JP5490347 | Name of product: Estac ibu TT Active ingredient: Ibuprofen Magnesium oxide Glycyrrhizinic acid Ingredient: Low substituted hydroxypropyl cellulose |
| 2016-700273 (■) | JP5490347 | Name of product: Estac ibu TT Active ingredient: Ibuprofen Magnesium oxide Glycyrrhizinic acid Ingredient: Low substituted hydroxypropyl cellulose |
| 2016-700272 (○) | JP5919606 | Name written on approval letter: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700272 (■) | JP5919606 | Name written on approval letter: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700271 (○) | JP5840364 | Name written on approval letter: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700270 (○) | JP5748317 | Name written on approval letter: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700270 (■) | JP5748317 | Name written on approval letter: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700269 (○) | JP5759526 | Name written on approval letter: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700269 (■) | JP5759526 | Name written on approval letter: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700268 (○) | JP5422501 | Name written on approval letter: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700268 (■) | JP5422501 | Name written on approval letter: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700267 (○) | JP4890997 | Name written on approval letter: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700267 (■) | JP4890997 | Name written on approval letter: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700266 (○) | JP4404181 | Name written on approval letter: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700266 (■) | JP4404181 | Name written on approval letter: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700265 (○) | JP3861118 | Name written on approval letter: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700265 (■) | JP3861118 | Name written on approval letter: Humira subcutaneous injection 80 mg syringe 0.8 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700264 (○) | JP5919606 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700264 (■) | JP5919606 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700263 (○) | JP5840364 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700262 (○) | JP5748317 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700262 (■) | JP5748317 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700261 (○) | JP5759526 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700261 (■) | JP5759526 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700260 (○) | JP5422501 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700260 (■) | JP5422501 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700259 (○) | JP4890997 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700259 (■) | JP4890997 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700258 (○) | JP4404181 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700258 (■) | JP4404181 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700257 (○) | JP3861118 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700257 (■) | JP3861118 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.4 mL Active ingredient: Adalimumab drug substance (as Adalimumab (genetically modified)) |
| 2016-700256 (○) | JP5748317 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: Adalimumab (genetically modified) |
| 2016-700256 (■) | JP5748317 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: Adalimumab (genetically modified) |
| 2016-700255 (○) | JP4925582 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: Adalimumab (genetically modified) |
| 2016-700255 (■) | JP4925582 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: Adalimumab (genetically modified) |
| 2016-700254 (○) | JP5951056 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: Adalimumab (genetically modified) |
| 2016-700254 (■) | JP5951056 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: Adalimumab (genetically modified) |
| 2016-700253 (○) | JP5759526 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: Adalimumab (genetically modified) |
| 2016-700253 (■) | JP5759526 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: Adalimumab (genetically modified) |
| 2016-700252 (○) | JP4890997 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: Adalimumab (genetically modified) |
| 2016-700252 (■) | JP4890997 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: Adalimumab (genetically modified) |
| 2016-700251 (○) | JP4404181 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: Adalimumab (genetically modified) |
| 2016-700251 (■) | JP4404181 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: Adalimumab (genetically modified) |
| 2016-700250 (○) | JP3861118 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: Adalimumab (genetically modified) |
| 2016-700250 (■) | JP3861118 | Name written in approval letter: Humira subcutaneous injection 40 mg syringe 0.8 mL Active ingredient: Adalimumab (genetically modified) |
| 2016-700249 (○) | JP5612662 | Name of sale: Genvoya combination tablet Active ingredient: Elvitegravir, Cobicistat / silicon dioxide mixture, emtricitabine, and tenofovir alafenamide fumarate |
| 2016-700248 (○) | JP5925171 | Name of sale: Genvoya combination tablet Active ingredient: Elvitegravir, Cobicistat / silicon dioxide mixture, emtricitabine, and tenofovir alafenamide fumarate |
| 2016-700248 (■) | JP5925171 | Name of sale: Genvoya combination tablet Active ingredient: Elvitegravir, Cobicistat / silicon dioxide mixture, emtricitabine, and tenofovir alafenamide fumarate |
| 2016-700247 (○) | JP5722213 | Name of sale: Genvoya combination tablet Active ingredient: Elvitegravir, Cobicistat / silicon dioxide mixture, emtricitabine, and tenofovir alafenamide fumarate |
| 2016-700247 (■) | JP5722213 | Name of sale: Genvoya combination tablet Active ingredient: Elvitegravir, Cobicistat / silicon dioxide mixture, emtricitabine, and tenofovir alafenamide fumarate |
| 2016-700246 (○) | JP5554300 | Name of sale: Genvoya combination tablet Active ingredient: Elvitegravir, Cobicistat / silicon dioxide mixture, emtricitabine, and tenofovir alafenamide fumarate |
| 2016-700246 (■) | JP5554300 | Name of sale: Genvoya combination tablet Active ingredient: Elvitegravir, Cobicistat / silicon dioxide mixture, emtricitabine, and tenofovir alafenamide fumarate |
| 2016-700245 (○) | JP4881446 | Name of sale: Genvoya combination tablet Active ingredient: Elvitegravir, Cobicistat / silicon dioxide mixture, emtricitabine, and tenofovir alafenamide fumarate |
| 2016-700245 (■) | JP4881446 | Name of sale: Genvoya combination tablet Active ingredient: Elvitegravir, Cobicistat / silicon dioxide mixture, emtricitabine, and tenofovir alafenamide fumarate |
| 2016-700244 (○) | JP5651275 | Name of sale: Genvoya combination tablet Active ingredient: Elvitegravir, Cobicistat / silicon dioxide mixture, emtricitabine, and tenofovir alafenamide fumarate |
| 2016-700244 (■) | JP5651275 | Name of sale: Genvoya combination tablet Active ingredient: Elvitegravir, Cobicistat / silicon dioxide mixture, emtricitabine, and tenofovir alafenamide fumarate |
| 2016-700243 (○) | JP5111551 | Name of sale: Genvoya combination tablet Active ingredient: Elvitegravir, Cobicistat / silicon dioxide mixture, emtricitabine, and tenofovir alafenamide fumarate |
| 2016-700243 (■) | JP5111551 | Name of sale: Genvoya combination tablet Active ingredient: Elvitegravir, Cobicistat / silicon dioxide mixture, emtricitabine, and tenofovir alafenamide fumarate |
| 2016-700242 (○) | JP4651264 | Name of sale: Genvoya combination tablet Active ingredient: Elvitegravir, Cobicistat / silicon dioxide mixture, emtricitabine, and tenofovir alafenamide fumarate |
| 2016-700242 (■) | JP4651264 | Name of sale: Genvoya combination tablet Active ingredient: Elvitegravir, Cobicistat / silicon dioxide mixture, emtricitabine, and tenofovir alafenamide fumarate |
| 2016-700241 (○) | JP4669040 | Name of sale: Genvoya combination tablet Active ingredient: (General name) Elvitegravir, (General name) covisistat / silicon dioxide mixture, (General name) Emtricitabine, (General name) Tenofovir Alafenamide Fumaric acid salt |
| 2016-700241 (■) | JP4669040 | Name of sale: Genvoya combination tablet Active ingredient: (General name) Elvitegravir, (General name) covisistat / silicon dioxide mixture, (General name) Emtricitabine, (General name) Tenofovir Alafenamide Fumaric acid salt |
| 2016-700240 (○) | JP4629104 | Name of sale: Genvoya combination tablet Active ingredient: (General name) Elvitegravir, (General name) covisistat / silicon dioxide mixture, (General name) Emtricitabine, (General name) Tenofovir Alafenamide Fumaric acid salt |
| 2016-700240 (■) | JP4629104 | Name of sale: Genvoya combination tablet Active ingredient: (General name) Elvitegravir, (General name) covisistat / silicon dioxide mixture, (General name) Emtricitabine, (General name) Tenofovir Alafenamide Fumaric acid salt |
| 2016-700239 (○) | JP3754064 | Name of sale: Genvoya combination tablet Active ingredient: (General name) Elvitegravir, (General name) covisistat / silicon dioxide mixture, (General name) Emtricitabine, (General name) Tenofovir Alafenamide Fumaric acid salt |
| 2016-700239 (■) | JP3754064 | Name of sale: Genvoya combination tablet Active ingredient: (General name) Elvitegravir, (General name) covisistat / silicon dioxide mixture, (General name) Emtricitabine, (General name) Tenofovir Alafenamide Fumaric acid salt |
| 2016-700238 (○) | JP3567162 | Name of sale: Genvoya combination tablet Active ingredient: (General name) Elvitegravir, (General name) covisistat / silicon dioxide mixture, (General name) Emtricitabine, (General name) Tenofovir Alafenamide Fumaric acid salt |
| 2016-700238 (■) | JP3567162 | Name of sale: Genvoya combination tablet Active ingredient: (General name) Elvitegravir, (General name) covisistat / silicon dioxide mixture, (General name) Emtricitabine, (General name) Tenofovir Alafenamide Fumaric acid salt |
| 2016-700237 (○) | JP5584534 | Benfotiamine, adenosine triphosphate disodium hydrate, cyanocobalamin, tocopherol succinate calcium, gamma-oryzanol, calcium pantothenate and processed daisan powder (sales name: Kewpie Kowa Cochector) |
| 2016-700237 (■) | JP5584534 | Benfotiamine, adenosine triphosphate disodium hydrate, cyanocobalamin, tocopherol succinate calcium, gamma-oryzanol, calcium pantothenate and processed disan powder (brand name: Kewpie Kowa Tecnector) |
| 2016-700236 (○) | JP5114399 | Benfotiamine, adenosine triphosphate disodium hydrate, cyanocobalamin, tocopherol succinate calcium, gamma-oryzanol, calcium pantothenate and processed daisan powder (sales name: Kewpie Kowa Cochector) |
| 2016-700236 (■) | JP5114399 | Benfotiamine, adenosine triphosphate disodium hydrate, cyanocobalamin, tocopherol succinate calcium, gamma-oryzanol, calcium pantothenate and processed disan powder (brand name: Kewpie Kowa Tecnector) |
| 2016-700235 (○) | JP3145414 | Bimaput Tablets 100mg (Active Ingredient: Lacosamide) |
| 2016-700235 (■) | JP3145414 | Bimaput Tablets 100mg (Active Ingredient: Lacosamide) |
| 2016-700234 (○) | JP3145414 | Bimaput Tablets 50mg (Active Ingredient: Lacosamide) |
| 2016-700234 (■) | JP3145414 | Bimaput Tablets 50mg (Active Ingredient: Lacosamide) |
| 2016-700233 (○) | JP5695029 | Hemanzior syrup for children 0.375% |
| 2016-700233 (■) | JP5695029 | Hemanzior syrup for children 0.375% |
| 2016-700232 (○) | JP5552700 | Hemanzior syrup for children 0.375% |
| 2016-700232 (■) | JP5552700 | Hemanzior syrup for children 0.375% |
| 2016-700231 (○) | JP4484023 | Pesticide type: amiculblom hydrate Pesticide name: Lymei flowable Active ingredient type: 3- (3-bromo-6-fluoro-2-methylindol-1-ylsulfonyl) -N, N -Dimethyl-1,2,4-triazole-1-sulfonamide |
| 2016-700231 (■) | JP4484023 | Pesticide type: amiculblom hydrate Pesticide name: Lymei flowable Active ingredient type: 3- (3-bromo-6-fluoro-2-methylindol-1-ylsulfonyl) -N, N -Dimethyl-1,2,4-triazole-1-sulfonamide |
| 2016-700230 (○) | JP3957765 | Name of sale: Avastin for intravenous drip infusion 400 mg / 16 mL Common name: bevacizumab (genetically modified) |
| 2016-700230 (■) | JP3957765 | Name of sale: Avastin for intravenous drip infusion 400 mg / 16 mL Common name: bevacizumab (genetically modified) |
| 2016-700229 (○) | JP3957765 | Name of sale: Avastin for intravenous drip infusion 100 mg / 4 mL Common name: bevacizumab (genetically modified) |
| 2016-700229 (■) | JP3957765 | Name of sale: Avastin for intravenous drip infusion 100 mg / 4 mL Common name: bevacizumab (genetically modified) |
| 2016-700228 (○) | JP5476404 | Name of Sale: Syramza Infusion Solution 500mg Active Ingredient: Rhamsylumab (genetically modified) |
| 2016-700228 (■) | JP5476404 | Name of Sale: Syramza Infusion Solution 500mg Active Ingredient: Rhamsylumab (genetically modified) |
| 2016-700227 (○) | JP5476404 | Name of sale: Syramza drip infusion 100 mg Active ingredient: Rhamcylumab (genetically modified) |
| 2016-700227 (■) | JP5476404 | Name of sale: Syramza drip infusion 100 mg Active ingredient: Rhamcylumab (genetically modified) |
| 2016-700226 (○) | JP5476404 | Name of Sale: Syramza Infusion Solution 500mg Active Ingredient: Rhamsylumab (genetically modified) |
| 2016-700226 (■) | JP5476404 | Name of Sale: Syramza Infusion Solution 500mg Active Ingredient: Rhamsylumab (genetically modified) |
| 2016-700225 (○) | JP5476404 | Name of sale: Syramza drip infusion 100 mg Active ingredient: Rhamcylumab (genetically modified) |
| 2016-700225 (■) | JP5476404 | Name of sale: Syramza drip infusion 100 mg Active ingredient: Rhamcylumab (genetically modified) |
| 2016-700224 (○) | JP4970483 | Name of Sale: Syramza Infusion Solution 500mg Active Ingredient: Rhamsylumab (genetically modified) |
| 2016-700224 (■) | JP4970483 | Name of Sale: Syramza Infusion Solution 500mg Active Ingredient: Rhamsylumab (genetically modified) |
| 2016-700223 (○) | JP4970483 | Name of sale: Syramza drip infusion 100 mg Active ingredient: Rhamcylumab (genetically modified) |
| 2016-700223 (■) | JP4970483 | Name of sale: Syramza drip infusion 100 mg Active ingredient: Rhamcylumab (genetically modified) |
| 2016-700222 (○) | JP4970483 | Name of Sale: Syramza Infusion Solution 500mg Active Ingredient: Rhamsylumab (genetically modified) |
| 2016-700222 (■) | JP4970483 | Name of Sale: Syramza Infusion Solution 500mg Active Ingredient: Rhamsylumab (genetically modified) |
| 2016-700221 (○) | JP4970483 | Name of sale: Syramza drip infusion 100 mg Active ingredient: Rhamcylumab (genetically modified) |
| 2016-700221 (■) | JP4970483 | Name of sale: Syramza drip infusion 100 mg Active ingredient: Rhamcylumab (genetically modified) |
| 2016-700220 (○) | JP5907396 | Name of sale: Feburic tablet 40 mg Name of active ingredient: febuxostat |
| 2016-700220 (■) | JP5907396 | Name of sale: Feburic Tablet 40 mg Name of active ingredient: febuxostat |
| 2016-700219 (○) | JP5907396 | Name of sale: Feburic tablet 20 mg Name of active ingredient: febuxostat |
| 2016-700219 (■) | JP5907396 | Name of sale: Feburic Tablet 20 mg Name of active ingredient: febuxostat |
| 2016-700218 (○) | JP5907396 | Name of sale: Feburic Tablet 10 mg Name of active ingredient: febuxostat |
| 2016-700218 (■) | JP5907396 | Name of sale: Feburic tablet 10 mg Name of active ingredient: febuxostat |
| 2016-700217 (○) | JP4084309 | Name of sale: Feburic tablet 40 mg Name of active ingredient: febuxostat |
| 2016-700217 (■) | JP4084309 | Name of sale: Feburic Tablet 40 mg Name of active ingredient: febuxostat |
| 2016-700216 (○) | JP4084309 | Name of sale: Feburic tablet 20 mg Name of active ingredient: febuxostat |
| 2016-700216 (■) | JP4084309 | Name of sale: Feburic Tablet 20 mg Name of active ingredient: febuxostat |
| 2016-700215 (○) | JP4084309 | Name of sale: Feburic Tablet 10 mg Name of active ingredient: febuxostat |
| 2016-700215 (■) | JP4084309 | Name of sale: Feburic tablet 10 mg Name of active ingredient: febuxostat |
| 2016-700214 (○) | JP3547707 | Name of sale: Feburic tablet 40 mg Name of active ingredient: febuxostat |
| 2016-700213 (○) | JP3547707 | Name of sale: Feburic tablet 20 mg Name of active ingredient: febuxostat |
| 2016-700212 (○) | JP3547707 | Name of sale: Feburic Tablet 10 mg Name of active ingredient: febuxostat |
| 2016-700211 (○) | JP4484023 | Pesticide type: amiculblom hydrate Pesticide name: Lymei flowable Active ingredient type: 3- (3-bromo-6-fluoro-2-methylindol-1-ylsulfonyl) -N, N -Dimethyl-1,2,4-triazole-1-sulfonamide |
| 2016-700211 (■) | JP4484023 | Pesticide type: amiculblom hydrate Pesticide name: Lymei flowable Active ingredient type: 3- (3-bromo-6-fluoro-2-methylindol-1-ylsulfonyl) -N, N -Dimethyl-1,2,4-triazole-1-sulfonamide |
| 2016-700210 (○) | JP5905999 | Vet Medien Chewable 5mg (Active Ingredient: Pimobendan) |
| 2016-700210 (■) | JP5905999 | Vet Medien Chewable 5mg (active ingredient: pimobendan) |
| 2016-700209 (○) | JP5905999 | Vet Medien Chewable 2.5 mg (active ingredient: pimobendan) |
| 2016-700209 (■) | JP5905999 | Vet Medien Chewable 2.5 mg (Active ingredient: Pimobendan) |
| 2016-700208 (○) | JP5905999 | Vet Medien Chewable 1.25mg (active ingredient: pimobendan) |
| 2016-700208 (■) | JP5905999 | Vet Medien Chewable 1.25mg (active ingredient: pimobendan) |
| 2016-700207 (○) | JP5702933 | Tefuryltrione triafamone granules Councill complete 1 kilogram granules 2- {2-chloro-4-mesyl-3-[(tetrahydrofuran-2-ylmethoxy) methyl] benzoyl} cyclohexane-1,3-dione (General name: teh Furyltrione), and 2 '-[(4,6-dimethoxy-1,3,5-triazin-2-yl) carbonyl] -1,1,6'-trifluoro-N-methylmethanesulfonanilide (common name) : Triafammon) |
| 2016-700207 (■) | JP5702933 | Tefuryl trion triafamone granules |
| 2016-700206 (○) | JP5702933 | Tefuryltrione triafamone granules Councill complete jumbo 2- {2-chloro-4-mesyl-3-[(tetrahydrofuran-2-ylmethoxy) methyl] benzoyl} cyclohexane-1,3-dione (General name: tefuryltrione) And 2 '-[(4,6-dimethoxy-1,3,5-triazin-2-yl) carbonyl] -1,1,6'-trifluoro-N-methylmethanesulfonanilide (General name: triafamone) |
| 2016-700206 (■) | JP5702933 | Tefuryl trion triafamone granules |
| 2016-700205 (○) | JP5702933 | Council complete flowable 2- {2-chloro-4-mesyl-3-[(tetrahydrofuran-2-ylmethoxy) methyl] benzoyl} cyclohexane-1,3-dione ( Common names: tefuryltrione), and 2 '-[(4,6-dimethoxy-1,3,5-triazin-2-yl) carbonyl] -1,1,6'-trifluoro-N-methylmethanesulfone Anilide (General name: triafamone) |
| 2016-700205 (■) | JP5702933 | Tefuryl trione triafammon water dispersible |
| 2016-700204 (○) | JP5702933 | Triaphamone ・ Fentrazamide ・ benzophenap granules Council top 1 kg granules 2 '-[(4,6-dimethoxy-1,3,5-triazin-2-yl) carbonyl] -1,1 , 6'-Trifluoro-N-methylmethanesulfonanilide (General name: triafamone), 4- (2-chlorophenyl) -N-cyclohexyl-N-ethyl-4,5-dihydro-5-oxo-1H-tetrazole- 1-carboxamide (General name: phentrazamide), and 2- [4- (2,4-dichloro-m-toluoyl) -1,3-dimethylpyrazol-5-yloxy] -4'-methylacetophenone (General name: benzo) Fenap) |
| 2016-700204 (■) | JP5702933 | Triafammon Fentrazamide Benzofenap granules |
| 2016-700203 (○) | JP5097116 | Tefuryltrione triafamone granules Councill complete 1 kilogram granules 2- {2-chloro-4-mesyl-3-[(tetrahydrofuran-2-ylmethoxy) methyl] benzoyl} cyclohexane-1,3-dione (General name: teh Furyltrione), and 2 '-[(4,6-dimethoxy-1,3,5-triazin-2-yl) carbonyl] -1,1,6'-trifluoro-N-methylmethanesulfonanilide (common name) : Triafammon) |
| 2016-700203 (■) | JP5097116 | Tefuryl trion triafamone granules |
| 2016-700202 (○) | JP5097116 | Tefuryltrione triafamone granules Councill complete jumbo 2- {2-chloro-4-mesyl-3-[(tetrahydrofuran-2-ylmethoxy) methyl] benzoyl} cyclohexane-1,3-dione (General name: tefuryltrione) And 2 '-[(4,6-dimethoxy-1,3,5-triazin-2-yl) carbonyl] -1,1,6'-trifluoro-N-methylmethanesulfonanilide (General name: triafamone) |
| 2016-700202 (■) | JP5097116 | Tefuryl trion triafamone granules |
| 2016-700201 (○) | JP5097116 | Council complete flowable 2- {2-chloro-4-mesyl-3-[(tetrahydrofuran-2-ylmethoxy) methyl] benzoyl} cyclohexane-1,3-dione ( Common names: tefuryltrione), and 2 '-[(4,6-dimethoxy-1,3,5-triazin-2-yl) carbonyl] -1,1,6'-trifluoro-N-methylmethanesulfone Anilide (General name: triafamone) |
| 2016-700201 (■) | JP5097116 | Tefuryl trione triafammon water dispersible |
| 2016-700200 (○) | JP5097116 | Triaphamone ・ Fentrazamide ・ benzophenap granules Council top 1 kg granules 2 '-[(4,6-Dimethoxy-1,3,5-triazin-2-yl) carbonyl] -1,1,6'-trifluoro -N-Methylmethanesulfonanilide (General name: triaphamone), 4- (2-chlorophenyl) -N-cyclohexyl-N-ethyl-4, 5-dihydro-5-oxo-1H-tetrazole-1-carboxamide (General name) : Fentrazamide), and 2- [4- (2,4-dichloro-m-toluoyl) -1,3-dimethylpyrazol-5-yloxy] -4'-methylacetophenone (General name: benzophenap) |
| 2016-700200 (■) | JP5097116 | Triafammon Fentrazamide Benzofenap granules |
| 2016-700199 (○) | JP5069107 | Tefuryltrione triafamone granules Councill complete 1 kilogram granules 2- {2-chloro-4-mesyl-3-[(tetrahydrofuran-2-ylmethoxy) methyl] benzoyl} cyclohexane-1,3-dione (General name: teh Furyltrione), and 2 '-[(4,6-dimethoxy-1,3,5-triazin-2-yl) carbonyl] -1,1,6'-trifluoro-N-methylmethanesulfonanilide (common name) : Triafammon) |
| 2016-700199 (■) | JP5069107 | Tefuryl trion triafamone granules |
| 2016-700198 (○) | JP5069107 | Tefuryltrione triafamone granules Councill complete jumbo 2- {2-chloro-4-mesyl-3-[(tetrahydrofuran-2-ylmethoxy) methyl] benzoyl} cyclohexane-1,3-dione (General name: tefuryltrione) And 2 '-[(4,6-dimethoxy-1,3,5-triazin-2-yl) carbonyl] -1,1,6'-trifluoro-N-methylmethanesulfonanilide (General name: triafamone) |
| 2016-700198 (■) | JP5069107 | Tefuryl trion triafamone granules |
| 2016-700197 (○) | JP5069107 | Council complete flowable 2- {2-chloro-4-mesyl-3-[(tetrahydrofuran-2-ylmethoxy) methyl] benzoyl} cyclohexane-1,3-dione ( Common names: tefuryltrione), and 2 '-[(4,6-dimethoxy-1,3,5-triazin-2-yl) carbonyl] -1,1,6'-trifluoro-N-methylmethanesulfone Anilide (General name: triafamone) |
| 2016-700197 (■) | JP5069107 | Tefuryl trione triafammon water dispersible |
| 2016-700196 (○) | JP5069107 | Triaphamone ・ Fentrazamide ・ benzophenap granules Council top 1 kg granules 2 '-[(4,6-dimethoxy-1,3,5-triazin-2-yl) carbonyl] -1,1 , 6'-Trifluoro-N-methylmethanesulfonanilide (General name: triafamone), 4- (2-chlorophenyl) -N-cyclohexyl-N-ethyl-4,5-dihydro-5-oxo-1H-tetrazole- 1-carboxamide (General name: phentrazamide), and 2- [4- (2,4-dichloro-m-toluoyl) -1,3-dimethylpyrazol-5-yloxy] -4'-methylacetophenone (General name: benzo) Fenap) |
| 2016-700196 (■) | JP5069107 | Triafammon Fentrazamide Benzofenap granules |
| 2016-700195 (○) | JP5537704 | (I) Name: Tagrisso Tablet 80 mg (ii) Active ingredient: Osimertinib mesylate |
| 2016-700195 (■) | JP5537704 | (I) Name: Tagrisso Tablet 80 mg (ii) Active ingredient: Osimertinib mesylate |
| 2016-700194 (○) | JP5537704 | (I) Name: Tagrisso Tablet 40 mg (ii) Active Ingredient: Osimartinib Mesylate |
| 2016-700194 (■) | JP5537704 | (I) Name: Tagrisso Tablet 40 mg (ii) Active Ingredient: Osimartinib Mesylate |
| 2016-700193 (○) | JP5427321 | (I) Name: Tagrisso Tablet 80 mg (ii) Active ingredient: Osimertinib mesylate |
| 2016-700193 (■) | JP5427321 | (I) Name: Tagrisso Tablet 80 mg (ii) Active ingredient: Osimertinib mesylate |
| 2016-700192 (○) | JP5427321 | (I) Name: Tagrisso Tablet 40 mg (ii) Active Ingredient: Osimartinib Mesylate |
| 2016-700192 (■) | JP5427321 | (I) Name: Tagrisso Tablet 40 mg (ii) Active Ingredient: Osimartinib Mesylate |
| 2016-700191 (○) | JP5841998 | Name: IMBRUVICA Capsule 140mg Active Ingredient: Ibrutinib |
| 2016-700191 (■) | JP5841998 | Name: IMBRUVICA Capsule 140mg Active Ingredient: Ibrutinib |
| 2016-700190 (○) | JP4934197 | Name: IMBRUVICA Capsule 140mg Active Ingredient: Ibrutinib |
| 2016-700190 (■) | JP4934197 | Name: IMBRUVICA Capsule 140mg Active Ingredient: Ibrutinib |
| 2016-700189 (○) | JP5693728 | Kanuma drip infusion solution 20 mg |
| 2016-700189 (■) | JP5693728 | Kanuma drip infusion solution 20 mg |
| 2016-700188 (○) | JP5539607 | Ruri octocog alpha pegol (genetically modified) |
| 2016-700188 (■) | JP5539607 | Ruri octocog alpha pegol (genetically modified) |
| 2016-700187 (○) | JP5539607 | Ruri octocog alpha pegol (genetically modified) |
| 2016-700187 (■) | JP5539607 | Ruri octocog alpha pegol (genetically modified) |
| 2016-700186 (○) | JP5539607 | Ruri octocog alpha pegol (genetically modified) |
| 2016-700186 (■) | JP5539607 | Ruri octocog alpha pegol (genetically modified) |
| 2016-700185 (○) | JP5539607 | Ruri octocog alpha pegol (genetically modified) |
| 2016-700185 (■) | JP5539607 | Ruri octocog alpha pegol (genetically modified) |
| 2016-700184 (○) | JP5433490 | Zofigo IV |
| 2016-700184 (■) | JP5433490 | Zofigo IV |
| 2016-700183 (○) | JP5419944 | FiCompa Tablet 4mg (Active Ingredient: Peran Panel Hydrate) |
| 2016-700183 (■) | JP5419944 | FiCompa Tablet 4mg (Active Ingredient: Peran Panel Hydrate) |
| 2016-700182 (○) | JP5419944 | Ficompa Tablet 2 mg (Active Ingredient: Peran Panel Hydrate) |
| 2016-700182 (■) | JP5419944 | Ficompa Tablet 2 mg (Active Ingredient: Peran Panel Hydrate) |
| 2016-700181 (○) | JP5030206 | FiCompa Tablet 4mg (Active Ingredient: Peran Panel Hydrate) |
| 2016-700181 (■) | JP5030206 | FiCompa Tablet 4mg (Active Ingredient: Peran Panel Hydrate) |
| 2016-700180 (○) | JP5030206 | Ficompa Tablet 2 mg (Active Ingredient: Peran Panel Hydrate) |
| 2016-700180 (■) | JP5030206 | Ficompa Tablet 2 mg (Active Ingredient: Peran Panel Hydrate) |
| 2016-700179 (○) | JP3922368 | FiCompa Tablet 4mg (Active Ingredient: Peran Panel Hydrate) |
| 2016-700179 (■) | JP3922368 | FiCompa Tablet 4mg (Active Ingredient: Peran Panel Hydrate) |
| 2016-700178 (○) | JP3922368 | Ficompa Tablet 2 mg (Active Ingredient: Peran Panel Hydrate) |
| 2016-700178 (■) | JP3922368 | Ficompa Tablet 2 mg (Active Ingredient: Peran Panel Hydrate) |
| 2016-700177 (○) | JP5718929 | Name of sale: Mekinist tablet 2 mg Active ingredient: Trametinib dimethyl sulfoxide adduct |
| 2016-700177 (■) | JP5718929 | Name of Sale: Mekinist Tablet 2mg Active Ingredient: Trametinib Dimethylsulfoxide Adduct |
| 2016-700176 (○) | JP5718929 | Name of Sale: Mekinist Tablet 0.5mg Active Ingredient: Trametinib Dimethyl sulfoxide Adduct |
| 2016-700176 (■) | JP5718929 | Name of Sale: Mekinist Tablets 0.5mg Active Ingredient: Trametinib Dimethyl sulfoxide adduct |
| 2016-700175 (○) | JP5718929 | Name of Sale: Taffiner Capsule 75mg Active Ingredient: Dabrafenib Mesilate |
| 2016-700175 (■) | JP5718929 | Name of Sale: Taffiner Capsule 75mg Active Ingredient: Dabrafenib Mesilate |
| 2016-700174 (○) | JP5718929 | Name of sale: Taffiner capsule 50 mg Active ingredient: Dabrafenib mesylate |
| 2016-700174 (■) | JP5718929 | Name of sale: Taffiner capsule 50 mg Active ingredient: Dabrafenib mesylate |
| 2016-700173 (○) | JP5426664 | Name of Sale: Taffiner Capsule 75mg Active Ingredient: Dabrafenib Mesilate |
| 2016-700173 (■) | JP5426664 | Name of Sale: Taffiner Capsule 75mg Active Ingredient: Dabrafenib Mesilate |
| 2016-700172 (○) | JP5426664 | Name of sale: Taffiner capsule 50 mg Active ingredient: Dabrafenib mesylate |
| 2016-700172 (■) | JP5426664 | Name of sale: Taffiner capsule 50 mg Active ingredient: Dabrafenib mesylate |
| 2016-700171 (○) | JP5421974 | Name of sale: Mekinist tablet 2 mg Active ingredient: (Common name) Trametinib dimethyl sulfoxide adduct |
| 2016-700171 (■) | JP5421974 | Name of sale: Mekinist tablet 2 mg Active ingredient: (Common name) Trametinib dimethyl sulfoxide adduct |
| 2016-700170 (○) | JP5421974 | Name of sale: Mekinist tablet 0.5 mg Active ingredient: (Common name) Trametinib dimethyl sulfoxide adduct |
| 2016-700170 (■) | JP5421974 | Name of sale: Mekinist tablet 0.5 mg Active ingredient: (Common name) Trametinib dimethyl sulfoxide adduct |
| 2016-700169 (○) | JP4913768 | Name of sale: Mekinist tablet 2 mg Active ingredient: (Common name) Trametinib dimethyl sulfoxide adduct |
| 2016-700169 (■) | JP4913768 | Name of sale: Mekinist tablet 2 mg Active ingredient: (Common name) Trametinib dimethyl sulfoxide adduct |
| 2016-700168 (○) | JP4913768 | Name of sale: Mekinist tablet 0.5 mg Active ingredient: (Common name) Trametinib dimethyl sulfoxide adduct |
| 2016-700168 (■) | JP4913768 | Name of sale: Mekinist tablet 0.5 mg Active ingredient: (Common name) Trametinib dimethyl sulfoxide adduct |
| 2016-700167 (○) | JP4163738 | Name of sale: Mekinist tablet 2 mg Active ingredient: (Common name) Trametinib dimethyl sulfoxide adduct |
| 2016-700167 (■) | JP4163738 | Name of sale: Mekinist tablet 2 mg Active ingredient: (Common name) Trametinib dimethyl sulfoxide adduct |
| 2016-700166 (○) | JP4163738 | Name of sale: Mekinist tablet 0.5 mg Active ingredient: (Common name) Trametinib dimethyl sulfoxide adduct |
| 2016-700166 (■) | JP4163738 | Name of sale: Mekinist tablet 0.5 mg Active ingredient: (Common name) Trametinib dimethyl sulfoxide adduct |
| 2016-700165 (○) | JP4077055 | Name of sale: Kovar Tory Intravenous Kit 3000 General name: Octocog beta (genetically modified) |
| 2016-700165 (■) | JP4077055 | Name of Sale: Kovar Tory Intravenous Kit 3000 Common Name: Oktocog Beta (genetically modified) |
| 2016-700164 (○) | JP4077055 | Name of Sale: Kovar Tory Intravenous Kit 2000 Common Name: Oktocog Beta (genetically modified) |
| 2016-700164 (■) | JP4077055 | Name of Sale: Kovar Tory Intravenous Kit 2000 General name: Oktocog Beta (genetically modified) |
| 2016-700163 (○) | JP4077055 | Name of sale: Kovar Tory Intravenous Kit 1000 General name: Oktocog beta (genetically modified) |
| 2016-700163 (■) | JP4077055 | Name of Sale: Kovar Tory Intravenous Kit 1000 General name: Oktocog Beta (genetically modified) |
| 2016-700162 (○) | JP4077055 | Name of Sale: Kovar Tory Intravenous Kit 500 Common Name: Oktocog Beta (genetically modified) |
| 2016-700162 (■) | JP4077055 | Name of Sale: Kovar Tory Intravenous Kit 500 Common Name: Oktocog Beta (genetically modified) |
| 2016-700161 (○) | JP4077055 | Name of sale: Kovar Tory Intravenous Kit 250 General name: Oktocog beta (genetically modified) |
| 2016-700161 (■) | JP4077055 | Name of sale: Kovar Tory Intravenous Kit 250 General name: Octocog beta (genetically modified) |
| 2016-700160 (○) | JP4077055 | Name of sale: Kovar Tory Intravenous 3000 Common name: Oktocog beta (genetically modified) |
| 2016-700160 (■) | JP4077055 | Name of Sale: Kobaert Toi Intravenous 3000 Common Name: Oktocog Beta (genetically modified) |
| 2016-700159 (○) | JP4077055 | Name of sale: Kovar Tory Intravenous injection 2000 Common name: Oktocog beta (genetically modified) |
| 2016-700159 (■) | JP4077055 | Name of Sale: Kovar Tory Intravenous Injection 2000 Common Name: Oktocog Beta (genetically modified) |
| 2016-700158 (○) | JP4077055 | Name of Sale: Kobaert Toi Intravenous 1000 Common Name: Oktocog Beta (genetically modified) |
| 2016-700158 (■) | JP4077055 | Name of Sale: Kobaert Toi Intravenous 1000 Common Name: Oktocog Beta (genetically modified) |
| 2016-700157 (○) | JP4077055 | Name of sale: Kovar Toryi IV 500 Common name: Oktocog beta (genetically modified) |
| 2016-700157 (■) | JP4077055 | Name of sale: Kovar Toryi IV 500 General name: Oktocog beta (genetically modified) |
| 2016-700156 (○) | JP4077055 | Name of sale: Kovar Tory IV 250 General name: Oktocog beta (genetically modified) |
| 2016-700156 (■) | JP4077055 | Name of sale: Kovar Tory IV 250 General name: Oktocog beta (genetically modified) |
| 2016-700155 (○) | JP4712694 | Name of sale: Kovar Tory Intravenous Kit 3000 General name: Octocog beta (genetically modified) |
| 2016-700155 (■) | JP4712694 | Name of Sale: Kovar Tory Intravenous Kit 3000 Common Name: Oktocog Beta (genetically modified) |
| 2016-700154 (○) | JP4712694 | Name of Sale: Kovar Tory Intravenous Kit 2000 Common Name: Oktocog Beta (genetically modified) |
| 2016-700154 (■) | JP4712694 | Name of Sale: Kovar Tory Intravenous Kit 2000 General name: Oktocog Beta (genetically modified) |
| 2016-700153 (○) | JP4712694 | Name of sale: Kovar Tory Intravenous Kit 1000 General name: Oktocog beta (genetically modified) |
| 2016-700153 (■) | JP4712694 | Name of Sale: Kovar Tory Intravenous Kit 1000 General name: Oktocog Beta (genetically modified) |
| 2016-700152 (○) | JP4712694 | Name of Sale: Kovar Tory Intravenous Kit 500 Common Name: Oktocog Beta (genetically modified) |
| 2016-700152 (■) | JP4712694 | Name of Sale: Kovar Tory Intravenous Kit 500 Common Name: Oktocog Beta (genetically modified) |
| 2016-700151 (○) | JP4712694 | Name of sale: Kovar Tory Intravenous Kit 250 General name: Oktocog beta (genetically modified) |
| 2016-700151 (■) | JP4712694 | Name of sale: Kovar Tory Intravenous Kit 250 General name: Octocog beta (genetically modified) |
| 2016-700150 (○) | JP4712694 | Name of sale: Kovar Tory Intravenous 3000 Common name: Oktocog beta (genetically modified) |
| 2016-700150 (■) | JP4712694 | Name of Sale: Kobaert Toi Intravenous 3000 Common Name: Oktocog Beta (genetically modified) |
| 2016-700149 (○) | JP4712694 | Name of sale: Kovar Tory Intravenous injection 2000 Common name: Oktocog beta (genetically modified) |
| 2016-700149 (■) | JP4712694 | Name of Sale: Kovar Tory Intravenous Injection 2000 Common Name: Oktocog Beta (genetically modified) |
| 2016-700148 (○) | JP4712694 | Name of Sale: Kobaert Toi Intravenous 1000 Common Name: Oktocog Beta (genetically modified) |
| 2016-700148 (■) | JP4712694 | Name of Sale: Kobaert Toi Intravenous 1000 Common Name: Oktocog Beta (genetically modified) |
| 2016-700147 (○) | JP4712694 | Name of sale: Kovar Toryi IV 500 Common name: Oktocog beta (genetically modified) |
| 2016-700147 (■) | JP4712694 | Name of sale: Kovar Toryi IV 500 General name: Oktocog beta (genetically modified) |
| 2016-700146 (○) | JP4712694 | Name of sale: Kovar Tory IV 250 General name: Oktocog beta (genetically modified) |
| 2016-700146 (■) | JP4712694 | Name of sale: Kovar Tory IV 250 General name: Oktocog beta (genetically modified) |
| 2016-700145 (○) | JP4257685 | Name of sale: Kovar Tory Intravenous Kit 3000 General name: Octocog beta (genetically modified) |
| 2016-700145 (■) | JP4257685 | Name of Sale: Kovar Tory Intravenous Kit 3000 Common Name: Oktocog Beta (genetically modified) |
| 2016-700144 (○) | JP4257685 | Name of Sale: Kovar Tory Intravenous Kit 2000 Common Name: Oktocog Beta (genetically modified) |
| 2016-700144 (■) | JP4257685 | Name of Sale: Kovar Tory Intravenous Kit 2000 General name: Oktocog Beta (genetically modified) |
| 2016-700143 (○) | JP4257685 | Name of sale: Kovar Tory Intravenous Kit 1000 General name: Oktocog beta (genetically modified) |
| 2016-700143 (■) | JP4257685 | Name of Sale: Kovar Tory Intravenous Kit 1000 General name: Oktocog Beta (genetically modified) |
| 2016-700142 (○) | JP4257685 | Name of Sale: Kovar Tory Intravenous Kit 500 Common Name: Oktocog Beta (genetically modified) |
| 2016-700142 (■) | JP4257685 | Name of Sale: Kovar Tory Intravenous Kit 500 Common Name: Oktocog Beta (genetically modified) |
| 2016-700141 (○) | JP4257685 | Name of sale: Kovar Tory Intravenous Kit 250 General name: Oktocog beta (genetically modified) |
| 2016-700141 (■) | JP4257685 | Name of sale: Kovar Tory Intravenous Kit 250 General name: Octocog beta (genetically modified) |
| 2016-700140 (○) | JP4257685 | Name of sale: Kovar Tory Intravenous 3000 Common name: Oktocog beta (genetically modified) |
| 2016-700140 (■) | JP4257685 | Name of Sale: Kobaert Toi Intravenous 3000 Common Name: Oktocog Beta (genetically modified) |
| 2016-700139 (○) | JP4257685 | Name of sale: Kovar Tory Intravenous injection 2000 Common name: Oktocog beta (genetically modified) |
| 2016-700139 (■) | JP4257685 | Name of Sale: Kovar Tory Intravenous Injection 2000 Common Name: Oktocog Beta (genetically modified) |
| 2016-700138 (○) | JP4257685 | Name of Sale: Kobaert Toi Intravenous 1000 Common Name: Oktocog Beta (genetically modified) |
| 2016-700138 (■) | JP4257685 | Name of Sale: Kobaert Toi Intravenous 1000 Common Name: Oktocog Beta (genetically modified) |
| 2016-700137 (○) | JP4257685 | Name of sale: Kovar Toryi IV 500 Common name: Oktocog beta (genetically modified) |
| 2016-700137 (■) | JP4257685 | Name of sale: Kovar Toryi IV 500 General name: Oktocog beta (genetically modified) |
| 2016-700136 (○) | JP4257685 | Name of sale: Kovar Tory IV 250 General name: Oktocog beta (genetically modified) |
| 2016-700136 (■) | JP4257685 | Name of sale: Kovar Tory IV 250 General name: Oktocog beta (genetically modified) |
| 2016-700135 (○) | JP5837095 | Name of sale: Dicadia Capsule 150 mg General name: seritinib |
| 2016-700135 (■) | JP5837095 | Name of sale: Dicadia Capsule 150 mg General name: seritinib |
| 2016-700134 (○) | JP4634367 | Name of sale: Dicadia Capsule 150 mg General name: seritinib |
| 2016-700134 (■) | JP4634367 | Name of sale: Dicadia Capsule 150 mg General name: seritinib |
| 2016-700133 (○) | JP4607879 | Name of sale: Dicadia Capsule 150 mg General name: seritinib |
| 2016-700133 (■) | JP4607879 | Name of sale: Dicadia Capsule 150 mg General name: seritinib |
| 2016-700132 (○) | JP4796487 | Name of sale: Dicadia Capsule 150 mg General name: seritinib |
| 2016-700132 (■) | JP4796487 | Name of sale: Dicadia Capsule 150 mg General name: seritinib |
| 2016-700131 (○) | JP5208123 | Name of sale: Dicadia Capsule 150 mg General name: seritinib |
| 2016-700131 (■) | JP5208123 | Name of sale: Dicadia Capsule 150 mg General name: seritinib |
| 2016-700130 (○) | JP5859166 | Name of sale: Potassium iodide internal medicine jelly 16.3mg "Nichikoko" Name of active ingredient: Potassium iodide |
| 2016-700130 (■) | JP5859166 | Name of sale: Potassium iodide Idol jelly 16.3mg "Nichikoko" Ingredient of active ingredient: Potassium iodide |
| 2016-700129 (○) | JP5805897 | Name of sale: Potassium iodide internal medicine jelly 16.3mg "Nichikoko" Name of active ingredient: Potassium iodide |
| 2016-700129 (■) | JP5805897 | Name of sale: Potassium iodide internal medicine jelly 16.3mg "Nichikoko" Name of active ingredient: Potassium iodide |
| 2016-700128 (○) | JP3665498 | Name of sale: Potassium iodide internal medicine jelly 16.3mg "Nichikoko" Name of active ingredient: Potassium iodide |
| 2016-700128 (■) | JP3665498 | Name of sale: Potassium iodide internal medicine jelly 16.3mg "Nichikoko" Name of active ingredient: Potassium iodide |
| 2016-700127 (○) | JP5058151 | General name: Asenapine Maleate Sublingual Tablet Name: Cicrest Sublingual Tablet 10 mg Active Ingredients: Asenapine Maleate |
| 2016-700127 (■) | JP5058151 | Common Name: Asenapine Maleate Sublingual Tablet Name: Cicrest Sublingual Tablet 10 mg Active Ingredient: Asenapine Maleic Acid |
| 2016-700126 (○) | JP5058151 | General name: Asenapine Maleate Sublingual Tablet Name: Cicrest Sublingual Tablet 5 mg Active Ingredient: Asenapine Maleate |
| 2016-700126 (■) | JP5058151 | General name: Asenapine Maleate Sublingual Tablet Name: Shicrest Sublingual Tablet 5 mg Active Ingredient: Asenapine Maleic Salt |
| 2016-700125 (○) | JP5726206 | ABILIFY 400mg Syringe for Continuous Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700125 (■) | JP5726206 | ABILIFY 400mg Syringe for Continuous Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700124 (○) | JP5726206 | ABILIFY 300mg Syringe for Permanent Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700124 (■) | JP5726206 | ABILIFY 300mg Syringe for Permanent Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700123 (○) | JP4902945 | ABILIFY lasting water suspension injection 400 mg (common name: aripiprazole hydrate) |
| 2016-700123 (■) | JP4902945 | ABILIFY lasting water suspension injection 400 mg (common name: aripiprazole hydrate) |
| 2016-700122 (○) | JP4902945 | ABILIFY lasting water suspension injection 300 mg (common name: aripiprazole hydrate) |
| 2016-700122 (■) | JP4902945 | ABILIFY lasting water suspension injection 300 mg (common name: aripiprazole hydrate) |
| 2016-700121 (○) | JP4902945 | ABILIFY 400mg Syringe for Continuous Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700121 (■) | JP4902945 | ABILIFY 400mg Syringe for Continuous Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700120 (○) | JP4902945 | ABILIFY 300mg Syringe for Permanent Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700120 (■) | JP4902945 | ABILIFY 300mg Syringe for Permanent Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700119 (○) | JP5683010 | ABILIFY lasting water suspension injection 400 mg (common name: aripiprazole hydrate) |
| 2016-700118 (○) | JP5683010 | ABILIFY lasting water suspension injection 300 mg (common name: aripiprazole hydrate) |
| 2016-700117 (○) | JP5683010 | ABILIFY 400mg Syringe for Continuous Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700116 (○) | JP5683010 | ABILIFY 300mg Syringe for Permanent Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700115 (○) | JP4879349 | ABILIFY lasting water suspension injection 400 mg (common name: aripiprazole hydrate) |
| 2016-700115 (■) | JP4879349 | ABILIFY lasting water suspension injection 400 mg (common name: aripiprazole hydrate) |
| 2016-700114 (○) | JP4879349 | ABILIFY lasting water suspension injection 300 mg (common name: aripiprazole hydrate) |
| 2016-700114 (■) | JP4879349 | ABILIFY lasting water suspension injection 300 mg (common name: aripiprazole hydrate) |
| 2016-700113 (○) | JP4879349 | ABILIFY 400mg Syringe for Continuous Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700113 (■) | JP4879349 | ABILIFY 400mg Syringe for Continuous Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700112 (○) | JP4879349 | ABILIFY 300mg Syringe for Permanent Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700112 (■) | JP4879349 | ABILIFY 300mg Syringe for Permanent Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700111 (○) | JP5300194 | ABILIFY lasting water suspension injection 400 mg (common name: aripiprazole hydrate) |
| 2016-700111 (■) | JP5300194 | ABILIFY lasting water suspension injection 400 mg (common name: aripiprazole hydrate) |
| 2016-700110 (○) | JP5300194 | ABILIFY lasting water suspension injection 300 mg (common name: aripiprazole hydrate) |
| 2016-700110 (■) | JP5300194 | ABILIFY lasting water suspension injection 300 mg (common name: aripiprazole hydrate) |
| 2016-700109 (○) | JP5300194 | ABILIFY 400mg Syringe for Continuous Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700109 (■) | JP5300194 | ABILIFY 400mg Syringe for Continuous Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700108 (○) | JP5300194 | ABILIFY 300mg Syringe for Permanent Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700108 (■) | JP5300194 | ABILIFY 300mg Syringe for Permanent Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700107 (○) | JP5453194 | ABILIFY lasting water suspension injection 400 mg (common name: aripiprazole hydrate) |
| 2016-700107 (■) | JP5453194 | ABILIFY lasting water suspension injection 400 mg (common name: aripiprazole hydrate) |
| 2016-700106 (○) | JP5453194 | ABILIFY lasting water suspension injection 300 mg (common name: aripiprazole hydrate) |
| 2016-700106 (■) | JP5453194 | ABILIFY lasting water suspension injection 300 mg (common name: aripiprazole hydrate) |
| 2016-700105 (○) | JP5453194 | ABILIFY 400mg Syringe for Continuous Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700105 (■) | JP5453194 | ABILIFY 400mg Syringe for Continuous Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700104 (○) | JP5453194 | ABILIFY 300mg Syringe for Permanent Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700104 (■) | JP5453194 | ABILIFY 300mg Syringe for Permanent Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700103 (○) | JP5372032 | ABILIFY lasting water suspension injection 400 mg (common name: aripiprazole hydrate) |
| 2016-700103 (■) | JP5372032 | ABILIFY lasting water suspension injection 400 mg (common name: aripiprazole hydrate) |
| 2016-700102 (○) | JP5372032 | ABILIFY lasting water suspension injection 300 mg (common name: aripiprazole hydrate) |
| 2016-700102 (■) | JP5372032 | ABILIFY lasting water suspension injection 300 mg (common name: aripiprazole hydrate) |
| 2016-700101 (○) | JP5372032 | ABILIFY 400mg Syringe for Continuous Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700101 (■) | JP5372032 | ABILIFY 400mg Syringe for Continuous Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700100 (○) | JP5372032 | ABILIFY 300mg Syringe for Permanent Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700100 (■) | JP5372032 | ABILIFY 300mg Syringe for Permanent Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700099 (○) | JP4836797 | ABILIFY lasting water suspension injection 400 mg (common name: aripiprazole hydrate) |
| 2016-700099 (■) | JP4836797 | ABILIFY lasting water suspension injection 400 mg (common name: aripiprazole hydrate) |
| 2016-700098 (○) | JP4836797 | ABILIFY lasting water suspension injection 300 mg (common name: aripiprazole hydrate) |
| 2016-700098 (■) | JP4836797 | ABILIFY lasting water suspension injection 300 mg (common name: aripiprazole hydrate) |
| 2016-700097 (○) | JP4836797 | ABILIFY 400mg Syringe for Continuous Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700097 (■) | JP4836797 | ABILIFY 400mg Syringe for Continuous Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700096 (○) | JP4836797 | ABILIFY 300mg Syringe for Permanent Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700096 (■) | JP4836797 | ABILIFY 300mg Syringe for Permanent Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700095 (○) | JP3760264 | ABILIFY lasting water suspension injection 400 mg (common name: aripiprazole hydrate) |
| 2016-700095 (■) | JP3760264 | ABILIFY lasting water suspension injection 400 mg (common name: aripiprazole hydrate) |
| 2016-700094 (○) | JP3760264 | ABILIFY lasting water suspension injection 300 mg (common name: aripiprazole hydrate) |
| 2016-700094 (■) | JP3760264 | ABILIFY lasting water suspension injection 300 mg (common name: aripiprazole hydrate) |
| 2016-700093 (○) | JP3760264 | ABILIFY 400mg Syringe for Continuous Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700093 (■) | JP3760264 | ABILIFY 400mg Syringe for Continuous Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700092 (○) | JP3760264 | ABILIFY 300mg Syringe for Permanent Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700092 (■) | JP3760264 | ABILIFY 300mg Syringe for Permanent Suspension Injection (General name: aripiprazole hydrate) |
| 2016-700091 (○) | JP5366233 | Product Name: Risperdal OD Tablet 2 mg Common Name: Risperidone Chemical Name: 3- {2- [4- (6-Fluoro-1,2-benzisoxazol-3-yl) piperidin-1-yl ] Ethyl} -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one |
| 2016-700091 (■) | JP5366233 | Product Name: Risperdal OD Tablet 2 mg Common Name: Risperidone Chemical Name: 3- {2- [4- (6-Fluoro-1,2-benzisoxazol-3-yl) piperidin-1-yl ] Ethyl} -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one |
| 2016-700090 (○) | JP5366233 | Product Name: Risperdal OD Tablet 1 mg Common Name: Risperidone Chemical Name: 3- {2- [4- (6-Fluoro-1,2-benzisoxazol-3-yl) piperidin-1-yl ] Ethyl} -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one |
| 2016-700090 (■) | JP5366233 | Product Name: Risperdal OD Tablet 1 mg Common Name: Risperidone Chemical Name: 3- {2- [4- (6-Fluoro-1,2-benzisoxazol-3-yl) piperidin-1-yl ] Ethyl} -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one |
| 2016-700089 (○) | JP5366233 | Product Name: Risperdal OD Tablet 0.5 mg Common Name: Risperidone Chemical Name: 3- {2- [4- (6-Fluoro-1,2-benzisoxazol-3-yl) piperidine-1 -Yl] ethyl} -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one |
| 2016-700089 (■) | JP5366233 | Product Name: Risperdal OD Tablet 0.5 mg Common Name: Risperidone Chemical Name: 3- {2- [4- (6-Fluoro-1,2-benzisoxazol-3-yl) piperidine-1 -Yl] ethyl} -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one |
| 2016-700088 (○) | JP5275815 | Product Name: Risperdal OD Tablet 2 mg Common Name: Risperidone Chemical Name: 3- {2- [4- (6-Fluoro-1,2-benzisoxazol-3-yl) piperidin-1-yl ] Ethyl} -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one |
| 2016-700088 (■) | JP5275815 | Product Name: Risperdal OD Tablet 2 mg Common Name: Risperidone Chemical Name: 3- {2- [4- (6-Fluoro-1,2-benzisoxazol-3-yl) piperidin-1-yl ] Ethyl} -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one |
| 2016-700087 (○) | JP5275815 | Product Name: Risperdal OD Tablet 1 mg Common Name: Risperidone Chemical Name: 3- {2- [4- (6-Fluoro-1,2-benzisoxazol-3-yl) piperidin-1-yl ] Ethyl} -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one |
| 2016-700087 (■) | JP5275815 | Product Name: Risperdal OD Tablet 1 mg Common Name: Risperidone Chemical Name: 3- {2- [4- (6-Fluoro-1,2-benzisoxazol-3-yl) piperidin-1-yl ] Ethyl} -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one |
| 2016-700086 (○) | JP5275815 | Product Name: Risperdal OD Tablet 0.5 mg Common Name: Risperidone Chemical Name: 3- {2- [4- (6-Fluoro-1,2-benzoisoxazol-3-yl) piperidine-1 -Yl] ethyl} -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one |
| 2016-700086 (■) | JP5275815 | Product Name: Risperdal OD Tablet 0.5 mg Common Name: Risperidone Chemical Name: 3- {2- [4- (6-Fluoro-1,2-benzoisoxazol-3-yl) piperidine-1 -Yl] ethyl} -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one |
| 2016-700085 (○) | JP5569916 | Name: Risperdal OD Tablet 2 mg Common Name: Risperidone Chemical Name: 3- {2- [4- (6-Fluoro-1,2-benzisoxazol-3-yl) piperidin-1-yl ] Ethyl} -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one |
| 2016-700085 (■) | JP5569916 | Name: Risperdal OD Tablet 2 mg Common Name: Risperidone Chemical Name: 3- {2- [4- (6-Fluoro-1,2-benzisoxazol-3-yl) piperidin-1-yl ] Ethyl} -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one |
| 2016-700084 (○) | JP5569916 | Product Name: Risperdal OD Tablet 1 mg Common Name: Risperidone Chemical Name: 3- {2- [4- (6-Fluoro-1,2-benzisoxazol-3-yl) piperidin-1-yl ] Ethyl} -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one |
| 2016-700084 (■) | JP5569916 | Product Name: Risperdal OD Tablet 1 mg Common Name: Risperidone Chemical Name: 3- {2- [4- (6-Fluoro-1,2-benzisoxazol-3-yl) piperidin-1-yl ] Ethyl} -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one |
| 2016-700083 (○) | JP5569916 | Product Name: Risperdal OD Tablet 0.5 mg Common Name: Risperidone Chemical Name: 3- {2- [4- (6-Fluoro-1,2-benzoisoxazol-3-yl) piperidine-1 -Yl] ethyl} -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one |
| 2016-700083 (■) | JP5569916 | Product Name: Risperdal OD Tablet 0.5 mg Common Name: Risperidone Chemical Name: 3- {2- [4- (6-Fluoro-1,2-benzoisoxazol-3-yl) piperidine-1 -Yl] ethyl} -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one |
| 2016-700082 (○) | JP4361545 | Name of sale: Opdivo IV 100 mg Active ingredient name: Nivolumab (genetically modified) |
| 2016-700082 (■) | JP4361545 | Name of sale: Opdivo IV 100 mg Active ingredient name: Nivolumab (genetically modified) |
| 2016-700081 (○) | JP4361545 | Name of Sale: Opdivo Intravenous Drip Injection 20mg Active Ingredient Name: Nivolumab (genetically modified) |
| 2016-700081 (■) | JP4361545 | Name of Sale: Opdivo Intravenous Drip Injection 20mg Active Ingredient Name: Nivolumab (genetically modified) |
| 2016-700080 (○) | JP5859166 | Name of sale: Potassium iodide internal medicine jelly 32.6mg "Nichikoko" Ingredient name of active ingredient: Potassium iodide |
| 2016-700080 (■) | JP5859166 | Name of sale: Potassium iodide oral jelly 32.5mg "Nichikoko" Ingredient name of active ingredient: Potassium iodide |
| 2016-700079 (○) | JP5805897 | Name of sale: Potassium iodide internal medicine jelly 32.6mg "Nichikoko" Ingredient name of active ingredient: Potassium iodide |
| 2016-700079 (■) | JP5805897 | Name of sale: Potassium iodide oral jelly 32.5mg "Nichikoko" Ingredient name of active ingredient: Potassium iodide |
| 2016-700078 (○) | JP3665498 | Name of sale: Potassium iodide internal medicine jelly 32.6mg "Nichikoko" Ingredient name of active ingredient: Potassium iodide |
| 2016-700078 (■) | JP3665498 | Name of sale: Potassium iodide oral jelly 32.5mg "Nichikoko" Ingredient name of active ingredient: Potassium iodide |
| 2016-700077 (○) | JP4409430 | Name of Sale: Opdivo Intravenous Drip Injection 100mg Active Ingredient: Nivolumab (genetically modified) |
| 2016-700077 (■) | JP4409430 | Name of Sale: Opdivo Intravenous Drip Injection 100mg Active Ingredient: Nivolumab (genetically modified) |
| 2016-700076 (○) | JP4409430 | Name of Sale: Opdivo Intravenous Drip Injection 20mg Active Ingredient: Nivolumab (genetically modified) |
| 2016-700076 (■) | JP4409430 | Name of Sale: Opdivo Intravenous Drip Injection 20mg Active Ingredient: Nivolumab (genetically modified) |
| 2016-700075 (○) | JP5215666 | Sorafenib tosylate (brand name: Nexavar Tablet 200 mg) |
| 2016-700075 (■) | JP5215666 | Sorafenib tosylate (brand name: Nexavar Tablet 200 mg) |
| 2016-700074 (○) | JP5304241 | Sorafenib tosylate (brand name: Nexavar Tablet 200 mg) |
| 2016-700074 (■) | JP5304241 | Sorafenib tosylate (brand name: Nexavar Tablet 200 mg) |
| 2016-700073 (○) | JP3845792 | Sorafenib tosylate (brand name: Nexavar Tablet 200 mg) |
| 2016-700073 (■) | JP3845792 | Sorafenib tosylate (brand name: Nexavar Tablet 200 mg) |
| 2016-700072 (○) | JP5538309 | Name of sale: Orensea hypodermic injection 125 mg Autoinjector 1 mL Active ingredient · Common name: Abatacept (genetically modified) |
| 2016-700072 (■) | JP5538309 | Name of sale: Orensea hypodermic injection 125 mg Autoinjector 1 mL Active ingredient · Common name: Abatacept (genetically modified) |
| 2016-700071 (○) | JP5097194 | Name of sale: Orensea hypodermic injection 125 mg Autoinjector 1 mL Active ingredient · Common name: Abatacept (genetically modified) |
| 2016-700071 (■) | JP5097194 | Name of sale: Orensea hypodermic injection 125 mg Autoinjector 1 mL Active ingredient · Common name: Abatacept (genetically modified) |
| 2016-700070 (○) | JP5247467 | Name of sale: Orensea hypodermic injection 125 mg Autoinjector 1 mL Active ingredient · Common name: Abatacept (genetically modified) |
| 2016-700070 (■) | JP5247467 | Name of sale: Orensea hypodermic injection 125 mg Autoinjector 1 mL Active ingredient · Common name: Abatacept (genetically modified) |
| 2016-700069 (○) | JP5096369 | Name of sale: Orensea hypodermic injection 125 mg Autoinjector 1 mL Active ingredient · Common name: Abatacept (genetically modified) |
| 2016-700069 (■) | JP5096369 | Name of sale: Orensea hypodermic injection 125 mg Autoinjector 1 mL Active ingredient · Common name: Abatacept (genetically modified) |
| 2016-700068 (○) | JP5226304 | Haraven IV 1 mg |
| 2016-700068 (■) | JP5226304 | Haraven IV 1 mg |
| 2016-700067 (○) | JP5062940 | Product Name: Crestor OD Tablet 5 mg Common Name: Rosuvastatin Calcium Chemical Name: Bis ((3R, 5S, 6E) -7- {4- (4-Fluorophenyl) -6-isopropyl-2- [ Methanesulfonyl (methyl) amino] pyrimidin-5-yl} -3,5-dihydroxyhept-6-enoic acid) calcium |
| 2016-700067 (■) | JP5062940 | Product Name: Crestor OD Tablet 5 mg Common Name: Rosuvastatin Calcium Chemical Name: Bis ((3R, 5S, 6E) -7- {4- (4-Fluorophenyl) -6-isopropyl-2- [ Methanesulfonyl (methyl) amino] pyrimidin-5-yl} -3,5-dihydroxyhept-6-enoic acid) calcium |
| 2016-700066 (○) | JP5062940 | Product Name: Crestor OD Tablet 2.5 mg Common Name: Rosuvastatin Calcium Chemical Name: Bis ((3R, 5S, 6E) -7- {4- (4-Fluorophenyl) -6-isopropyl-2 -[Methanesulfonyl (methyl) amino] pyrimidin-5-yl} -3,5-dihydroxyhept-6-enoic acid) calcium |
| 2016-700066 (■) | JP5062940 | Product Name: Crestor OD Tablet 2.5 mg Common Name: Rosuvastatin Calcium Chemical Name: Bis ((3R, 5S, 6E) -7- {4- (4-Fluorophenyl) -6-isopropyl-2 -[Methanesulfonyl (methyl) amino] pyrimidin-5-yl} -3,5-dihydroxyhept-6-enoic acid) calcium |
| 2016-700065 (○) | JP5366233 | Product Name: Crestor OD Tablet 5 mg Common Name: Rosuvastatin Calcium Chemical Name: Bis ((3R, 5S, 6E) -7- {4- (4-Fluorophenyl) -6-isopropyl-2- [ Methanesulfonyl (methyl) amino] pyrimidin-5-yl} -3,5-dihydroxyhept-6-enoic acid) calcium |
| 2016-700065 (■) | JP5366233 | Product Name: Crestor OD Tablet 5 mg Common Name: Rosuvastatin Calcium Chemical Name: Bis ((3R, 5S, 6E) -7- {4- (4-Fluorophenyl) -6-isopropyl-2- [ Methanesulfonyl (methyl) amino] pyrimidin-5-yl} -3,5-dihydroxyhept-6-enoic acid) calcium |
| 2016-700064 (○) | JP5366233 | Product Name: Crestor OD Tablet 2.5 mg Common Name: Rosuvastatin Calcium Chemical Name: Bis ((3R, 5S, 6E) -7- {4- (4-Fluorophenyl) -6-isopropyl-2 -[Methanesulfonyl (methyl) amino] pyrimidin-5-yl} -3,5-dihydroxyhept-6-enoic acid) calcium |
| 2016-700064 (■) | JP5366233 | Product Name: Crestor OD Tablet 2.5 mg Common Name: Rosuvastatin Calcium Chemical Name: Bis ((3R, 5S, 6E) -7- {4- (4-Fluorophenyl) -6-isopropyl-2- [methane Sulfonyl (methyl) amino] pyrimidin-5-yl} -3,5-dihydroxyhept-6-enoic acid) calcium |
| 2016-700063 (○) | JP5557989 | Name of sale: Bonviva tablet 100 mg Active ingredient: ibandronate sodium hydrate |
| 2016-700063 (■) | JP5557989 | Name of sale: Bonviva tablet 100 mg Active ingredient: ibandronate sodium hydrate |
| 2016-700062 (○) | JP5345937 | Name: Luconac nail solution 5% General name: luliconazole |
| 2016-700062 (■) | JP5345937 | Name: Luconac nail solution 5% General name: luliconazole |
| 2016-700061 (○) | JP5184342 | Name: Luconac nail solution 5% General name: luliconazole |
| 2016-700061 (■) | JP5184342 | Name: Luconac nail solution 5% General name: luliconazole |
| 2016-700060 (○) | JP5184341 | Name: Luconac nail solution 5% General name: luliconazole |
| 2016-700060 (■) | JP5184341 | Name: Luconac nail solution 5% General name: luliconazole |
| 2016-700059 (○) | JP5160409 | Name: Luconac nail solution 5% General name: luliconazole |
| 2016-700059 (■) | JP5160409 | Name: Luconac nail solution 5% General name: luliconazole |
| 2016-700058 (○) | JP5589130 | Name: Luconac nail solution 5% General name: luliconazole |
| 2016-700058 (■) | JP5589130 | Name: Luconac nail solution 5% General name: luliconazole |
| 2016-700057 (○) | JP5453559 | Name: Luconac nail solution 5% General name: luliconazole |
| 2016-700057 (■) | JP5453559 | Name: Luconac nail solution 5% General name: luliconazole |
| 2016-700056 (○) | JP5441905 | Name of sale: Repatha subcutaneous injection 140 mg pen Active ingredient: Evolocumab (genetically modified) |
| 2016-700056 (■) | JP5441905 | Name of sale: Repatha subcutaneous injection 140 mg pen Active ingredient: Evolocumab (genetically modified) |
| 2016-700055 (○) | JP5441905 | Name of sale: Repatha subcutaneous injection 140 mg syringe Active ingredient: Evolocumab (genetically modified) |
| 2016-700055 (■) | JP5441905 | Name of sale: Repatha subcutaneous injection 140 mg syringe Active ingredient: Evolocumab (genetically modified) |
| 2016-700054 (○) | JP4454151 | Haraven IV 1 mg |
| 2016-700054 (■) | JP4454151 | Haraven IV 1 mg |
| 2016-700053 (○) | JP5837552 | Name of sale: Bonviva tablet 100 mg Active ingredient: ibandronate sodium hydrate |
| 2016-700053 (■) | JP5837552 | Name of sale: Bonviva tablet 100 mg Active ingredient: ibandronate sodium hydrate |
| 2016-700052 (○) | JP4274453 | Name of sale: Bonviva tablet 100 mg Active ingredient: ibandronate sodium hydrate |
| 2016-700052 (■) | JP4274453 | Name of sale: Bonviva tablet 100 mg Active ingredient: ibandronate sodium hydrate |
| 2016-700051 (○) | JP5363307 | Name of sale: EFIENT Tablets 20 mg Active ingredient: Prasugrel hydrochloride |
| 2016-700051 (■) | JP5363307 | Name of sale: EFIENT Tablets 20 mg Active ingredient: Prasugrel hydrochloride |
| 2016-700050 (○) | JP5274261 | Name of sale: EFIENT Tablets 20 mg Active ingredient: Prasugrel hydrochloride |
| 2016-700050 (■) | JP5274261 | Name of sale: EFIENT Tablets 20 mg Active ingredient: Prasugrel hydrochloride |
| 2016-700049 (○) | JP5289975 | Name of sale: EFIENT Tablets 20 mg Active ingredient: Prasugrel hydrochloride |
| 2016-700049 (■) | JP5289975 | Name of sale: EFIENT Tablets 20 mg Active ingredient: Prasugrel hydrochloride |
| 2016-700048 (○) | JP4029974 | Name of sale: EFIENT Tablets 20 mg Active ingredient: Prasugrel hydrochloride |
| 2016-700048 (■) | JP4029974 | Name of sale: EFIENT Tablets 20 mg Active ingredient: Prasugrel hydrochloride |
| 2016-700047 (○) | JP4874482 | Name of sale: EFIENT Tablets 20 mg Active ingredient: Prasugrel hydrochloride |
| 2016-700047 (■) | JP4874482 | Name of sale: EFIENT Tablets 20 mg Active ingredient: Prasugrel hydrochloride |
| 2016-700046 (○) | JP4001199 | Name of sale: EFIENT Tablets 20 mg Active ingredient: Prasugrel hydrochloride |
| 2016-700046 (■) | JP4001199 | Name of sale: EFIENT Tablets 20 mg Active ingredient: Prasugrel hydrochloride |
| 2016-700045 (○) | JP3996944 | Name of Sale: Kick Lynn Capsule 250mg Common Name of Active Ingredient: Bixalomer |
| 2016-700045 (■) | JP3996944 | Name of Sale: Kick Lynn Capsule 250mg Common Name of Active Ingredient: Bixalomer |
| 2016-700044 (○) | JP5713421 | General name: miglitol (brand name: Sable OD tablet 25 mg) |
| 2016-700044 (■) | JP5713421 | General name: miglitol (brand name: Sable OD tablet 25 mg) |
| 2016-700043 (○) | JP5846647 | Name of sale: ERICIUS Tablet 5mg Active ingredient ・ General name: Apixaban |
| 2016-700043 (■) | JP5846647 | Name of sale: ERICIUS Tablet 5mg Active ingredient ・ General name: Apixaban |
| 2016-700042 (○) | JP5846647 | Name of sale: ERICIUS Tablet 2.5 mg Active ingredient ・ General name: Apixaban |
| 2016-700042 (■) | JP5846647 | Name of sale: ERICIUS Tablet 2.5 mg Active ingredient ・ General name: Apixaban |
| 2016-700041 (○) | JP4249621 | Name of sale: ERICIUS Tablet 5mg Active ingredient ・ General name: Apixaban |
| 2016-700041 (■) | JP4249621 | Name of sale: ERICIUS Tablet 5mg Active ingredient ・ General name: Apixaban |
| 2016-700040 (○) | JP4249621 | Name of sale: ERICIUS Tablet 2.5 mg Active ingredient ・ General name: Apixaban |
| 2016-700040 (■) | JP4249621 | Name of sale: ERICIUS Tablet 2.5 mg Active ingredient ・ General name: Apixaban |
| 2016-700039 (○) | JP5213847 | Types of pesticides: Flupyra di fron granules Name of pesticides: Shivanto box granules Active ingredients Compounds: 4-[(6-chloro-3-pyridylmethyl) (2, 2-difluoroethyl) amino] furan- 2 (5H)-on (General name: flupyrazifron) |
| 2016-700039 (■) | JP5213847 | Flupyradifron granules |
| 2016-700038 (○) | JP4733037 | Name of sale: Revlimid capsule 5 mg Active ingredient: Lenalidomide hydrate |
| 2016-700038 (■) | JP4733037 | Name of sale: Revlimid capsule 5 mg Active ingredient: Lenalidomide hydrate |
| 2016-700037 (○) | JP4733037 | Name of sale: Revlimid capsule 2.5 mg Active ingredient: Lenalidomide hydrate |
| 2016-700037 (■) | JP4733037 | Name of sale: Revlimid capsule 2.5 mg Active ingredient: Lenalidomide hydrate |
| 2016-700036 (○) | JP4065567 | Name of sale: Revlimid capsule 5 mg Active ingredient: Lenalidomide hydrate |
| 2016-700036 (■) | JP4065567 | Name of sale: Revlimid capsule 5 mg Active ingredient: Lenalidomide hydrate |
| 2016-700035 (○) | JP4065567 | Name of sale: Revlimid capsule 2.5 mg Active ingredient: Lenalidomide hydrate |
| 2016-700035 (■) | JP4065567 | Name of sale: Revlimid capsule 2.5 mg Active ingredient: Lenalidomide hydrate |
| 2016-700034 (○) | JP4361545 | Name of sale: Opdivo IV 100 mg Active ingredient name: Nivolumab (genetically modified) |
| 2016-700034 (■) | JP4361545 | Name of sale: Opdivo IV 100 mg Active ingredient name: Nivolumab (genetically modified) |
| 2016-700033 (○) | JP4361545 | Name of Sale: Opdivo Intravenous Drip Injection 20mg Active Ingredient Name: Nivolumab (genetically modified) |
| 2016-700033 (■) | JP4361545 | Name of Sale: Opdivo Intravenous Drip Injection 20mg Active Ingredient Name: Nivolumab (genetically modified) |
| 2016-700032 (○) | JP5537740 | Name of sale: Cosentertics for subcutaneous injection 150 mg Common name: Sequkinumab (genetically modified) |
| 2016-700032 (■) | JP5537740 | Name of sale: Cosentertics for subcutaneous injection 150 mg Common name: Sequkinumab (genetically modified) |
| 2016-700031 (○) | JP5537740 | Name of sale: Cosentix subcutaneous injection 150 mg syringe Common name: Sequkinumab (genetically modified) |
| 2016-700031 (■) | JP5537740 | Name of sale: Cosentix subcutaneous injection 150 mg syringe Common name: Sequkinumab (genetically modified) |
| 2016-700030 (○) | JP4682200 | Name of sale: Cosentertics for subcutaneous injection 150 mg Common name: Sequkinumab (genetically modified) |
| 2016-700030 (■) | JP4682200 | Name of sale: Cosentertics for subcutaneous injection 150 mg Common name: Sequkinumab (genetically modified) |
| 2016-700029 (○) | JP4682200 | Name of sale: Cosentix subcutaneous injection 150 mg syringe Common name: Sequkinumab (genetically modified) |
| 2016-700029 (■) | JP4682200 | Name of sale: Cosentix subcutaneous injection 150 mg syringe Common name: Sequkinumab (genetically modified) |
| 2016-700028 (○) | JP5159730 | Name of Sale: Opdivo Intravenous Drip Injection 100mg Active Ingredient: Nivolumab (genetically modified) |
| 2016-700028 (■) | JP5159730 | Name of Sale: Opdivo Intravenous Drip Injection 100mg Active Ingredient: Nivolumab (genetically modified) |
| 2016-700027 (○) | JP5159730 | Name of Sale: Opdivo Intravenous Drip Injection 20mg Active Ingredient: Nivolumab (genetically modified) |
| 2016-700027 (■) | JP5159730 | Name of Sale: Opdivo Intravenous Drip Injection 20mg Active Ingredient: Nivolumab (genetically modified) |
| 2016-700026 (○) | JP3278738 | Luconac nail external solution 5% luriconazole |
| 2016-700026 (■) | JP3278738 | Luconac nail external solution 5% luriconazole |
| 2016-700025 (○) | JP4184378 | General name: anagliptin (sale name: Swinee Tablet 100 mg) |
| 2016-700025 (■) | JP4184378 | General name: anagliptin (sale name: swiney tablet 100 mg) |
| 2016-700024 (○) | JP5311742 | Active Ingredients: Rivaroxaban Name: Xarelto Fine Granules 10 mg |
| 2016-700024 (■) | JP5311742 | Active Ingredients: Rivaroxaban Name: Xarelto Fine Granules 10 mg |
| 2016-700023 (○) | JP5311742 | Active Ingredients: Rivaroxaban Name: Xizarelto Fine Granule 15 mg |
| 2016-700023 (■) | JP5311742 | Active Ingredients: Rivaroxaban Name: Xizarelto Fine Granule 15 mg |
| 2016-700022 (○) | JP4852423 | Active Ingredients: Rivaroxaban Name: Xarelto Fine Granules 10 mg |
| 2016-700022 (■) | JP4852423 | Active Ingredients: Rivaroxaban Name: Xarelto Fine Granules 10 mg |
| 2016-700021 (○) | JP4852423 | Active Ingredients: Rivaroxaban Name: Xizarelto Fine Granule 15 mg |
| 2016-700021 (■) | JP4852423 | Active Ingredients: Rivaroxaban Name: Xizarelto Fine Granule 15 mg |
| 2016-700020 (○) | JP4143297 | Name of sale: Xazarelt fine particle package 10mg |
| 2016-700020 (■) | JP4143297 | Active Ingredients: Rivaroxaban Name: Xarelto Fine Granules 10 mg |
| 2016-700019 (○) | JP4143297 | Active Ingredients: Rivaroxaban Name: Xizarelto Fine Granule 15 mg |
| 2016-700019 (■) | JP4143297 | Active Ingredients: Rivaroxaban Name: Xizarelto Fine Granule 15 mg |
| 2016-700018 (○) | JP3390741 | Name of sale: Tykerb Tablet 250 mg Common name of active ingredient: Lapatinib tosylate hydrate |
| 2016-700018 (■) | JP3390741 | Name of sale: Tykerb Tablet 250 mg Common name of active ingredient: Lapatinib tosylate hydrate |
| 2016-700017 (○) | JP4102185 | Name of sale: Tykerb Tablet 250 mg Common name of active ingredient: Lapatinib tosylate hydrate |
| 2016-700017 (■) | JP4102185 | Name of sale: Tykerb Tablet 250 mg Common name of active ingredient: Lapatinib tosylate hydrate |
| 2016-700016 (○) | JP5202302 | Name of sale: Tykerb Tablet 250 mg Common name of active ingredient: Lapatinib tosylate hydrate |
| 2016-700016 (■) | JP5202302 | Name of sale: Tykerb Tablet 250 mg Common name of active ingredient: Lapatinib tosylate hydrate |
| 2016-700015 (○) | JP4430229 | Name of Sale: ELPLAT Intravenous Drip Solution 200mg Active Ingredient: Oxaliplatin |
| 2016-700014 (○) | JP4430229 | Name of Sale: ELPLAT Intravenous Drip Solution 100mg Active Ingredient: Oxaliplatin |
| 2016-700013 (○) | JP4430229 | Name of sale: ELPLAT Intravenous Drip Solution 50mg Active Ingredient: Oxaliplatin |
| 2016-700012 (○) | JP5719811 | Name of Sale: Rexapro Tablet 10 mg Active Ingredient: Escitalopram oxalate |
| 2016-700011 (○) | JP5192568 | Name of Sale: Rexapro Tablet 10 mg Active Ingredient: Escitalopram oxalate |
| 2016-700011 (■) | JP5192568 | Name of Sale: Rexapro Tablet 10 mg Active Ingredient: Escitalopram oxalate |
| 2016-700010 (○) | JP5100619 | Name of sale: Loxonin S premium Active ingredient: Loxoprofen sodium hydrate allyl isopropyl acetyl urea anhydrous caffeine magnesium aluminometasilicate |
| 2016-700010 (■) | JP5100619 | Name of Sale: Loxonin S Premium Active Ingredient: Loxoprofen Sodium Hydrate Allyl Isopropyl Acetylurea Anhydrous Caffeine Magnesium Aluminate Metasilicate |
| 2016-700009 (○) | JP4936579 | Name of sale: Loxonin S premium Active ingredient: Loxoprofen sodium hydrate allyl isopropyl acetyl urea anhydrous caffeine magnesium aluminometasilicate |
| 2016-700009 (■) | JP4936579 | Name of Sale: Loxonin S Premium Active Ingredient: Loxoprofen Sodium Hydrate Allyl Isopropyl Acetylurea Anhydrous Caffeine Magnesium Aluminate Metasilicate |
| 2016-700008 (○) | JP5013329 | Types of Pesticides Glycerin Acetate Fatty Acid Ester Emulsion Pesticide Name: Bemidecta (Active Ingredient: Acetyl Glycerin = Fatty Acid Ester) |
| 2016-700008 (■) | JP5013329 | Types of pesticides: Glycerin acetic acid fatty acid ester emulsion Name of pesticide: Bemidect (active ingredient: acetyl glycerin = fatty acid ester) |
| 2016-700007 (○) | JP4481828 | Name of sale: Revlimid capsule 2.5 mg Active ingredient: Lenalidomide hydrate |
| 2016-700007 (■) | JP4481828 | Name of sale: Revlimid capsule 2.5 mg Active ingredient: Lenalidomide hydrate |
| 2016-700006 (○) | JP4733037 | Name of sale: Revlimid capsule 2.5 mg Active ingredient: Lenalidomide hydrate |
| 2016-700006 (■) | JP4733037 | Name of sale: Revlimid capsule 2.5 mg Active ingredient: Lenalidomide hydrate |
| 2016-700005 (○) | JP4733037 | Name of sale: Revlimid capsule 2.5 mg Active ingredient: Lenalidomide hydrate |
| 2016-700005 (■) | JP4733037 | Name of sale: Revlimid capsule 2.5 mg Active ingredient: Lenalidomide hydrate |
| 2016-700004 (○) | JP4065567 | Name of sale: Revlimid capsule 2.5 mg Active ingredient: Lenalidomide hydrate |
| 2016-700004 (■) | JP4065567 | Name of sale: Revlimid capsule 2.5 mg Active ingredient: Lenalidomide hydrate |
| 2016-700003 (○) | JP4065567 | Name of sale: Revlimid capsule 2.5 mg Active ingredient: Lenalidomide hydrate |
| 2016-700003 (■) | JP4065567 | Name of sale: Revlimid capsule 2.5 mg Active ingredient: Lenalidomide hydrate |
| 2016-700002 (○) | JP4438919 | Types of Pesticide: Amisulbrom Powder Name of Pesticide: Oracle Powder Type of Active Ingredient: 3- (3-Bromo-6-fluoro-2-methylindol-1-ylsulfonyl) -N, N-dimethyl -1,2,4-Triazole-1-sulfonamide |
| 2016-700002 (■) | JP4438919 | Types of Pesticide: Amisulbrom Powder Name of Pesticide: Oracle Powder Type of Active Ingredient: 3- (3-Bromo-6-fluoro-2-methylindol-1-ylsulfonyl) -N, N-dimethyl -1,2,4-Triazole-1-sulfonamide |
| 2016-700001 (○) | JP4438919 | Types of Pesticides: Amisulbrom Water Hydrate Name of Pesticides: Oracle Granule Water Repellent Types of Active Ingredients: 3- (3-Bromo-6-fluoro-2-methylindol-1-ylsulfonyl)- N, N-Dimethyl-1,2,4-triazole-1-sulfonamide |
| 2016-700001 (■) | JP4438919 | Types of Pesticides: Amisulbrom Water Hydrate Name of Pesticides: Oracle Granule Water Repellent Types of Active Ingredients: 3- (3-Bromo-6-fluoro-2-methylindol-1-ylsulfonyl)- N, N-Dimethyl-1,2,4-triazole-1-sulfonamide |
![[Medical device] Firm Ranking of the number of Japanese granted patents in the Medical device field in 2020](https://japanese-patent.com/wp-content/uploads/2019/01/Medicaldevice-200x200.jpg)
